{
 "cells": [
  {
   "metadata": {
    "collapsed": true,
    "ExecuteTime": {
     "end_time": "2025-05-18T00:01:33.428226Z",
     "start_time": "2025-05-18T00:01:31.339760Z"
    }
   },
   "cell_type": "code",
   "source": [
    "import torch\n",
    "\n",
    "from transformers import AutoModelForCausalLM\n",
    "\n",
    "from data.q_and_a.train_and_eval import TrainAndEval\n",
    "from data.q_and_a.eval_with_answers import EvalWithAnswers\n",
    "\n",
    "from models_.building.pubmed_tokenizer import  load_query_tokenizer as load_tokenizer\n",
    "\n",
    "from data.pubmed.from_json import FromJsonDataset\n",
    "from data.pubmed.contents import ContentsDataset\n",
    "\n",
    "\n",
    "from storage.faiss_ import FaissStorage\n",
    "\n",
    "from rag.tokenization.llama import build_tokenizer_function\n",
    "from rag.quering import build_querier\n",
    "\n",
    "from q_and_a.forward import build_forwarder\n",
    "from q_and_a.prompts import prompt\n",
    "from q_and_a.picking.from_logits import build_from_logits\n",
    "from q_and_a.eval import evaluate"
   ],
   "id": "initial_id",
   "outputs": [],
   "execution_count": 1
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-05-18T00:01:33.766275Z",
     "start_time": "2025-05-18T00:01:33.512594Z"
    }
   },
   "cell_type": "code",
   "source": [
    "device = \"cuda\" if torch.cuda.is_available() else \"cpu\"\n",
    "device"
   ],
   "id": "e0666cbe58586ddf",
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'cuda'"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "execution_count": 2
  },
  {
   "metadata": {},
   "cell_type": "markdown",
   "source": "# Loading data: augmentation and question and answer",
   "id": "655073c16ef21725"
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-05-18T00:01:37.392796Z",
     "start_time": "2025-05-18T00:01:33.776872Z"
    }
   },
   "cell_type": "code",
   "source": [
    "train = TrainAndEval(\"../../data/pubmed_QA_train.json\")\n",
    "evaluationData = TrainAndEval(\"../../data/pubmed_QA_eval.json\")\n",
    "evaluateWithAnswers = EvalWithAnswers(evaluationData)\n",
    "\n",
    "augmented_data = FromJsonDataset(json_file=\"../../data/pubmed_500K.json\")\n",
    "augmented_data = ContentsDataset(augmented_data)"
   ],
   "id": "77a379766b65d5af",
   "outputs": [],
   "execution_count": 3
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-05-18T00:01:37.406596Z",
     "start_time": "2025-05-18T00:01:37.403537Z"
    }
   },
   "cell_type": "code",
   "source": "print(evaluateWithAnswers[0])",
   "id": "36a02355f4f6679f",
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'id': 'pubmed23n0012_5208', 'excerpt': 'Temporal changes in medial basal hypothalamic LH-RH correlated with plasma LH during the rat estrous cycle and following electrochemical stimulation of the medial preoptic area in pentobarbital-treated proestrous rats. In the present studies we have simultaneously measured changes in medial basal hypothalamic (MBH) leutenizing hormone-releasing hormone (LH-RH) and in plasma LH by radioimmunoassay in female rats at various hours during the 4-day estrous cycle and under experimental conditions known to alter pituitary LH secretion. In groups of rats decapitated at 12.00 h and 15.00 h on estrus and diestrus, plasma LH remained at basal levels (5-8 ng/ml) and MBH-LH-RH concentrations showed average steady state concentrations of 2231 +/- 205 pg/mg. On the day of proestrus hourly measurements of MBH-LH-RH between 12.00 h and 21.00 h suggested rhythmic rises and falls in the decapeptide concomitant with rises and falls in plasma LH. In a second group of pentobarbital-anesthetized proestrous rats a significant decline in MBH-LH-RH occurred (to 573 +/- 137 pg/mg) which then remained at low concentrations between 14.00 h and 18.00 h proestrus. Following bilateral preoptic area (MPOA) electrochemical stimulation of pentobarbital-treated proestrous rats, LH was significantly increased by 30 min, peaked between 90-120 min and returned to basal levels by 210 min poststimulation. In the same animals within 15 min poststimulation, MBH-LH-RH increased from the basal concentrations noted after pentobarbital anesthesia to elevated levels comparable to those observed throughout estrus, diestrus and on proestrous morning. Further, as plasma LH rose to peak concentrations and declined to basal plasma values, rhythmic rises and falls in MBH-LH-RH were observed with intervals between pulses of approximately 60 min. Seemingly, hypothalamic LH-RH is released as pulsatile pulses from a releasable pool; this pool is replenished and again LH-RH is discharged in response to constant stimulation by the preoptic brain.', 'statement': 'Temporal fluctuations in medial basal hypothalamic LH-RH levels correlate with plasma LH changes during the rat estrous cycle and following stimulation of the medial preoptic area.', 'question': 'What relationship exists between medial basal hypothalamic LH-RH levels and plasma LH changes during the rat estrous cycle and after stimulation of the medial preoptic area?', 'distractors': ['Medial basal hypothalamic LH-RH levels remain constant throughout the rat estrous cycle and do not affect plasma LH changes.', 'There is no relationship between medial basal hypothalamic LH-RH levels and plasma LH changes during the rat estrous cycle.', 'Increased medial basal hypothalamic LH-RH levels lead to a decrease in plasma LH during the rat estrous cycle.', 'Temporal fluctuations in medial basal hypothalamic LH-RH levels correlate with plasma LH changes during the rat estrous cycle and following stimulation of the medial preoptic area.'], 'options': ['Medial basal hypothalamic LH-RH levels remain constant throughout the rat estrous cycle and do not affect plasma LH changes.', 'There is no relationship between medial basal hypothalamic LH-RH levels and plasma LH changes during the rat estrous cycle.', 'Increased medial basal hypothalamic LH-RH levels lead to a decrease in plasma LH during the rat estrous cycle.', 'Temporal fluctuations in medial basal hypothalamic LH-RH levels correlate with plasma LH changes during the rat estrous cycle and following stimulation of the medial preoptic area.'], 'answer_idx': 3}\n"
     ]
    }
   ],
   "execution_count": 4
  },
  {
   "metadata": {},
   "cell_type": "markdown",
   "source": "# Building the RAG system",
   "id": "4d765b5efcca19a3"
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-05-18T00:01:38.505825Z",
     "start_time": "2025-05-18T00:01:37.452728Z"
    }
   },
   "cell_type": "code",
   "source": [
    "storage = FaissStorage(\n",
    "    dimension=800,\n",
    ")\n",
    "\n",
    "storage.load(\"../../outputs/store/pubmed_500K.index\")\n",
    "\n",
    "tokenizer = load_tokenizer()\n",
    "tokenizer_fn = build_tokenizer_function(tokenizer)\n",
    "\n",
    "querier = build_querier(storage, augmented_data, tokenizer_fn)"
   ],
   "id": "147eaaa63c7ef980",
   "outputs": [],
   "execution_count": 5
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-05-18T00:01:38.567221Z",
     "start_time": "2025-05-18T00:01:38.563413Z"
    }
   },
   "cell_type": "code",
   "source": "tokenizer",
   "id": "575a03bd7d728539",
   "outputs": [
    {
     "data": {
      "text/plain": [
       "BertTokenizerFast(name_or_path='ncbi/MedCPT-Query-Encoder', vocab_size=30522, model_max_length=1000000000000000019884624838656, is_fast=True, padding_side='right', truncation_side='right', special_tokens={'unk_token': '[UNK]', 'sep_token': '[SEP]', 'pad_token': '[PAD]', 'cls_token': '[CLS]', 'mask_token': '[MASK]'}, clean_up_tokenization_spaces=True, added_tokens_decoder={\n",
       "\t0: AddedToken(\"[PAD]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=True),\n",
       "\t1: AddedToken(\"[UNK]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=True),\n",
       "\t2: AddedToken(\"[CLS]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=True),\n",
       "\t3: AddedToken(\"[SEP]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=True),\n",
       "\t4: AddedToken(\"[MASK]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=True),\n",
       "}\n",
       ")"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "execution_count": 6
  },
  {
   "metadata": {},
   "cell_type": "markdown",
   "source": "# Building question and answer system",
   "id": "6f97c28a829420fc"
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-05-18T00:01:41.159517Z",
     "start_time": "2025-05-18T00:01:38.622110Z"
    }
   },
   "cell_type": "code",
   "source": [
    "MODEL_NAME = \"meta-llama/Llama-3.2-1B\"\n",
    "\n",
    "model = AutoModelForCausalLM.from_pretrained(MODEL_NAME, torch_dtype=torch.float16)\n",
    "model = model.to(device)\n",
    "\n",
    "model"
   ],
   "id": "e0ff64cfade0b3c9",
   "outputs": [
    {
     "data": {
      "text/plain": [
       "LlamaForCausalLM(\n",
       "  (model): LlamaModel(\n",
       "    (embed_tokens): Embedding(128256, 2048)\n",
       "    (layers): ModuleList(\n",
       "      (0-15): 16 x LlamaDecoderLayer(\n",
       "        (self_attn): LlamaAttention(\n",
       "          (q_proj): Linear(in_features=2048, out_features=2048, bias=False)\n",
       "          (k_proj): Linear(in_features=2048, out_features=512, bias=False)\n",
       "          (v_proj): Linear(in_features=2048, out_features=512, bias=False)\n",
       "          (o_proj): Linear(in_features=2048, out_features=2048, bias=False)\n",
       "        )\n",
       "        (mlp): LlamaMLP(\n",
       "          (gate_proj): Linear(in_features=2048, out_features=8192, bias=False)\n",
       "          (up_proj): Linear(in_features=2048, out_features=8192, bias=False)\n",
       "          (down_proj): Linear(in_features=8192, out_features=2048, bias=False)\n",
       "          (act_fn): SiLU()\n",
       "        )\n",
       "        (input_layernorm): LlamaRMSNorm((2048,), eps=1e-05)\n",
       "        (post_attention_layernorm): LlamaRMSNorm((2048,), eps=1e-05)\n",
       "      )\n",
       "    )\n",
       "    (norm): LlamaRMSNorm((2048,), eps=1e-05)\n",
       "    (rotary_emb): LlamaRotaryEmbedding()\n",
       "  )\n",
       "  (lm_head): Linear(in_features=2048, out_features=128256, bias=False)\n",
       ")"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "execution_count": 7
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-05-18T00:01:41.168259Z",
     "start_time": "2025-05-18T00:01:41.163860Z"
    }
   },
   "cell_type": "code",
   "source": [
    "question = train[0][\"question\"]\n",
    "question"
   ],
   "id": "3f67d270e97241c2",
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'What did the study reveal about the role of external calcium concentration in the action potential and contraction recovery time of crayfish muscle fibers?'"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "execution_count": 8
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-05-18T00:01:41.226508Z",
     "start_time": "2025-05-18T00:01:41.223051Z"
    }
   },
   "cell_type": "code",
   "source": [
    "answer = train[0][\"statement\"]\n",
    "answer"
   ],
   "id": "982905dc87d0f4c4",
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'The study investigated how changes in external calcium concentration affect the action potential and contraction recovery time in crayfish muscle fibers, revealing that calcium entry through TTS membranes is crucial for excitation-contraction coupling.'"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "execution_count": 9
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-05-18T00:01:41.283526Z",
     "start_time": "2025-05-18T00:01:41.279474Z"
    }
   },
   "cell_type": "code",
   "source": [
    "options = train[0][\"distractors\"]\n",
    "# append the answer to the options\n",
    "options.append(answer)\n",
    "options"
   ],
   "id": "5330e63da28421ba",
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['The study found that increasing external calcium concentration had no effect on the action potential or contraction recovery time in crayfish muscle fibers.',\n",
       " 'The research concluded that magnesium ions play a more significant role than calcium in the action potential and contraction recovery of crayfish muscle fibers.',\n",
       " 'The investigation revealed that external calcium concentration only affects the resting potential of crayfish muscle fibers, not the action potential or contraction recovery.',\n",
       " 'The study investigated how changes in external calcium concentration affect the action potential and contraction recovery time in crayfish muscle fibers, revealing that calcium entry through TTS membranes is crucial for excitation-contraction coupling.']"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "execution_count": 10
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-05-18T00:01:41.718372Z",
     "start_time": "2025-05-18T00:01:41.334803Z"
    }
   },
   "cell_type": "code",
   "source": [
    "augmented_data = querier(question, 5)\n",
    "augmented_data"
   ],
   "id": "d713c963695a4145",
   "outputs": [
    {
     "data": {
      "text/plain": [
       "([171539365888.0,\n",
       "  224323747840.0,\n",
       "  226616344576.0,\n",
       "  232986050560.0,\n",
       "  234069245952.0],\n",
       " [\"3,3'-Diiodothyronine production, a major pathway of peripheral iodothyronine metabolism in man. 3,3'-Diiodothyronine (3,3'-T(2)) has been detected in human serum and in thyroglobulin. However, no quantitative assessment of its clearance rate (CR), production rate (PR), or of the importance of extrathyroidal sources of 3,3'-T(2) relative to direct thyroidal secretion is yet available. This study examines these parameters in seven euthyroid subjects, and in eight athyreotic subjects (H) eumetabolic due to thyroxine therapy (HT(4)) (n = 5) or triiodothyronine replacement (HT(3)) (n = 3). A highly specific radioimmunoassay for the measurement of 3,3'-T(2) in whole serum was developed. Serum 3,3'-T(2) concentrations were (mean +/- SD) 6.0+/-1.0 ng/100 ml in 13 normal subjects, 9.0+/-4.6 ng/100 ml in 25 hyperthyroid patients, and 2.7+/-1.1 ng/100 ml in 17 hypothyroid patients. The values in each of the latter two groups were significantly different from normal. 3,3'-T(2) was detected regularly in normal concentrations in 11 hypothyroid patients eumetabolic by treatment with synthetic T(4), in 10 eumetabolic patients suffering from nonthyroidal systemic illness, and in 2 subjects with elevated serum T(4)-binding globulin. The 3,3'-T(2) CR was assessed from data acquired from the (125)I-3,3'-T(2) constant infusion technique. The 3,3'-T(2) PR was calculated from CR and serum concentration of 3,3'-T(2) determined by radio-immunoassay. In the HT(4) subjects the 3,3'-T(2) CR averaged 840+/-377 liters/day and 3,3'-T(2) PR 33.9+/-12.5 mug/day. These results were not significantly different from those in the control group: 3,3'-T(2) CR 628+/-218 liters/day and 3,3'-T(2) PR 39.8+/-19.8 mug/day (all corrected to 70 kg body wt). In addition to 3,3'-T(2) PR, T(3), and reverse triiodothyronine (rT(3)) PR were determined in three of the HT(4) subjects. In each case studied, the 3,3'-T(2) PR was close to the combined triiodothyronine (T(3) + rT(3)) PR. The mean molar ratio of T(2) PR/(T(3) + rT(3)) PR was 1.08+/-0.10. The results obtained in the HT(4) subjects indicate that the production of 3,3'-T(2) is a major route of T(4) metabolism. The combined studies of 3,3'-T(2), T(3) and rT(3) PR in the HT(4) subjects indicate that both T(3) and rT(3) are major precursors of 3,3'-T(2). In the HT(3) subjects, the conversion of T(3) to 3,3'-T(2), determined as the molar ratio of 3,3'-T(2) PR to T(3) PR, ranged from 0.36 to 0.92, providing further evidence that T(3) is a precursor of 3,3'-T(2). From the close agreement between the mean values for 3,3'-T(2) PR in the euthyroid and HT(4) group it is concluded that most, if not all of the 3,3'-T(2) produced in normal humans is derived by extrathyroidal conversion from T(3) and rT(3).\",\n",
       "  \"Physiological and pharmacological influences on thyroxine to 3,5,3'-triiodothyronine conversion and nuclear 3,5,3'-triiodothyronine binding in rat anterior pituitary. Our recent in vivo studies have suggested that intrapituitary l-thyroxine (T(4)) to 3,5,3'-triiodo-l-thyronine (T(3)) conversion with subsequent nuclear binding of T(3) is an important pathway by which circulating T(4) can inhibit thyrotropin release. The present studies were performed to evaluate various physiological and pharmacological influences on these two processes in rat anterior pituitary tissue. Intact pituitary fragments were incubated in buffer-1% bovine serum albumin containing 0.14 ng/ml [(131)I]T(3) and 3.8 ng/ml [(125)I]T(4). Nuclei were isolated after 3 h of incubation and the bound iodothyronines identified by paper chromatography. There was 0.3-1% [(125)I]T(3) contaminating the medium [(125)I]T(4), and this did not change during incubation. Nuclear [(125)I]T(4) was not decreased by 650-fold excesses of medium T(3) or T(4), suggesting that it was nonspecifically bound. The ratio of nuclear to medium [(131)I]- and [(125)I]T(3) were expressed as nuclear counts per minute per milligram wet weight of tissue:counts per minute per microliter medium. Intrapituitary T(4) to T(3) conversion was evidenced by the fact that the nuclear:medium (N:M) ratio for [(131)I]T(3) was 0.45+/-0.21, whereas that for [(125)I]T(3) was 2.23+/-1.28 (mean+/-SD, n = 51). A ratio (R), the N:M [(125)I]T(3) divided by the N:M [(131)I]T(3), was used as an index of intrapituitary T(4) to T(3) conversion. Increasing medium T(3) concentrations up to 50 ng/ml caused a progressive decrease in the N:M ratio for both T(3) isotopes, but no change in the value for R, indicating that both competed for the same limited-capacity nuclear receptors. Increasing concentrations of medium T(4) caused no change in the N:M [(131)I]T(3) but did cause a significant decrease in R in three of four experiments. These results suggest saturation of T(4)-5'-monodeiodination occurred at lower T(4) concentrations than saturation of nuclear T(3) binding sites. In hypothyroid rats, the N:M ratios for both [(131)I]T(3) and [(125)I]T(3) were increased (P &lt; 0.005), but R was three-fold higher than in controls (P &lt; 0.005). Animals given 10 mug T(4)/100 g body wt per d for 5 d had significantly decreased N:M ratios for both [(131)I]T(3) and [(125)I]T(3), as well as a decreased value for R. In fasted rats, neither N:M ratio was depressed, although hepatic T(4) to T(3) conversion in the same animals was 50% of control (P &lt; 0.005). Iopanoic acid (13 muM), but not 6-n-propylthiouracil (29 muM), decreased the N:M [(125)I]T(3) with a significant decrease in the value for R (P &lt; 0.025 or less). Neither sodium iodide (6 muM) nor thyrotropin-releasing hormone (7-700 nM) affected the T(3) N:M ratios. These results indicate that intrapituitary T(4) to T(3) conversion is stimulated in hypothyroidism and depressed in T(4)-treated animals, whereas opposite changes occur in hepatic T(4)-5'-monodeiodination. Unlike liver, anterior pituitary T(4)-5'-monodeiodination is not affected by fasting or incubation with 6-n-propyl-2-thiouracil, but T(4) to T(3) conversion is inhibited in both by iopanoic acid. These results indicate that there are important differences between anterior pituitary and other tissues in the regulation of T(4)-5'-monodeiodination.\",\n",
       "  'Metabolism of resorcinylic compounds by bacteria. Purification and properties of orcinol hydroxylase from Pseudomonas putida 01. Orcinol hydroxylase (EC 1.14.13.6), which catalyzes the first reaction of orcinol catabolism in Pseudomonas putida 01, has been purified to homogeneity, and crystallized. Orcinol hydroxylase catalyzes the hydroxylation of orcinol with equimolar consumption of O2 and NADH (or NADPH) to 2, 3, 5-trihydroxytoluene, which is nonenzymically oxidized to a quinone. The visible absorption spectrum of the enzyme shows maxima at 373 and 454 nm and a shoulder at 480 nm. FAD can be dissociated from the protein. Reconstitution of enzymic activity was achieved with FAD, and to a limited extent by FMN. The enzyme has a molecular weight of 63,000 to 68,000 and contains 1 mol of FAD per mol of protein. K-m values for the three substrates orcinol, NADH, and O2 are 0.03, 0.13, and 0.07mM, RESPECTIVELY. The molecular activity of the crystalline enzyme is 1560 min minus 1. In the absence of orcinol, NADH is only slowly oxidized with formation of H2O2. Several analogs of orcinol also serve as substrates for hydroxylation, namely resorcinol, 4-methylresorcinol, and 4-bromoresorcinol. Other analogs, m-cresol, m-ethylphenol, 4-ethylresorcinol, and phloroglucinol, mimic orcinol as effectors, in that they (a) accelerate electron flow from NADH to the flavin and (b) decrease the apparent K-m for NADH but not to the same extent as the substrates that are hydroxylated. The latter compounds are not hydroxylated. Instead H2O2 accumulates as the only product of O2 reduction. The enzyme therefore behaves either as a hydroxylase or an oxidase. The ratio of hydroxylase to oxidase activities of the enzyme is decreased by an increase in the temperature of incubation; at 60 degrees the reaction with orcinol is almost 50% uncoupled from hydroxylation. The apparent K-m values for the effectors are in good agreement with the D-D values obtained for orcinol, resorcinol, and m-cresol. K-D values were obtained by measurement of the effector-induced perturbations of the visible absorption spectrum of the flavoprotein by difference absorption spectroscopy. The circular dichroism spectrum of orcinol hydroxylase is also altered in the presence of orcinol. The participation of the flavin in the over-all reaction is demonstrated by its rapid reduction under anaerobic conditions by NADH in the presence or orcinol, resorcinol, or m-cresol. Subsequent introduction of oxygen restores the oxidized form and yields H2O2 when m-cresol is the effector, but not when orcinol is the effector. Transfer of reducing equivalents from the reduced flavoprotein to free FAD may also occur. Reduction of orcinol hydroxylase by NADH in the absence of an effector is 10-4-fold slower than in the presence of an effector. The minimal structural requirements for effectors appear to be a 1,3-dihydroxy or 1-alkyl-3-hydorxybenzene, but only the former are substrates for hydroxylation.',\n",
       "  \"[Production and absorption rate of cerebrospinal fluid in the spinal subarachnoid space of the dog (author's transl)]. Adult mongrel dogs, weighing 10-17 kg. were anesthetized with Nembutal and cervical and lumbosacral laminectomy was performed. The spinal subarachnoid space was blocked by extradural ligation at the level of the C4 to interrupt CSF communication between the cranial and spinal space. Polyethylene catheters were placed in the cervical and lumbosacral subarachnoid space, and artificial Mock CSF buffer, pH 7.35-7.40, containing inulin of 25 mg/dl or 14C-inulin of 1.5-2 muCi/dl as a tracer was perfused in the sacro-cervical direction through the catheter. After a steady state of perfusion was acommplished, the CSF was collected from the outlet catheter. Production and absorption rate of the CSF were calculated after Pappenheimer and Heisey's equation. 1) Effects of CSF pressure on the rate of production (Vf) and absorption (Va) of CSF and on the difference between outflow fluid rate (Vo) and inflow fluid rate (Vi) were studied within the pressure range of -100 to +600 mmH2O. Then, regression lines were calculated by means of the least square method. See Article. Vf was little affected by changes in CSF pressure, while Va increased linearly as CSF pressure elevated. This suggests that the spinal subarachnoid space plays an important role as a site of CSF absorption when the intracranial pressure increases. Vo-Vi, that is difference between absorption and production rate, decreased linearly as the CSF pressure increased. 2) Under a constant CSF pressure of +200 mmH2O, the effects of glucocorticoids (dexamethasone, 0.25 mg/kg and hydrocortisone, 4.15 mg/kg) and a carbonic anhydrase inhibitor (acetazolamide, 10 mg/kg) upon the production and absorption rate of CSF were determined 1/2, 1, 2 and 3 hours after intravenous administration. a) Effect of dexamethasone: The rate of CSF production was reduced to 60.5 +/- 2.4% (p less than 0.001) of the control level. The absorption rate of CSF also decreased to 59.2 +/- 6.09% (p less than 0.001) of the control. b) Effect of hydrocortisone: The production rate of CSF decreased to 67.4 +/- 6.61% (p less than 0.001), and the absorption rate to 76.5 +/- 3.94% (p less than 0.001) of the control level. c) Effect of acetazolamide: The production and absorption rate also decreased to 57.2 +/- 5.61% (p less than 0.001) and to 56.9 +/- 7.02% (p less than 0.001), respectively. 3) Pentration of tritiated dexamethasone and tritiated hydrocortisone from plasma to CSF. The penetration of tritiated dexamethasone and tritiated hydrocortisone from plasma to CSF in the spinal and cranial subarachnoid space was observed after the intravenous administration. The CSF/Plasma ratio of dexamethasone was 30.9% at 15 minutes and gradually increased to 91.5% and 93.5%, respectively, in the cranial and spinal CSF at 3 hours after the injection.\",\n",
       "  \"The role of sulfhydryl groups on the impaired hepatic 3',3,5-triiodothyronine generation from thyroxine in the hypothyroid, starved, fetal, and neonatal rodent. The role of nonprotein sulfhydryl groups (NPSH) in the decreased in vitro hepatic 3',3,5-triiodothyronine (T(3)) generation from thyroxine (T(4)) in the starved, hypothyroid, fetal and 1- to 4-d-old neonatal rat and dwarf mouse was assessed. NPSH were measured in fresh 25% liver homogenates prepared in 0.1 M PO(4)/10 mM EDTA buffer. As compared with values in adult male rats, NPSH concentration was decreased in the 2-d-starved (1.1+/-0.04 (mean+/-SE) vs. 2.2+/-0.15 mmol/250 g wet liver weight, P &lt; 0.001), fetal (1.0+/-0.04 vs. 3.2+/-0.08, P &lt; 0.001), 1-d-old neonatal (1.1+/-0.03 vs. 2.1+/-0.04, P &lt; 0.001), and hypothyroid (thyroidectomized 60 d) (1.4+/-0.06 vs. 2.2+/-0.15 P &lt; 0.001) rat. NPSH were also decreased in the hypothyroid, hypopituitary dwarf mouse as compared with values in their normal litter mates (1.3+/-0.03 vs. 2.0+/-0.2, P &lt; 0.01). Chronic administration of T(3) (0.5 mug/100 g body wt per d) markedly increased hepatic T(3) generation from T(4) in the thyroidectomized rat and in the dwarf mouse to values similar to those observed in the normal rodent without affecting NPSH concentration. In contrast, T(3) administration to the starved rat did not alter either hepatic T(3) generation from T(4) or NPSH. Reduced glutathione concentration was also markedly decreased in the starved rat (fed; 1.05+/-0.075 mmol/250 g wet tissue vs. starved 0.38+/-0.02, P &lt; 0.001). Dithiothreitol (DTT), a thiol reducing agent, increased hepatic T(3) generation from T(4) in the normal adult male rat by 45+/-5% in six experiments. When compared to DTT-stimulated control homogenates, the addition of DTT completely restored hepatic T(3) generation in starved rats, partially restored T(3) generation in 1- and 4-d-old neonates, but had little or no effect in the fetal and hypothyroid rat and dwarf mouse. Liver homogenates stored for 6 mo at -20 degrees C lost their capacity to generate T(3) from T(4). NPSH concentrations in the frozen homogenates decreased progressively with increasing storage and were absent by 6 mo. 5'-Deiodinase activity correlated with NPSH concentration in the stored homogenates (r = 0.95, P &lt; 0.005). Addition of DTT partially restored hepatic T(3) generation in the frozen homogenate. It is concluded that NPSH are important for the action of the liver 5'-deiodinase. The decreased hepatic T(3) generation in the starved rat is associated with decreased NPSH but not with a decrease in the absolute quantity of 5'-deiodinase because provision of sulfhydryl groups restored hepatic T(3) generation to normal. In contrast, the decreased hepatic T(3) generation in the adult hypothyroid rodent and in the fetal rat is probably due to a decrease in the enzyme concentration per se. In the 1- and 4-d neonatal rat, the decrease in hepatic T(3) generation is secondary to a decrease in NPSH and the deiodinating enzyme.\"])"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "execution_count": 11
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-05-18T00:01:42.470103Z",
     "start_time": "2025-05-18T00:01:41.735654Z"
    }
   },
   "cell_type": "code",
   "source": [
    "forward = build_forwarder(\n",
    "    model,\n",
    "    tokenizer,\n",
    "    querier,\n",
    "    k_augmentations=5,\n",
    "    prompt_builder=prompt,\n",
    "    device=device,\n",
    ")\n",
    "\n",
    "forward_and_get_last_logit = lambda question, options: forward(\n",
    "    question,\n",
    "    options=options,\n",
    ").logits[0][-1]\n",
    "\n",
    "result = forward_and_get_last_logit(\n",
    "    question,\n",
    "    options=options,\n",
    ")"
   ],
   "id": "6eda71576945843",
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Prompt: You are an expert in multiple-choice questions. Your task is to select the best answer from the given options based on the provided context. \n",
      "\n",
      "Context:\n",
      "3,3'-Diiodothyronine production, a major pathway of peripheral iodothyronine metabolism in man. 3,3'-Diiodothyronine (3,3'-T(2)) has been detected in human serum and in thyroglobulin. However, no quantitative assessment of its clearance rate (CR), production rate (PR), or of the importance of extrathyroidal sources of 3,3'-T(2) relative to direct thyroidal secretion is yet available. This study examines these parameters in seven euthyroid subjects, and in eight athyreotic subjects (H) eumetabolic due to thyroxine therapy (HT(4)) (n = 5) or triiodothyronine replacement (HT(3)) (n = 3). A highly specific radioimmunoassay for the measurement of 3,3'-T(2) in whole serum was developed. Serum 3,3'-T(2) concentrations were (mean +/- SD) 6.0+/-1.0 ng/100 ml in 13 normal subjects, 9.0+/-4.6 ng/100 ml in 25 hyperthyroid patients, and 2.7+/-1.1 ng/100 ml in 17 hypothyroid patients. The values in each of the latter two groups were significantly different from normal. 3,3'-T(2) was detected regularly in normal concentrations in 11 hypothyroid patients eumetabolic by treatment with synthetic T(4), in 10 eumetabolic patients suffering from nonthyroidal systemic illness, and in 2 subjects with elevated serum T(4)-binding globulin. The 3,3'-T(2) CR was assessed from data acquired from the (125)I-3,3'-T(2) constant infusion technique. The 3,3'-T(2) PR was calculated from CR and serum concentration of 3,3'-T(2) determined by radio-immunoassay. In the HT(4) subjects the 3,3'-T(2) CR averaged 840+/-377 liters/day and 3,3'-T(2) PR 33.9+/-12.5 mug/day. These results were not significantly different from those in the control group: 3,3'-T(2) CR 628+/-218 liters/day and 3,3'-T(2) PR 39.8+/-19.8 mug/day (all corrected to 70 kg body wt). In addition to 3,3'-T(2) PR, T(3), and reverse triiodothyronine (rT(3)) PR were determined in three of the HT(4) subjects. In each case studied, the 3,3'-T(2) PR was close to the combined triiodothyronine (T(3) + rT(3)) PR. The mean molar ratio of T(2) PR/(T(3) + rT(3)) PR was 1.08+/-0.10. The results obtained in the HT(4) subjects indicate that the production of 3,3'-T(2) is a major route of T(4) metabolism. The combined studies of 3,3'-T(2), T(3) and rT(3) PR in the HT(4) subjects indicate that both T(3) and rT(3) are major precursors of 3,3'-T(2). In the HT(3) subjects, the conversion of T(3) to 3,3'-T(2), determined as the molar ratio of 3,3'-T(2) PR to T(3) PR, ranged from 0.36 to 0.92, providing further evidence that T(3) is a precursor of 3,3'-T(2). From the close agreement between the mean values for 3,3'-T(2) PR in the euthyroid and HT(4) group it is concluded that most, if not all of the 3,3'-T(2) produced in normal humans is derived by extrathyroidal conversion from T(3) and rT(3).\n",
      "Physiological and pharmacological influences on thyroxine to 3,5,3'-triiodothyronine conversion and nuclear 3,5,3'-triiodothyronine binding in rat anterior pituitary. Our recent in vivo studies have suggested that intrapituitary l-thyroxine (T(4)) to 3,5,3'-triiodo-l-thyronine (T(3)) conversion with subsequent nuclear binding of T(3) is an important pathway by which circulating T(4) can inhibit thyrotropin release. The present studies were performed to evaluate various physiological and pharmacological influences on these two processes in rat anterior pituitary tissue. Intact pituitary fragments were incubated in buffer-1% bovine serum albumin containing 0.14 ng/ml [(131)I]T(3) and 3.8 ng/ml [(125)I]T(4). Nuclei were isolated after 3 h of incubation and the bound iodothyronines identified by paper chromatography. There was 0.3-1% [(125)I]T(3) contaminating the medium [(125)I]T(4), and this did not change during incubation. Nuclear [(125)I]T(4) was not decreased by 650-fold excesses of medium T(3) or T(4), suggesting that it was nonspecifically bound. The ratio of nuclear to medium [(131)I]- and [(125)I]T(3) were expressed as nuclear counts per minute per milligram wet weight of tissue:counts per minute per microliter medium. Intrapituitary T(4) to T(3) conversion was evidenced by the fact that the nuclear:medium (N:M) ratio for [(131)I]T(3) was 0.45+/-0.21, whereas that for [(125)I]T(3) was 2.23+/-1.28 (mean+/-SD, n = 51). A ratio (R), the N:M [(125)I]T(3) divided by the N:M [(131)I]T(3), was used as an index of intrapituitary T(4) to T(3) conversion. Increasing medium T(3) concentrations up to 50 ng/ml caused a progressive decrease in the N:M ratio for both T(3) isotopes, but no change in the value for R, indicating that both competed for the same limited-capacity nuclear receptors. Increasing concentrations of medium T(4) caused no change in the N:M [(131)I]T(3) but did cause a significant decrease in R in three of four experiments. These results suggest saturation of T(4)-5'-monodeiodination occurred at lower T(4) concentrations than saturation of nuclear T(3) binding sites. In hypothyroid rats, the N:M ratios for both [(131)I]T(3) and [(125)I]T(3) were increased (P &lt; 0.005), but R was three-fold higher than in controls (P &lt; 0.005). Animals given 10 mug T(4)/100 g body wt per d for 5 d had significantly decreased N:M ratios for both [(131)I]T(3) and [(125)I]T(3), as well as a decreased value for R. In fasted rats, neither N:M ratio was depressed, although hepatic T(4) to T(3) conversion in the same animals was 50% of control (P &lt; 0.005). Iopanoic acid (13 muM), but not 6-n-propylthiouracil (29 muM), decreased the N:M [(125)I]T(3) with a significant decrease in the value for R (P &lt; 0.025 or less). Neither sodium iodide (6 muM) nor thyrotropin-releasing hormone (7-700 nM) affected the T(3) N:M ratios. These results indicate that intrapituitary T(4) to T(3) conversion is stimulated in hypothyroidism and depressed in T(4)-treated animals, whereas opposite changes occur in hepatic T(4)-5'-monodeiodination. Unlike liver, anterior pituitary T(4)-5'-monodeiodination is not affected by fasting or incubation with 6-n-propyl-2-thiouracil, but T(4) to T(3) conversion is inhibited in both by iopanoic acid. These results indicate that there are important differences between anterior pituitary and other tissues in the regulation of T(4)-5'-monodeiodination.\n",
      "Metabolism of resorcinylic compounds by bacteria. Purification and properties of orcinol hydroxylase from Pseudomonas putida 01. Orcinol hydroxylase (EC 1.14.13.6), which catalyzes the first reaction of orcinol catabolism in Pseudomonas putida 01, has been purified to homogeneity, and crystallized. Orcinol hydroxylase catalyzes the hydroxylation of orcinol with equimolar consumption of O2 and NADH (or NADPH) to 2, 3, 5-trihydroxytoluene, which is nonenzymically oxidized to a quinone. The visible absorption spectrum of the enzyme shows maxima at 373 and 454 nm and a shoulder at 480 nm. FAD can be dissociated from the protein. Reconstitution of enzymic activity was achieved with FAD, and to a limited extent by FMN. The enzyme has a molecular weight of 63,000 to 68,000 and contains 1 mol of FAD per mol of protein. K-m values for the three substrates orcinol, NADH, and O2 are 0.03, 0.13, and 0.07mM, RESPECTIVELY. The molecular activity of the crystalline enzyme is 1560 min minus 1. In the absence of orcinol, NADH is only slowly oxidized with formation of H2O2. Several analogs of orcinol also serve as substrates for hydroxylation, namely resorcinol, 4-methylresorcinol, and 4-bromoresorcinol. Other analogs, m-cresol, m-ethylphenol, 4-ethylresorcinol, and phloroglucinol, mimic orcinol as effectors, in that they (a) accelerate electron flow from NADH to the flavin and (b) decrease the apparent K-m for NADH but not to the same extent as the substrates that are hydroxylated. The latter compounds are not hydroxylated. Instead H2O2 accumulates as the only product of O2 reduction. The enzyme therefore behaves either as a hydroxylase or an oxidase. The ratio of hydroxylase to oxidase activities of the enzyme is decreased by an increase in the temperature of incubation; at 60 degrees the reaction with orcinol is almost 50% uncoupled from hydroxylation. The apparent K-m values for the effectors are in good agreement with the D-D values obtained for orcinol, resorcinol, and m-cresol. K-D values were obtained by measurement of the effector-induced perturbations of the visible absorption spectrum of the flavoprotein by difference absorption spectroscopy. The circular dichroism spectrum of orcinol hydroxylase is also altered in the presence of orcinol. The participation of the flavin in the over-all reaction is demonstrated by its rapid reduction under anaerobic conditions by NADH in the presence or orcinol, resorcinol, or m-cresol. Subsequent introduction of oxygen restores the oxidized form and yields H2O2 when m-cresol is the effector, but not when orcinol is the effector. Transfer of reducing equivalents from the reduced flavoprotein to free FAD may also occur. Reduction of orcinol hydroxylase by NADH in the absence of an effector is 10-4-fold slower than in the presence of an effector. The minimal structural requirements for effectors appear to be a 1,3-dihydroxy or 1-alkyl-3-hydorxybenzene, but only the former are substrates for hydroxylation.\n",
      "[Production and absorption rate of cerebrospinal fluid in the spinal subarachnoid space of the dog (author's transl)]. Adult mongrel dogs, weighing 10-17 kg. were anesthetized with Nembutal and cervical and lumbosacral laminectomy was performed. The spinal subarachnoid space was blocked by extradural ligation at the level of the C4 to interrupt CSF communication between the cranial and spinal space. Polyethylene catheters were placed in the cervical and lumbosacral subarachnoid space, and artificial Mock CSF buffer, pH 7.35-7.40, containing inulin of 25 mg/dl or 14C-inulin of 1.5-2 muCi/dl as a tracer was perfused in the sacro-cervical direction through the catheter. After a steady state of perfusion was acommplished, the CSF was collected from the outlet catheter. Production and absorption rate of the CSF were calculated after Pappenheimer and Heisey's equation. 1) Effects of CSF pressure on the rate of production (Vf) and absorption (Va) of CSF and on the difference between outflow fluid rate (Vo) and inflow fluid rate (Vi) were studied within the pressure range of -100 to +600 mmH2O. Then, regression lines were calculated by means of the least square method. See Article. Vf was little affected by changes in CSF pressure, while Va increased linearly as CSF pressure elevated. This suggests that the spinal subarachnoid space plays an important role as a site of CSF absorption when the intracranial pressure increases. Vo-Vi, that is difference between absorption and production rate, decreased linearly as the CSF pressure increased. 2) Under a constant CSF pressure of +200 mmH2O, the effects of glucocorticoids (dexamethasone, 0.25 mg/kg and hydrocortisone, 4.15 mg/kg) and a carbonic anhydrase inhibitor (acetazolamide, 10 mg/kg) upon the production and absorption rate of CSF were determined 1/2, 1, 2 and 3 hours after intravenous administration. a) Effect of dexamethasone: The rate of CSF production was reduced to 60.5 +/- 2.4% (p less than 0.001) of the control level. The absorption rate of CSF also decreased to 59.2 +/- 6.09% (p less than 0.001) of the control. b) Effect of hydrocortisone: The production rate of CSF decreased to 67.4 +/- 6.61% (p less than 0.001), and the absorption rate to 76.5 +/- 3.94% (p less than 0.001) of the control level. c) Effect of acetazolamide: The production and absorption rate also decreased to 57.2 +/- 5.61% (p less than 0.001) and to 56.9 +/- 7.02% (p less than 0.001), respectively. 3) Pentration of tritiated dexamethasone and tritiated hydrocortisone from plasma to CSF. The penetration of tritiated dexamethasone and tritiated hydrocortisone from plasma to CSF in the spinal and cranial subarachnoid space was observed after the intravenous administration. The CSF/Plasma ratio of dexamethasone was 30.9% at 15 minutes and gradually increased to 91.5% and 93.5%, respectively, in the cranial and spinal CSF at 3 hours after the injection.\n",
      "The role of sulfhydryl groups on the impaired hepatic 3',3,5-triiodothyronine generation from thyroxine in the hypothyroid, starved, fetal, and neonatal rodent. The role of nonprotein sulfhydryl groups (NPSH) in the decreased in vitro hepatic 3',3,5-triiodothyronine (T(3)) generation from thyroxine (T(4)) in the starved, hypothyroid, fetal and 1- to 4-d-old neonatal rat and dwarf mouse was assessed. NPSH were measured in fresh 25% liver homogenates prepared in 0.1 M PO(4)/10 mM EDTA buffer. As compared with values in adult male rats, NPSH concentration was decreased in the 2-d-starved (1.1+/-0.04 (mean+/-SE) vs. 2.2+/-0.15 mmol/250 g wet liver weight, P &lt; 0.001), fetal (1.0+/-0.04 vs. 3.2+/-0.08, P &lt; 0.001), 1-d-old neonatal (1.1+/-0.03 vs. 2.1+/-0.04, P &lt; 0.001), and hypothyroid (thyroidectomized 60 d) (1.4+/-0.06 vs. 2.2+/-0.15 P &lt; 0.001) rat. NPSH were also decreased in the hypothyroid, hypopituitary dwarf mouse as compared with values in their normal litter mates (1.3+/-0.03 vs. 2.0+/-0.2, P &lt; 0.01). Chronic administration of T(3) (0.5 mug/100 g body wt per d) markedly increased hepatic T(3) generation from T(4) in the thyroidectomized rat and in the dwarf mouse to values similar to those observed in the normal rodent without affecting NPSH concentration. In contrast, T(3) administration to the starved rat did not alter either hepatic T(3) generation from T(4) or NPSH. Reduced glutathione concentration was also markedly decreased in the starved rat (fed; 1.05+/-0.075 mmol/250 g wet tissue vs. starved 0.38+/-0.02, P &lt; 0.001). Dithiothreitol (DTT), a thiol reducing agent, increased hepatic T(3) generation from T(4) in the normal adult male rat by 45+/-5% in six experiments. When compared to DTT-stimulated control homogenates, the addition of DTT completely restored hepatic T(3) generation in starved rats, partially restored T(3) generation in 1- and 4-d-old neonates, but had little or no effect in the fetal and hypothyroid rat and dwarf mouse. Liver homogenates stored for 6 mo at -20 degrees C lost their capacity to generate T(3) from T(4). NPSH concentrations in the frozen homogenates decreased progressively with increasing storage and were absent by 6 mo. 5'-Deiodinase activity correlated with NPSH concentration in the stored homogenates (r = 0.95, P &lt; 0.005). Addition of DTT partially restored hepatic T(3) generation in the frozen homogenate. It is concluded that NPSH are important for the action of the liver 5'-deiodinase. The decreased hepatic T(3) generation in the starved rat is associated with decreased NPSH but not with a decrease in the absolute quantity of 5'-deiodinase because provision of sulfhydryl groups restored hepatic T(3) generation to normal. In contrast, the decreased hepatic T(3) generation in the adult hypothyroid rodent and in the fetal rat is probably due to a decrease in the enzyme concentration per se. In the 1- and 4-d neonatal rat, the decrease in hepatic T(3) generation is secondary to a decrease in NPSH and the deiodinating enzyme.\n",
      "\n",
      "Question: What did the study reveal about the role of external calcium concentration in the action potential and contraction recovery time of crayfish muscle fibers?\n",
      "\n",
      "Options:\n",
      "A. The study found that increasing external calcium concentration had no effect on the action potential or contraction recovery time in crayfish muscle fibers.\n",
      "B. The research concluded that magnesium ions play a more significant role than calcium in the action potential and contraction recovery of crayfish muscle fibers.\n",
      "C. The investigation revealed that external calcium concentration only affects the resting potential of crayfish muscle fibers, not the action potential or contraction recovery.\n",
      "D. The study investigated how changes in external calcium concentration affect the action potential and contraction recovery time in crayfish muscle fibers, revealing that calcium entry through TTS membranes is crucial for excitation-contraction coupling.\n",
      "\n",
      "Answer(pick one between A, B, C and D):\n"
     ]
    }
   ],
   "execution_count": 12
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-05-18T00:01:42.782218Z",
     "start_time": "2025-05-18T00:01:42.777477Z"
    }
   },
   "cell_type": "code",
   "source": "result",
   "id": "a3dac6ce96dff89a",
   "outputs": [
    {
     "data": {
      "text/plain": [
       "tensor([13.4062, 10.6328, 12.8828,  ..., -0.0641, -0.0647, -0.0652],\n",
       "       device='cuda:0', dtype=torch.float16)"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "execution_count": 13
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-05-18T00:01:42.836883Z",
     "start_time": "2025-05-18T00:01:42.834302Z"
    }
   },
   "cell_type": "code",
   "source": "possible_answers = [\" A\", \" B\", \" C\", \"D\"]",
   "id": "c808e5e62e917869",
   "outputs": [],
   "execution_count": 14
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-05-18T00:01:42.907860Z",
     "start_time": "2025-05-18T00:01:42.884314Z"
    }
   },
   "cell_type": "code",
   "source": [
    "picker = build_from_logits(\n",
    "    tokenizer,\n",
    "    options=possible_answers,\n",
    ")\n",
    "\n",
    "selected_option = picker(result)"
   ],
   "id": "4aa6e4444a98b39c",
   "outputs": [],
   "execution_count": 15
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-05-18T00:01:42.945048Z",
     "start_time": "2025-05-18T00:01:42.941657Z"
    }
   },
   "cell_type": "code",
   "source": "selected_option",
   "id": "e59921bab48e1e24",
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0"
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "execution_count": 16
  },
  {
   "metadata": {},
   "cell_type": "markdown",
   "source": "# Lets evaluate the model ðŸ”¥",
   "id": "2a4db915fcf2598"
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-05-18T00:01:54.928883Z",
     "start_time": "2025-05-18T00:01:42.997818Z"
    }
   },
   "cell_type": "code",
   "source": [
    "accuracy = evaluate(\n",
    "    forward_fn=forward_and_get_last_logit,\n",
    "    picker_fn=picker,\n",
    "    eval_dataset=evaluateWithAnswers,\n",
    ")\n",
    "\n",
    "print(f\"Accuracy: {accuracy:.2f}\")"
   ],
   "id": "a30eb71e7d3e46b4",
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Prompt: You are an expert in multiple-choice questions. Your task is to select the best answer from the given options based on the provided context. \n",
      "\n",
      "Context:\n",
      "3,3'-Diiodothyronine production, a major pathway of peripheral iodothyronine metabolism in man. 3,3'-Diiodothyronine (3,3'-T(2)) has been detected in human serum and in thyroglobulin. However, no quantitative assessment of its clearance rate (CR), production rate (PR), or of the importance of extrathyroidal sources of 3,3'-T(2) relative to direct thyroidal secretion is yet available. This study examines these parameters in seven euthyroid subjects, and in eight athyreotic subjects (H) eumetabolic due to thyroxine therapy (HT(4)) (n = 5) or triiodothyronine replacement (HT(3)) (n = 3). A highly specific radioimmunoassay for the measurement of 3,3'-T(2) in whole serum was developed. Serum 3,3'-T(2) concentrations were (mean +/- SD) 6.0+/-1.0 ng/100 ml in 13 normal subjects, 9.0+/-4.6 ng/100 ml in 25 hyperthyroid patients, and 2.7+/-1.1 ng/100 ml in 17 hypothyroid patients. The values in each of the latter two groups were significantly different from normal. 3,3'-T(2) was detected regularly in normal concentrations in 11 hypothyroid patients eumetabolic by treatment with synthetic T(4), in 10 eumetabolic patients suffering from nonthyroidal systemic illness, and in 2 subjects with elevated serum T(4)-binding globulin. The 3,3'-T(2) CR was assessed from data acquired from the (125)I-3,3'-T(2) constant infusion technique. The 3,3'-T(2) PR was calculated from CR and serum concentration of 3,3'-T(2) determined by radio-immunoassay. In the HT(4) subjects the 3,3'-T(2) CR averaged 840+/-377 liters/day and 3,3'-T(2) PR 33.9+/-12.5 mug/day. These results were not significantly different from those in the control group: 3,3'-T(2) CR 628+/-218 liters/day and 3,3'-T(2) PR 39.8+/-19.8 mug/day (all corrected to 70 kg body wt). In addition to 3,3'-T(2) PR, T(3), and reverse triiodothyronine (rT(3)) PR were determined in three of the HT(4) subjects. In each case studied, the 3,3'-T(2) PR was close to the combined triiodothyronine (T(3) + rT(3)) PR. The mean molar ratio of T(2) PR/(T(3) + rT(3)) PR was 1.08+/-0.10. The results obtained in the HT(4) subjects indicate that the production of 3,3'-T(2) is a major route of T(4) metabolism. The combined studies of 3,3'-T(2), T(3) and rT(3) PR in the HT(4) subjects indicate that both T(3) and rT(3) are major precursors of 3,3'-T(2). In the HT(3) subjects, the conversion of T(3) to 3,3'-T(2), determined as the molar ratio of 3,3'-T(2) PR to T(3) PR, ranged from 0.36 to 0.92, providing further evidence that T(3) is a precursor of 3,3'-T(2). From the close agreement between the mean values for 3,3'-T(2) PR in the euthyroid and HT(4) group it is concluded that most, if not all of the 3,3'-T(2) produced in normal humans is derived by extrathyroidal conversion from T(3) and rT(3).\n",
      "Physiological and pharmacological influences on thyroxine to 3,5,3'-triiodothyronine conversion and nuclear 3,5,3'-triiodothyronine binding in rat anterior pituitary. Our recent in vivo studies have suggested that intrapituitary l-thyroxine (T(4)) to 3,5,3'-triiodo-l-thyronine (T(3)) conversion with subsequent nuclear binding of T(3) is an important pathway by which circulating T(4) can inhibit thyrotropin release. The present studies were performed to evaluate various physiological and pharmacological influences on these two processes in rat anterior pituitary tissue. Intact pituitary fragments were incubated in buffer-1% bovine serum albumin containing 0.14 ng/ml [(131)I]T(3) and 3.8 ng/ml [(125)I]T(4). Nuclei were isolated after 3 h of incubation and the bound iodothyronines identified by paper chromatography. There was 0.3-1% [(125)I]T(3) contaminating the medium [(125)I]T(4), and this did not change during incubation. Nuclear [(125)I]T(4) was not decreased by 650-fold excesses of medium T(3) or T(4), suggesting that it was nonspecifically bound. The ratio of nuclear to medium [(131)I]- and [(125)I]T(3) were expressed as nuclear counts per minute per milligram wet weight of tissue:counts per minute per microliter medium. Intrapituitary T(4) to T(3) conversion was evidenced by the fact that the nuclear:medium (N:M) ratio for [(131)I]T(3) was 0.45+/-0.21, whereas that for [(125)I]T(3) was 2.23+/-1.28 (mean+/-SD, n = 51). A ratio (R), the N:M [(125)I]T(3) divided by the N:M [(131)I]T(3), was used as an index of intrapituitary T(4) to T(3) conversion. Increasing medium T(3) concentrations up to 50 ng/ml caused a progressive decrease in the N:M ratio for both T(3) isotopes, but no change in the value for R, indicating that both competed for the same limited-capacity nuclear receptors. Increasing concentrations of medium T(4) caused no change in the N:M [(131)I]T(3) but did cause a significant decrease in R in three of four experiments. These results suggest saturation of T(4)-5'-monodeiodination occurred at lower T(4) concentrations than saturation of nuclear T(3) binding sites. In hypothyroid rats, the N:M ratios for both [(131)I]T(3) and [(125)I]T(3) were increased (P &lt; 0.005), but R was three-fold higher than in controls (P &lt; 0.005). Animals given 10 mug T(4)/100 g body wt per d for 5 d had significantly decreased N:M ratios for both [(131)I]T(3) and [(125)I]T(3), as well as a decreased value for R. In fasted rats, neither N:M ratio was depressed, although hepatic T(4) to T(3) conversion in the same animals was 50% of control (P &lt; 0.005). Iopanoic acid (13 muM), but not 6-n-propylthiouracil (29 muM), decreased the N:M [(125)I]T(3) with a significant decrease in the value for R (P &lt; 0.025 or less). Neither sodium iodide (6 muM) nor thyrotropin-releasing hormone (7-700 nM) affected the T(3) N:M ratios. These results indicate that intrapituitary T(4) to T(3) conversion is stimulated in hypothyroidism and depressed in T(4)-treated animals, whereas opposite changes occur in hepatic T(4)-5'-monodeiodination. Unlike liver, anterior pituitary T(4)-5'-monodeiodination is not affected by fasting or incubation with 6-n-propyl-2-thiouracil, but T(4) to T(3) conversion is inhibited in both by iopanoic acid. These results indicate that there are important differences between anterior pituitary and other tissues in the regulation of T(4)-5'-monodeiodination.\n",
      "Metabolism of resorcinylic compounds by bacteria. Purification and properties of orcinol hydroxylase from Pseudomonas putida 01. Orcinol hydroxylase (EC 1.14.13.6), which catalyzes the first reaction of orcinol catabolism in Pseudomonas putida 01, has been purified to homogeneity, and crystallized. Orcinol hydroxylase catalyzes the hydroxylation of orcinol with equimolar consumption of O2 and NADH (or NADPH) to 2, 3, 5-trihydroxytoluene, which is nonenzymically oxidized to a quinone. The visible absorption spectrum of the enzyme shows maxima at 373 and 454 nm and a shoulder at 480 nm. FAD can be dissociated from the protein. Reconstitution of enzymic activity was achieved with FAD, and to a limited extent by FMN. The enzyme has a molecular weight of 63,000 to 68,000 and contains 1 mol of FAD per mol of protein. K-m values for the three substrates orcinol, NADH, and O2 are 0.03, 0.13, and 0.07mM, RESPECTIVELY. The molecular activity of the crystalline enzyme is 1560 min minus 1. In the absence of orcinol, NADH is only slowly oxidized with formation of H2O2. Several analogs of orcinol also serve as substrates for hydroxylation, namely resorcinol, 4-methylresorcinol, and 4-bromoresorcinol. Other analogs, m-cresol, m-ethylphenol, 4-ethylresorcinol, and phloroglucinol, mimic orcinol as effectors, in that they (a) accelerate electron flow from NADH to the flavin and (b) decrease the apparent K-m for NADH but not to the same extent as the substrates that are hydroxylated. The latter compounds are not hydroxylated. Instead H2O2 accumulates as the only product of O2 reduction. The enzyme therefore behaves either as a hydroxylase or an oxidase. The ratio of hydroxylase to oxidase activities of the enzyme is decreased by an increase in the temperature of incubation; at 60 degrees the reaction with orcinol is almost 50% uncoupled from hydroxylation. The apparent K-m values for the effectors are in good agreement with the D-D values obtained for orcinol, resorcinol, and m-cresol. K-D values were obtained by measurement of the effector-induced perturbations of the visible absorption spectrum of the flavoprotein by difference absorption spectroscopy. The circular dichroism spectrum of orcinol hydroxylase is also altered in the presence of orcinol. The participation of the flavin in the over-all reaction is demonstrated by its rapid reduction under anaerobic conditions by NADH in the presence or orcinol, resorcinol, or m-cresol. Subsequent introduction of oxygen restores the oxidized form and yields H2O2 when m-cresol is the effector, but not when orcinol is the effector. Transfer of reducing equivalents from the reduced flavoprotein to free FAD may also occur. Reduction of orcinol hydroxylase by NADH in the absence of an effector is 10-4-fold slower than in the presence of an effector. The minimal structural requirements for effectors appear to be a 1,3-dihydroxy or 1-alkyl-3-hydorxybenzene, but only the former are substrates for hydroxylation.\n",
      "[Production and absorption rate of cerebrospinal fluid in the spinal subarachnoid space of the dog (author's transl)]. Adult mongrel dogs, weighing 10-17 kg. were anesthetized with Nembutal and cervical and lumbosacral laminectomy was performed. The spinal subarachnoid space was blocked by extradural ligation at the level of the C4 to interrupt CSF communication between the cranial and spinal space. Polyethylene catheters were placed in the cervical and lumbosacral subarachnoid space, and artificial Mock CSF buffer, pH 7.35-7.40, containing inulin of 25 mg/dl or 14C-inulin of 1.5-2 muCi/dl as a tracer was perfused in the sacro-cervical direction through the catheter. After a steady state of perfusion was acommplished, the CSF was collected from the outlet catheter. Production and absorption rate of the CSF were calculated after Pappenheimer and Heisey's equation. 1) Effects of CSF pressure on the rate of production (Vf) and absorption (Va) of CSF and on the difference between outflow fluid rate (Vo) and inflow fluid rate (Vi) were studied within the pressure range of -100 to +600 mmH2O. Then, regression lines were calculated by means of the least square method. See Article. Vf was little affected by changes in CSF pressure, while Va increased linearly as CSF pressure elevated. This suggests that the spinal subarachnoid space plays an important role as a site of CSF absorption when the intracranial pressure increases. Vo-Vi, that is difference between absorption and production rate, decreased linearly as the CSF pressure increased. 2) Under a constant CSF pressure of +200 mmH2O, the effects of glucocorticoids (dexamethasone, 0.25 mg/kg and hydrocortisone, 4.15 mg/kg) and a carbonic anhydrase inhibitor (acetazolamide, 10 mg/kg) upon the production and absorption rate of CSF were determined 1/2, 1, 2 and 3 hours after intravenous administration. a) Effect of dexamethasone: The rate of CSF production was reduced to 60.5 +/- 2.4% (p less than 0.001) of the control level. The absorption rate of CSF also decreased to 59.2 +/- 6.09% (p less than 0.001) of the control. b) Effect of hydrocortisone: The production rate of CSF decreased to 67.4 +/- 6.61% (p less than 0.001), and the absorption rate to 76.5 +/- 3.94% (p less than 0.001) of the control level. c) Effect of acetazolamide: The production and absorption rate also decreased to 57.2 +/- 5.61% (p less than 0.001) and to 56.9 +/- 7.02% (p less than 0.001), respectively. 3) Pentration of tritiated dexamethasone and tritiated hydrocortisone from plasma to CSF. The penetration of tritiated dexamethasone and tritiated hydrocortisone from plasma to CSF in the spinal and cranial subarachnoid space was observed after the intravenous administration. The CSF/Plasma ratio of dexamethasone was 30.9% at 15 minutes and gradually increased to 91.5% and 93.5%, respectively, in the cranial and spinal CSF at 3 hours after the injection.\n",
      "The role of sulfhydryl groups on the impaired hepatic 3',3,5-triiodothyronine generation from thyroxine in the hypothyroid, starved, fetal, and neonatal rodent. The role of nonprotein sulfhydryl groups (NPSH) in the decreased in vitro hepatic 3',3,5-triiodothyronine (T(3)) generation from thyroxine (T(4)) in the starved, hypothyroid, fetal and 1- to 4-d-old neonatal rat and dwarf mouse was assessed. NPSH were measured in fresh 25% liver homogenates prepared in 0.1 M PO(4)/10 mM EDTA buffer. As compared with values in adult male rats, NPSH concentration was decreased in the 2-d-starved (1.1+/-0.04 (mean+/-SE) vs. 2.2+/-0.15 mmol/250 g wet liver weight, P &lt; 0.001), fetal (1.0+/-0.04 vs. 3.2+/-0.08, P &lt; 0.001), 1-d-old neonatal (1.1+/-0.03 vs. 2.1+/-0.04, P &lt; 0.001), and hypothyroid (thyroidectomized 60 d) (1.4+/-0.06 vs. 2.2+/-0.15 P &lt; 0.001) rat. NPSH were also decreased in the hypothyroid, hypopituitary dwarf mouse as compared with values in their normal litter mates (1.3+/-0.03 vs. 2.0+/-0.2, P &lt; 0.01). Chronic administration of T(3) (0.5 mug/100 g body wt per d) markedly increased hepatic T(3) generation from T(4) in the thyroidectomized rat and in the dwarf mouse to values similar to those observed in the normal rodent without affecting NPSH concentration. In contrast, T(3) administration to the starved rat did not alter either hepatic T(3) generation from T(4) or NPSH. Reduced glutathione concentration was also markedly decreased in the starved rat (fed; 1.05+/-0.075 mmol/250 g wet tissue vs. starved 0.38+/-0.02, P &lt; 0.001). Dithiothreitol (DTT), a thiol reducing agent, increased hepatic T(3) generation from T(4) in the normal adult male rat by 45+/-5% in six experiments. When compared to DTT-stimulated control homogenates, the addition of DTT completely restored hepatic T(3) generation in starved rats, partially restored T(3) generation in 1- and 4-d-old neonates, but had little or no effect in the fetal and hypothyroid rat and dwarf mouse. Liver homogenates stored for 6 mo at -20 degrees C lost their capacity to generate T(3) from T(4). NPSH concentrations in the frozen homogenates decreased progressively with increasing storage and were absent by 6 mo. 5'-Deiodinase activity correlated with NPSH concentration in the stored homogenates (r = 0.95, P &lt; 0.005). Addition of DTT partially restored hepatic T(3) generation in the frozen homogenate. It is concluded that NPSH are important for the action of the liver 5'-deiodinase. The decreased hepatic T(3) generation in the starved rat is associated with decreased NPSH but not with a decrease in the absolute quantity of 5'-deiodinase because provision of sulfhydryl groups restored hepatic T(3) generation to normal. In contrast, the decreased hepatic T(3) generation in the adult hypothyroid rodent and in the fetal rat is probably due to a decrease in the enzyme concentration per se. In the 1- and 4-d neonatal rat, the decrease in hepatic T(3) generation is secondary to a decrease in NPSH and the deiodinating enzyme.\n",
      "\n",
      "Question: What relationship exists between medial basal hypothalamic LH-RH levels and plasma LH changes during the rat estrous cycle and after stimulation of the medial preoptic area?\n",
      "\n",
      "Options:\n",
      "A. Medial basal hypothalamic LH-RH levels remain constant throughout the rat estrous cycle and do not affect plasma LH changes.\n",
      "B. Temporal fluctuations in medial basal hypothalamic LH-RH levels correlate with plasma LH changes during the rat estrous cycle and following stimulation of the medial preoptic area.\n",
      "C. There is no relationship between medial basal hypothalamic LH-RH levels and plasma LH changes during the rat estrous cycle.\n",
      "D. Increased medial basal hypothalamic LH-RH levels lead to a decrease in plasma LH during the rat estrous cycle.\n",
      "\n",
      "Answer(pick one between A, B, C and D):\n",
      "Right answer: 1, picked: 0\n",
      "Accuracy at 0: 0.00\n",
      "Prompt: You are an expert in multiple-choice questions. Your task is to select the best answer from the given options based on the provided context. \n",
      "\n",
      "Context:\n",
      "3,3'-Diiodothyronine production, a major pathway of peripheral iodothyronine metabolism in man. 3,3'-Diiodothyronine (3,3'-T(2)) has been detected in human serum and in thyroglobulin. However, no quantitative assessment of its clearance rate (CR), production rate (PR), or of the importance of extrathyroidal sources of 3,3'-T(2) relative to direct thyroidal secretion is yet available. This study examines these parameters in seven euthyroid subjects, and in eight athyreotic subjects (H) eumetabolic due to thyroxine therapy (HT(4)) (n = 5) or triiodothyronine replacement (HT(3)) (n = 3). A highly specific radioimmunoassay for the measurement of 3,3'-T(2) in whole serum was developed. Serum 3,3'-T(2) concentrations were (mean +/- SD) 6.0+/-1.0 ng/100 ml in 13 normal subjects, 9.0+/-4.6 ng/100 ml in 25 hyperthyroid patients, and 2.7+/-1.1 ng/100 ml in 17 hypothyroid patients. The values in each of the latter two groups were significantly different from normal. 3,3'-T(2) was detected regularly in normal concentrations in 11 hypothyroid patients eumetabolic by treatment with synthetic T(4), in 10 eumetabolic patients suffering from nonthyroidal systemic illness, and in 2 subjects with elevated serum T(4)-binding globulin. The 3,3'-T(2) CR was assessed from data acquired from the (125)I-3,3'-T(2) constant infusion technique. The 3,3'-T(2) PR was calculated from CR and serum concentration of 3,3'-T(2) determined by radio-immunoassay. In the HT(4) subjects the 3,3'-T(2) CR averaged 840+/-377 liters/day and 3,3'-T(2) PR 33.9+/-12.5 mug/day. These results were not significantly different from those in the control group: 3,3'-T(2) CR 628+/-218 liters/day and 3,3'-T(2) PR 39.8+/-19.8 mug/day (all corrected to 70 kg body wt). In addition to 3,3'-T(2) PR, T(3), and reverse triiodothyronine (rT(3)) PR were determined in three of the HT(4) subjects. In each case studied, the 3,3'-T(2) PR was close to the combined triiodothyronine (T(3) + rT(3)) PR. The mean molar ratio of T(2) PR/(T(3) + rT(3)) PR was 1.08+/-0.10. The results obtained in the HT(4) subjects indicate that the production of 3,3'-T(2) is a major route of T(4) metabolism. The combined studies of 3,3'-T(2), T(3) and rT(3) PR in the HT(4) subjects indicate that both T(3) and rT(3) are major precursors of 3,3'-T(2). In the HT(3) subjects, the conversion of T(3) to 3,3'-T(2), determined as the molar ratio of 3,3'-T(2) PR to T(3) PR, ranged from 0.36 to 0.92, providing further evidence that T(3) is a precursor of 3,3'-T(2). From the close agreement between the mean values for 3,3'-T(2) PR in the euthyroid and HT(4) group it is concluded that most, if not all of the 3,3'-T(2) produced in normal humans is derived by extrathyroidal conversion from T(3) and rT(3).\n",
      "Physiological and pharmacological influences on thyroxine to 3,5,3'-triiodothyronine conversion and nuclear 3,5,3'-triiodothyronine binding in rat anterior pituitary. Our recent in vivo studies have suggested that intrapituitary l-thyroxine (T(4)) to 3,5,3'-triiodo-l-thyronine (T(3)) conversion with subsequent nuclear binding of T(3) is an important pathway by which circulating T(4) can inhibit thyrotropin release. The present studies were performed to evaluate various physiological and pharmacological influences on these two processes in rat anterior pituitary tissue. Intact pituitary fragments were incubated in buffer-1% bovine serum albumin containing 0.14 ng/ml [(131)I]T(3) and 3.8 ng/ml [(125)I]T(4). Nuclei were isolated after 3 h of incubation and the bound iodothyronines identified by paper chromatography. There was 0.3-1% [(125)I]T(3) contaminating the medium [(125)I]T(4), and this did not change during incubation. Nuclear [(125)I]T(4) was not decreased by 650-fold excesses of medium T(3) or T(4), suggesting that it was nonspecifically bound. The ratio of nuclear to medium [(131)I]- and [(125)I]T(3) were expressed as nuclear counts per minute per milligram wet weight of tissue:counts per minute per microliter medium. Intrapituitary T(4) to T(3) conversion was evidenced by the fact that the nuclear:medium (N:M) ratio for [(131)I]T(3) was 0.45+/-0.21, whereas that for [(125)I]T(3) was 2.23+/-1.28 (mean+/-SD, n = 51). A ratio (R), the N:M [(125)I]T(3) divided by the N:M [(131)I]T(3), was used as an index of intrapituitary T(4) to T(3) conversion. Increasing medium T(3) concentrations up to 50 ng/ml caused a progressive decrease in the N:M ratio for both T(3) isotopes, but no change in the value for R, indicating that both competed for the same limited-capacity nuclear receptors. Increasing concentrations of medium T(4) caused no change in the N:M [(131)I]T(3) but did cause a significant decrease in R in three of four experiments. These results suggest saturation of T(4)-5'-monodeiodination occurred at lower T(4) concentrations than saturation of nuclear T(3) binding sites. In hypothyroid rats, the N:M ratios for both [(131)I]T(3) and [(125)I]T(3) were increased (P &lt; 0.005), but R was three-fold higher than in controls (P &lt; 0.005). Animals given 10 mug T(4)/100 g body wt per d for 5 d had significantly decreased N:M ratios for both [(131)I]T(3) and [(125)I]T(3), as well as a decreased value for R. In fasted rats, neither N:M ratio was depressed, although hepatic T(4) to T(3) conversion in the same animals was 50% of control (P &lt; 0.005). Iopanoic acid (13 muM), but not 6-n-propylthiouracil (29 muM), decreased the N:M [(125)I]T(3) with a significant decrease in the value for R (P &lt; 0.025 or less). Neither sodium iodide (6 muM) nor thyrotropin-releasing hormone (7-700 nM) affected the T(3) N:M ratios. These results indicate that intrapituitary T(4) to T(3) conversion is stimulated in hypothyroidism and depressed in T(4)-treated animals, whereas opposite changes occur in hepatic T(4)-5'-monodeiodination. Unlike liver, anterior pituitary T(4)-5'-monodeiodination is not affected by fasting or incubation with 6-n-propyl-2-thiouracil, but T(4) to T(3) conversion is inhibited in both by iopanoic acid. These results indicate that there are important differences between anterior pituitary and other tissues in the regulation of T(4)-5'-monodeiodination.\n",
      "Metabolism of resorcinylic compounds by bacteria. Purification and properties of orcinol hydroxylase from Pseudomonas putida 01. Orcinol hydroxylase (EC 1.14.13.6), which catalyzes the first reaction of orcinol catabolism in Pseudomonas putida 01, has been purified to homogeneity, and crystallized. Orcinol hydroxylase catalyzes the hydroxylation of orcinol with equimolar consumption of O2 and NADH (or NADPH) to 2, 3, 5-trihydroxytoluene, which is nonenzymically oxidized to a quinone. The visible absorption spectrum of the enzyme shows maxima at 373 and 454 nm and a shoulder at 480 nm. FAD can be dissociated from the protein. Reconstitution of enzymic activity was achieved with FAD, and to a limited extent by FMN. The enzyme has a molecular weight of 63,000 to 68,000 and contains 1 mol of FAD per mol of protein. K-m values for the three substrates orcinol, NADH, and O2 are 0.03, 0.13, and 0.07mM, RESPECTIVELY. The molecular activity of the crystalline enzyme is 1560 min minus 1. In the absence of orcinol, NADH is only slowly oxidized with formation of H2O2. Several analogs of orcinol also serve as substrates for hydroxylation, namely resorcinol, 4-methylresorcinol, and 4-bromoresorcinol. Other analogs, m-cresol, m-ethylphenol, 4-ethylresorcinol, and phloroglucinol, mimic orcinol as effectors, in that they (a) accelerate electron flow from NADH to the flavin and (b) decrease the apparent K-m for NADH but not to the same extent as the substrates that are hydroxylated. The latter compounds are not hydroxylated. Instead H2O2 accumulates as the only product of O2 reduction. The enzyme therefore behaves either as a hydroxylase or an oxidase. The ratio of hydroxylase to oxidase activities of the enzyme is decreased by an increase in the temperature of incubation; at 60 degrees the reaction with orcinol is almost 50% uncoupled from hydroxylation. The apparent K-m values for the effectors are in good agreement with the D-D values obtained for orcinol, resorcinol, and m-cresol. K-D values were obtained by measurement of the effector-induced perturbations of the visible absorption spectrum of the flavoprotein by difference absorption spectroscopy. The circular dichroism spectrum of orcinol hydroxylase is also altered in the presence of orcinol. The participation of the flavin in the over-all reaction is demonstrated by its rapid reduction under anaerobic conditions by NADH in the presence or orcinol, resorcinol, or m-cresol. Subsequent introduction of oxygen restores the oxidized form and yields H2O2 when m-cresol is the effector, but not when orcinol is the effector. Transfer of reducing equivalents from the reduced flavoprotein to free FAD may also occur. Reduction of orcinol hydroxylase by NADH in the absence of an effector is 10-4-fold slower than in the presence of an effector. The minimal structural requirements for effectors appear to be a 1,3-dihydroxy or 1-alkyl-3-hydorxybenzene, but only the former are substrates for hydroxylation.\n",
      "[Production and absorption rate of cerebrospinal fluid in the spinal subarachnoid space of the dog (author's transl)]. Adult mongrel dogs, weighing 10-17 kg. were anesthetized with Nembutal and cervical and lumbosacral laminectomy was performed. The spinal subarachnoid space was blocked by extradural ligation at the level of the C4 to interrupt CSF communication between the cranial and spinal space. Polyethylene catheters were placed in the cervical and lumbosacral subarachnoid space, and artificial Mock CSF buffer, pH 7.35-7.40, containing inulin of 25 mg/dl or 14C-inulin of 1.5-2 muCi/dl as a tracer was perfused in the sacro-cervical direction through the catheter. After a steady state of perfusion was acommplished, the CSF was collected from the outlet catheter. Production and absorption rate of the CSF were calculated after Pappenheimer and Heisey's equation. 1) Effects of CSF pressure on the rate of production (Vf) and absorption (Va) of CSF and on the difference between outflow fluid rate (Vo) and inflow fluid rate (Vi) were studied within the pressure range of -100 to +600 mmH2O. Then, regression lines were calculated by means of the least square method. See Article. Vf was little affected by changes in CSF pressure, while Va increased linearly as CSF pressure elevated. This suggests that the spinal subarachnoid space plays an important role as a site of CSF absorption when the intracranial pressure increases. Vo-Vi, that is difference between absorption and production rate, decreased linearly as the CSF pressure increased. 2) Under a constant CSF pressure of +200 mmH2O, the effects of glucocorticoids (dexamethasone, 0.25 mg/kg and hydrocortisone, 4.15 mg/kg) and a carbonic anhydrase inhibitor (acetazolamide, 10 mg/kg) upon the production and absorption rate of CSF were determined 1/2, 1, 2 and 3 hours after intravenous administration. a) Effect of dexamethasone: The rate of CSF production was reduced to 60.5 +/- 2.4% (p less than 0.001) of the control level. The absorption rate of CSF also decreased to 59.2 +/- 6.09% (p less than 0.001) of the control. b) Effect of hydrocortisone: The production rate of CSF decreased to 67.4 +/- 6.61% (p less than 0.001), and the absorption rate to 76.5 +/- 3.94% (p less than 0.001) of the control level. c) Effect of acetazolamide: The production and absorption rate also decreased to 57.2 +/- 5.61% (p less than 0.001) and to 56.9 +/- 7.02% (p less than 0.001), respectively. 3) Pentration of tritiated dexamethasone and tritiated hydrocortisone from plasma to CSF. The penetration of tritiated dexamethasone and tritiated hydrocortisone from plasma to CSF in the spinal and cranial subarachnoid space was observed after the intravenous administration. The CSF/Plasma ratio of dexamethasone was 30.9% at 15 minutes and gradually increased to 91.5% and 93.5%, respectively, in the cranial and spinal CSF at 3 hours after the injection.\n",
      "The role of sulfhydryl groups on the impaired hepatic 3',3,5-triiodothyronine generation from thyroxine in the hypothyroid, starved, fetal, and neonatal rodent. The role of nonprotein sulfhydryl groups (NPSH) in the decreased in vitro hepatic 3',3,5-triiodothyronine (T(3)) generation from thyroxine (T(4)) in the starved, hypothyroid, fetal and 1- to 4-d-old neonatal rat and dwarf mouse was assessed. NPSH were measured in fresh 25% liver homogenates prepared in 0.1 M PO(4)/10 mM EDTA buffer. As compared with values in adult male rats, NPSH concentration was decreased in the 2-d-starved (1.1+/-0.04 (mean+/-SE) vs. 2.2+/-0.15 mmol/250 g wet liver weight, P &lt; 0.001), fetal (1.0+/-0.04 vs. 3.2+/-0.08, P &lt; 0.001), 1-d-old neonatal (1.1+/-0.03 vs. 2.1+/-0.04, P &lt; 0.001), and hypothyroid (thyroidectomized 60 d) (1.4+/-0.06 vs. 2.2+/-0.15 P &lt; 0.001) rat. NPSH were also decreased in the hypothyroid, hypopituitary dwarf mouse as compared with values in their normal litter mates (1.3+/-0.03 vs. 2.0+/-0.2, P &lt; 0.01). Chronic administration of T(3) (0.5 mug/100 g body wt per d) markedly increased hepatic T(3) generation from T(4) in the thyroidectomized rat and in the dwarf mouse to values similar to those observed in the normal rodent without affecting NPSH concentration. In contrast, T(3) administration to the starved rat did not alter either hepatic T(3) generation from T(4) or NPSH. Reduced glutathione concentration was also markedly decreased in the starved rat (fed; 1.05+/-0.075 mmol/250 g wet tissue vs. starved 0.38+/-0.02, P &lt; 0.001). Dithiothreitol (DTT), a thiol reducing agent, increased hepatic T(3) generation from T(4) in the normal adult male rat by 45+/-5% in six experiments. When compared to DTT-stimulated control homogenates, the addition of DTT completely restored hepatic T(3) generation in starved rats, partially restored T(3) generation in 1- and 4-d-old neonates, but had little or no effect in the fetal and hypothyroid rat and dwarf mouse. Liver homogenates stored for 6 mo at -20 degrees C lost their capacity to generate T(3) from T(4). NPSH concentrations in the frozen homogenates decreased progressively with increasing storage and were absent by 6 mo. 5'-Deiodinase activity correlated with NPSH concentration in the stored homogenates (r = 0.95, P &lt; 0.005). Addition of DTT partially restored hepatic T(3) generation in the frozen homogenate. It is concluded that NPSH are important for the action of the liver 5'-deiodinase. The decreased hepatic T(3) generation in the starved rat is associated with decreased NPSH but not with a decrease in the absolute quantity of 5'-deiodinase because provision of sulfhydryl groups restored hepatic T(3) generation to normal. In contrast, the decreased hepatic T(3) generation in the adult hypothyroid rodent and in the fetal rat is probably due to a decrease in the enzyme concentration per se. In the 1- and 4-d neonatal rat, the decrease in hepatic T(3) generation is secondary to a decrease in NPSH and the deiodinating enzyme.\n",
      "\n",
      "Question: What is the distribution of 42S and 26S mRNA in BHK cells infected with Sindbis virus in relation to polyribosomes?\n",
      "\n",
      "Options:\n",
      "A. In BHK cells infected with Sindbis virus, most 42S mRNA is associated with free polyribosomes, while 26S mRNA is found in both free and membrane-bound polyribosomes, with the latter likely linked to the B1 protein and influenced by the limited rough endoplasmic reticulum.\n",
      "B. 42S mRNA is primarily found in membrane-bound polyribosomes, while 26S mRNA is only associated with free polyribosomes.\n",
      "C. Both 42S and 26S mRNA are exclusively found in the nucleocapsid of BHK cells infected with Sindbis virus.\n",
      "D. 26S mRNA is only associated with the rough endoplasmic reticulum, while 42S mRNA is found in the cytoplasm.\n",
      "\n",
      "Answer(pick one between A, B, C and D):\n",
      "Prompt: You are an expert in multiple-choice questions. Your task is to select the best answer from the given options based on the provided context. \n",
      "\n",
      "Context:\n",
      "3,3'-Diiodothyronine production, a major pathway of peripheral iodothyronine metabolism in man. 3,3'-Diiodothyronine (3,3'-T(2)) has been detected in human serum and in thyroglobulin. However, no quantitative assessment of its clearance rate (CR), production rate (PR), or of the importance of extrathyroidal sources of 3,3'-T(2) relative to direct thyroidal secretion is yet available. This study examines these parameters in seven euthyroid subjects, and in eight athyreotic subjects (H) eumetabolic due to thyroxine therapy (HT(4)) (n = 5) or triiodothyronine replacement (HT(3)) (n = 3). A highly specific radioimmunoassay for the measurement of 3,3'-T(2) in whole serum was developed. Serum 3,3'-T(2) concentrations were (mean +/- SD) 6.0+/-1.0 ng/100 ml in 13 normal subjects, 9.0+/-4.6 ng/100 ml in 25 hyperthyroid patients, and 2.7+/-1.1 ng/100 ml in 17 hypothyroid patients. The values in each of the latter two groups were significantly different from normal. 3,3'-T(2) was detected regularly in normal concentrations in 11 hypothyroid patients eumetabolic by treatment with synthetic T(4), in 10 eumetabolic patients suffering from nonthyroidal systemic illness, and in 2 subjects with elevated serum T(4)-binding globulin. The 3,3'-T(2) CR was assessed from data acquired from the (125)I-3,3'-T(2) constant infusion technique. The 3,3'-T(2) PR was calculated from CR and serum concentration of 3,3'-T(2) determined by radio-immunoassay. In the HT(4) subjects the 3,3'-T(2) CR averaged 840+/-377 liters/day and 3,3'-T(2) PR 33.9+/-12.5 mug/day. These results were not significantly different from those in the control group: 3,3'-T(2) CR 628+/-218 liters/day and 3,3'-T(2) PR 39.8+/-19.8 mug/day (all corrected to 70 kg body wt). In addition to 3,3'-T(2) PR, T(3), and reverse triiodothyronine (rT(3)) PR were determined in three of the HT(4) subjects. In each case studied, the 3,3'-T(2) PR was close to the combined triiodothyronine (T(3) + rT(3)) PR. The mean molar ratio of T(2) PR/(T(3) + rT(3)) PR was 1.08+/-0.10. The results obtained in the HT(4) subjects indicate that the production of 3,3'-T(2) is a major route of T(4) metabolism. The combined studies of 3,3'-T(2), T(3) and rT(3) PR in the HT(4) subjects indicate that both T(3) and rT(3) are major precursors of 3,3'-T(2). In the HT(3) subjects, the conversion of T(3) to 3,3'-T(2), determined as the molar ratio of 3,3'-T(2) PR to T(3) PR, ranged from 0.36 to 0.92, providing further evidence that T(3) is a precursor of 3,3'-T(2). From the close agreement between the mean values for 3,3'-T(2) PR in the euthyroid and HT(4) group it is concluded that most, if not all of the 3,3'-T(2) produced in normal humans is derived by extrathyroidal conversion from T(3) and rT(3).\n",
      "Physiological and pharmacological influences on thyroxine to 3,5,3'-triiodothyronine conversion and nuclear 3,5,3'-triiodothyronine binding in rat anterior pituitary. Our recent in vivo studies have suggested that intrapituitary l-thyroxine (T(4)) to 3,5,3'-triiodo-l-thyronine (T(3)) conversion with subsequent nuclear binding of T(3) is an important pathway by which circulating T(4) can inhibit thyrotropin release. The present studies were performed to evaluate various physiological and pharmacological influences on these two processes in rat anterior pituitary tissue. Intact pituitary fragments were incubated in buffer-1% bovine serum albumin containing 0.14 ng/ml [(131)I]T(3) and 3.8 ng/ml [(125)I]T(4). Nuclei were isolated after 3 h of incubation and the bound iodothyronines identified by paper chromatography. There was 0.3-1% [(125)I]T(3) contaminating the medium [(125)I]T(4), and this did not change during incubation. Nuclear [(125)I]T(4) was not decreased by 650-fold excesses of medium T(3) or T(4), suggesting that it was nonspecifically bound. The ratio of nuclear to medium [(131)I]- and [(125)I]T(3) were expressed as nuclear counts per minute per milligram wet weight of tissue:counts per minute per microliter medium. Intrapituitary T(4) to T(3) conversion was evidenced by the fact that the nuclear:medium (N:M) ratio for [(131)I]T(3) was 0.45+/-0.21, whereas that for [(125)I]T(3) was 2.23+/-1.28 (mean+/-SD, n = 51). A ratio (R), the N:M [(125)I]T(3) divided by the N:M [(131)I]T(3), was used as an index of intrapituitary T(4) to T(3) conversion. Increasing medium T(3) concentrations up to 50 ng/ml caused a progressive decrease in the N:M ratio for both T(3) isotopes, but no change in the value for R, indicating that both competed for the same limited-capacity nuclear receptors. Increasing concentrations of medium T(4) caused no change in the N:M [(131)I]T(3) but did cause a significant decrease in R in three of four experiments. These results suggest saturation of T(4)-5'-monodeiodination occurred at lower T(4) concentrations than saturation of nuclear T(3) binding sites. In hypothyroid rats, the N:M ratios for both [(131)I]T(3) and [(125)I]T(3) were increased (P &lt; 0.005), but R was three-fold higher than in controls (P &lt; 0.005). Animals given 10 mug T(4)/100 g body wt per d for 5 d had significantly decreased N:M ratios for both [(131)I]T(3) and [(125)I]T(3), as well as a decreased value for R. In fasted rats, neither N:M ratio was depressed, although hepatic T(4) to T(3) conversion in the same animals was 50% of control (P &lt; 0.005). Iopanoic acid (13 muM), but not 6-n-propylthiouracil (29 muM), decreased the N:M [(125)I]T(3) with a significant decrease in the value for R (P &lt; 0.025 or less). Neither sodium iodide (6 muM) nor thyrotropin-releasing hormone (7-700 nM) affected the T(3) N:M ratios. These results indicate that intrapituitary T(4) to T(3) conversion is stimulated in hypothyroidism and depressed in T(4)-treated animals, whereas opposite changes occur in hepatic T(4)-5'-monodeiodination. Unlike liver, anterior pituitary T(4)-5'-monodeiodination is not affected by fasting or incubation with 6-n-propyl-2-thiouracil, but T(4) to T(3) conversion is inhibited in both by iopanoic acid. These results indicate that there are important differences between anterior pituitary and other tissues in the regulation of T(4)-5'-monodeiodination.\n",
      "Metabolism of resorcinylic compounds by bacteria. Purification and properties of orcinol hydroxylase from Pseudomonas putida 01. Orcinol hydroxylase (EC 1.14.13.6), which catalyzes the first reaction of orcinol catabolism in Pseudomonas putida 01, has been purified to homogeneity, and crystallized. Orcinol hydroxylase catalyzes the hydroxylation of orcinol with equimolar consumption of O2 and NADH (or NADPH) to 2, 3, 5-trihydroxytoluene, which is nonenzymically oxidized to a quinone. The visible absorption spectrum of the enzyme shows maxima at 373 and 454 nm and a shoulder at 480 nm. FAD can be dissociated from the protein. Reconstitution of enzymic activity was achieved with FAD, and to a limited extent by FMN. The enzyme has a molecular weight of 63,000 to 68,000 and contains 1 mol of FAD per mol of protein. K-m values for the three substrates orcinol, NADH, and O2 are 0.03, 0.13, and 0.07mM, RESPECTIVELY. The molecular activity of the crystalline enzyme is 1560 min minus 1. In the absence of orcinol, NADH is only slowly oxidized with formation of H2O2. Several analogs of orcinol also serve as substrates for hydroxylation, namely resorcinol, 4-methylresorcinol, and 4-bromoresorcinol. Other analogs, m-cresol, m-ethylphenol, 4-ethylresorcinol, and phloroglucinol, mimic orcinol as effectors, in that they (a) accelerate electron flow from NADH to the flavin and (b) decrease the apparent K-m for NADH but not to the same extent as the substrates that are hydroxylated. The latter compounds are not hydroxylated. Instead H2O2 accumulates as the only product of O2 reduction. The enzyme therefore behaves either as a hydroxylase or an oxidase. The ratio of hydroxylase to oxidase activities of the enzyme is decreased by an increase in the temperature of incubation; at 60 degrees the reaction with orcinol is almost 50% uncoupled from hydroxylation. The apparent K-m values for the effectors are in good agreement with the D-D values obtained for orcinol, resorcinol, and m-cresol. K-D values were obtained by measurement of the effector-induced perturbations of the visible absorption spectrum of the flavoprotein by difference absorption spectroscopy. The circular dichroism spectrum of orcinol hydroxylase is also altered in the presence of orcinol. The participation of the flavin in the over-all reaction is demonstrated by its rapid reduction under anaerobic conditions by NADH in the presence or orcinol, resorcinol, or m-cresol. Subsequent introduction of oxygen restores the oxidized form and yields H2O2 when m-cresol is the effector, but not when orcinol is the effector. Transfer of reducing equivalents from the reduced flavoprotein to free FAD may also occur. Reduction of orcinol hydroxylase by NADH in the absence of an effector is 10-4-fold slower than in the presence of an effector. The minimal structural requirements for effectors appear to be a 1,3-dihydroxy or 1-alkyl-3-hydorxybenzene, but only the former are substrates for hydroxylation.\n",
      "[Production and absorption rate of cerebrospinal fluid in the spinal subarachnoid space of the dog (author's transl)]. Adult mongrel dogs, weighing 10-17 kg. were anesthetized with Nembutal and cervical and lumbosacral laminectomy was performed. The spinal subarachnoid space was blocked by extradural ligation at the level of the C4 to interrupt CSF communication between the cranial and spinal space. Polyethylene catheters were placed in the cervical and lumbosacral subarachnoid space, and artificial Mock CSF buffer, pH 7.35-7.40, containing inulin of 25 mg/dl or 14C-inulin of 1.5-2 muCi/dl as a tracer was perfused in the sacro-cervical direction through the catheter. After a steady state of perfusion was acommplished, the CSF was collected from the outlet catheter. Production and absorption rate of the CSF were calculated after Pappenheimer and Heisey's equation. 1) Effects of CSF pressure on the rate of production (Vf) and absorption (Va) of CSF and on the difference between outflow fluid rate (Vo) and inflow fluid rate (Vi) were studied within the pressure range of -100 to +600 mmH2O. Then, regression lines were calculated by means of the least square method. See Article. Vf was little affected by changes in CSF pressure, while Va increased linearly as CSF pressure elevated. This suggests that the spinal subarachnoid space plays an important role as a site of CSF absorption when the intracranial pressure increases. Vo-Vi, that is difference between absorption and production rate, decreased linearly as the CSF pressure increased. 2) Under a constant CSF pressure of +200 mmH2O, the effects of glucocorticoids (dexamethasone, 0.25 mg/kg and hydrocortisone, 4.15 mg/kg) and a carbonic anhydrase inhibitor (acetazolamide, 10 mg/kg) upon the production and absorption rate of CSF were determined 1/2, 1, 2 and 3 hours after intravenous administration. a) Effect of dexamethasone: The rate of CSF production was reduced to 60.5 +/- 2.4% (p less than 0.001) of the control level. The absorption rate of CSF also decreased to 59.2 +/- 6.09% (p less than 0.001) of the control. b) Effect of hydrocortisone: The production rate of CSF decreased to 67.4 +/- 6.61% (p less than 0.001), and the absorption rate to 76.5 +/- 3.94% (p less than 0.001) of the control level. c) Effect of acetazolamide: The production and absorption rate also decreased to 57.2 +/- 5.61% (p less than 0.001) and to 56.9 +/- 7.02% (p less than 0.001), respectively. 3) Pentration of tritiated dexamethasone and tritiated hydrocortisone from plasma to CSF. The penetration of tritiated dexamethasone and tritiated hydrocortisone from plasma to CSF in the spinal and cranial subarachnoid space was observed after the intravenous administration. The CSF/Plasma ratio of dexamethasone was 30.9% at 15 minutes and gradually increased to 91.5% and 93.5%, respectively, in the cranial and spinal CSF at 3 hours after the injection.\n",
      "The role of sulfhydryl groups on the impaired hepatic 3',3,5-triiodothyronine generation from thyroxine in the hypothyroid, starved, fetal, and neonatal rodent. The role of nonprotein sulfhydryl groups (NPSH) in the decreased in vitro hepatic 3',3,5-triiodothyronine (T(3)) generation from thyroxine (T(4)) in the starved, hypothyroid, fetal and 1- to 4-d-old neonatal rat and dwarf mouse was assessed. NPSH were measured in fresh 25% liver homogenates prepared in 0.1 M PO(4)/10 mM EDTA buffer. As compared with values in adult male rats, NPSH concentration was decreased in the 2-d-starved (1.1+/-0.04 (mean+/-SE) vs. 2.2+/-0.15 mmol/250 g wet liver weight, P &lt; 0.001), fetal (1.0+/-0.04 vs. 3.2+/-0.08, P &lt; 0.001), 1-d-old neonatal (1.1+/-0.03 vs. 2.1+/-0.04, P &lt; 0.001), and hypothyroid (thyroidectomized 60 d) (1.4+/-0.06 vs. 2.2+/-0.15 P &lt; 0.001) rat. NPSH were also decreased in the hypothyroid, hypopituitary dwarf mouse as compared with values in their normal litter mates (1.3+/-0.03 vs. 2.0+/-0.2, P &lt; 0.01). Chronic administration of T(3) (0.5 mug/100 g body wt per d) markedly increased hepatic T(3) generation from T(4) in the thyroidectomized rat and in the dwarf mouse to values similar to those observed in the normal rodent without affecting NPSH concentration. In contrast, T(3) administration to the starved rat did not alter either hepatic T(3) generation from T(4) or NPSH. Reduced glutathione concentration was also markedly decreased in the starved rat (fed; 1.05+/-0.075 mmol/250 g wet tissue vs. starved 0.38+/-0.02, P &lt; 0.001). Dithiothreitol (DTT), a thiol reducing agent, increased hepatic T(3) generation from T(4) in the normal adult male rat by 45+/-5% in six experiments. When compared to DTT-stimulated control homogenates, the addition of DTT completely restored hepatic T(3) generation in starved rats, partially restored T(3) generation in 1- and 4-d-old neonates, but had little or no effect in the fetal and hypothyroid rat and dwarf mouse. Liver homogenates stored for 6 mo at -20 degrees C lost their capacity to generate T(3) from T(4). NPSH concentrations in the frozen homogenates decreased progressively with increasing storage and were absent by 6 mo. 5'-Deiodinase activity correlated with NPSH concentration in the stored homogenates (r = 0.95, P &lt; 0.005). Addition of DTT partially restored hepatic T(3) generation in the frozen homogenate. It is concluded that NPSH are important for the action of the liver 5'-deiodinase. The decreased hepatic T(3) generation in the starved rat is associated with decreased NPSH but not with a decrease in the absolute quantity of 5'-deiodinase because provision of sulfhydryl groups restored hepatic T(3) generation to normal. In contrast, the decreased hepatic T(3) generation in the adult hypothyroid rodent and in the fetal rat is probably due to a decrease in the enzyme concentration per se. In the 1- and 4-d neonatal rat, the decrease in hepatic T(3) generation is secondary to a decrease in NPSH and the deiodinating enzyme.\n",
      "\n",
      "Question: What were the observed effects of ethanol on THC distribution and metabolism in mice, particularly regarding tolerance and cross-tolerance between the two substances?\n",
      "\n",
      "Options:\n",
      "A. Ethanol increased the metabolism of THC, leading to higher blood THC levels in mice.\n",
      "B. In mice, tolerance and cross-tolerance were observed between ethanol and delta-9-tetrahydrocannabinol (THC), with ethanol affecting THC distribution and hepatic metabolism without altering THC metabolism or blood ethanol elimination.\n",
      "C. Mice showed no tolerance to either ethanol or THC, regardless of previous exposure to the substances.\n",
      "D. Ethanol treatment decreased the distribution of THC in brain tissues without affecting hepatic metabolism.\n",
      "\n",
      "Answer(pick one between A, B, C and D):\n",
      "Prompt: You are an expert in multiple-choice questions. Your task is to select the best answer from the given options based on the provided context. \n",
      "\n",
      "Context:\n",
      "3,3'-Diiodothyronine production, a major pathway of peripheral iodothyronine metabolism in man. 3,3'-Diiodothyronine (3,3'-T(2)) has been detected in human serum and in thyroglobulin. However, no quantitative assessment of its clearance rate (CR), production rate (PR), or of the importance of extrathyroidal sources of 3,3'-T(2) relative to direct thyroidal secretion is yet available. This study examines these parameters in seven euthyroid subjects, and in eight athyreotic subjects (H) eumetabolic due to thyroxine therapy (HT(4)) (n = 5) or triiodothyronine replacement (HT(3)) (n = 3). A highly specific radioimmunoassay for the measurement of 3,3'-T(2) in whole serum was developed. Serum 3,3'-T(2) concentrations were (mean +/- SD) 6.0+/-1.0 ng/100 ml in 13 normal subjects, 9.0+/-4.6 ng/100 ml in 25 hyperthyroid patients, and 2.7+/-1.1 ng/100 ml in 17 hypothyroid patients. The values in each of the latter two groups were significantly different from normal. 3,3'-T(2) was detected regularly in normal concentrations in 11 hypothyroid patients eumetabolic by treatment with synthetic T(4), in 10 eumetabolic patients suffering from nonthyroidal systemic illness, and in 2 subjects with elevated serum T(4)-binding globulin. The 3,3'-T(2) CR was assessed from data acquired from the (125)I-3,3'-T(2) constant infusion technique. The 3,3'-T(2) PR was calculated from CR and serum concentration of 3,3'-T(2) determined by radio-immunoassay. In the HT(4) subjects the 3,3'-T(2) CR averaged 840+/-377 liters/day and 3,3'-T(2) PR 33.9+/-12.5 mug/day. These results were not significantly different from those in the control group: 3,3'-T(2) CR 628+/-218 liters/day and 3,3'-T(2) PR 39.8+/-19.8 mug/day (all corrected to 70 kg body wt). In addition to 3,3'-T(2) PR, T(3), and reverse triiodothyronine (rT(3)) PR were determined in three of the HT(4) subjects. In each case studied, the 3,3'-T(2) PR was close to the combined triiodothyronine (T(3) + rT(3)) PR. The mean molar ratio of T(2) PR/(T(3) + rT(3)) PR was 1.08+/-0.10. The results obtained in the HT(4) subjects indicate that the production of 3,3'-T(2) is a major route of T(4) metabolism. The combined studies of 3,3'-T(2), T(3) and rT(3) PR in the HT(4) subjects indicate that both T(3) and rT(3) are major precursors of 3,3'-T(2). In the HT(3) subjects, the conversion of T(3) to 3,3'-T(2), determined as the molar ratio of 3,3'-T(2) PR to T(3) PR, ranged from 0.36 to 0.92, providing further evidence that T(3) is a precursor of 3,3'-T(2). From the close agreement between the mean values for 3,3'-T(2) PR in the euthyroid and HT(4) group it is concluded that most, if not all of the 3,3'-T(2) produced in normal humans is derived by extrathyroidal conversion from T(3) and rT(3).\n",
      "Physiological and pharmacological influences on thyroxine to 3,5,3'-triiodothyronine conversion and nuclear 3,5,3'-triiodothyronine binding in rat anterior pituitary. Our recent in vivo studies have suggested that intrapituitary l-thyroxine (T(4)) to 3,5,3'-triiodo-l-thyronine (T(3)) conversion with subsequent nuclear binding of T(3) is an important pathway by which circulating T(4) can inhibit thyrotropin release. The present studies were performed to evaluate various physiological and pharmacological influences on these two processes in rat anterior pituitary tissue. Intact pituitary fragments were incubated in buffer-1% bovine serum albumin containing 0.14 ng/ml [(131)I]T(3) and 3.8 ng/ml [(125)I]T(4). Nuclei were isolated after 3 h of incubation and the bound iodothyronines identified by paper chromatography. There was 0.3-1% [(125)I]T(3) contaminating the medium [(125)I]T(4), and this did not change during incubation. Nuclear [(125)I]T(4) was not decreased by 650-fold excesses of medium T(3) or T(4), suggesting that it was nonspecifically bound. The ratio of nuclear to medium [(131)I]- and [(125)I]T(3) were expressed as nuclear counts per minute per milligram wet weight of tissue:counts per minute per microliter medium. Intrapituitary T(4) to T(3) conversion was evidenced by the fact that the nuclear:medium (N:M) ratio for [(131)I]T(3) was 0.45+/-0.21, whereas that for [(125)I]T(3) was 2.23+/-1.28 (mean+/-SD, n = 51). A ratio (R), the N:M [(125)I]T(3) divided by the N:M [(131)I]T(3), was used as an index of intrapituitary T(4) to T(3) conversion. Increasing medium T(3) concentrations up to 50 ng/ml caused a progressive decrease in the N:M ratio for both T(3) isotopes, but no change in the value for R, indicating that both competed for the same limited-capacity nuclear receptors. Increasing concentrations of medium T(4) caused no change in the N:M [(131)I]T(3) but did cause a significant decrease in R in three of four experiments. These results suggest saturation of T(4)-5'-monodeiodination occurred at lower T(4) concentrations than saturation of nuclear T(3) binding sites. In hypothyroid rats, the N:M ratios for both [(131)I]T(3) and [(125)I]T(3) were increased (P &lt; 0.005), but R was three-fold higher than in controls (P &lt; 0.005). Animals given 10 mug T(4)/100 g body wt per d for 5 d had significantly decreased N:M ratios for both [(131)I]T(3) and [(125)I]T(3), as well as a decreased value for R. In fasted rats, neither N:M ratio was depressed, although hepatic T(4) to T(3) conversion in the same animals was 50% of control (P &lt; 0.005). Iopanoic acid (13 muM), but not 6-n-propylthiouracil (29 muM), decreased the N:M [(125)I]T(3) with a significant decrease in the value for R (P &lt; 0.025 or less). Neither sodium iodide (6 muM) nor thyrotropin-releasing hormone (7-700 nM) affected the T(3) N:M ratios. These results indicate that intrapituitary T(4) to T(3) conversion is stimulated in hypothyroidism and depressed in T(4)-treated animals, whereas opposite changes occur in hepatic T(4)-5'-monodeiodination. Unlike liver, anterior pituitary T(4)-5'-monodeiodination is not affected by fasting or incubation with 6-n-propyl-2-thiouracil, but T(4) to T(3) conversion is inhibited in both by iopanoic acid. These results indicate that there are important differences between anterior pituitary and other tissues in the regulation of T(4)-5'-monodeiodination.\n",
      "Metabolism of resorcinylic compounds by bacteria. Purification and properties of orcinol hydroxylase from Pseudomonas putida 01. Orcinol hydroxylase (EC 1.14.13.6), which catalyzes the first reaction of orcinol catabolism in Pseudomonas putida 01, has been purified to homogeneity, and crystallized. Orcinol hydroxylase catalyzes the hydroxylation of orcinol with equimolar consumption of O2 and NADH (or NADPH) to 2, 3, 5-trihydroxytoluene, which is nonenzymically oxidized to a quinone. The visible absorption spectrum of the enzyme shows maxima at 373 and 454 nm and a shoulder at 480 nm. FAD can be dissociated from the protein. Reconstitution of enzymic activity was achieved with FAD, and to a limited extent by FMN. The enzyme has a molecular weight of 63,000 to 68,000 and contains 1 mol of FAD per mol of protein. K-m values for the three substrates orcinol, NADH, and O2 are 0.03, 0.13, and 0.07mM, RESPECTIVELY. The molecular activity of the crystalline enzyme is 1560 min minus 1. In the absence of orcinol, NADH is only slowly oxidized with formation of H2O2. Several analogs of orcinol also serve as substrates for hydroxylation, namely resorcinol, 4-methylresorcinol, and 4-bromoresorcinol. Other analogs, m-cresol, m-ethylphenol, 4-ethylresorcinol, and phloroglucinol, mimic orcinol as effectors, in that they (a) accelerate electron flow from NADH to the flavin and (b) decrease the apparent K-m for NADH but not to the same extent as the substrates that are hydroxylated. The latter compounds are not hydroxylated. Instead H2O2 accumulates as the only product of O2 reduction. The enzyme therefore behaves either as a hydroxylase or an oxidase. The ratio of hydroxylase to oxidase activities of the enzyme is decreased by an increase in the temperature of incubation; at 60 degrees the reaction with orcinol is almost 50% uncoupled from hydroxylation. The apparent K-m values for the effectors are in good agreement with the D-D values obtained for orcinol, resorcinol, and m-cresol. K-D values were obtained by measurement of the effector-induced perturbations of the visible absorption spectrum of the flavoprotein by difference absorption spectroscopy. The circular dichroism spectrum of orcinol hydroxylase is also altered in the presence of orcinol. The participation of the flavin in the over-all reaction is demonstrated by its rapid reduction under anaerobic conditions by NADH in the presence or orcinol, resorcinol, or m-cresol. Subsequent introduction of oxygen restores the oxidized form and yields H2O2 when m-cresol is the effector, but not when orcinol is the effector. Transfer of reducing equivalents from the reduced flavoprotein to free FAD may also occur. Reduction of orcinol hydroxylase by NADH in the absence of an effector is 10-4-fold slower than in the presence of an effector. The minimal structural requirements for effectors appear to be a 1,3-dihydroxy or 1-alkyl-3-hydorxybenzene, but only the former are substrates for hydroxylation.\n",
      "[Production and absorption rate of cerebrospinal fluid in the spinal subarachnoid space of the dog (author's transl)]. Adult mongrel dogs, weighing 10-17 kg. were anesthetized with Nembutal and cervical and lumbosacral laminectomy was performed. The spinal subarachnoid space was blocked by extradural ligation at the level of the C4 to interrupt CSF communication between the cranial and spinal space. Polyethylene catheters were placed in the cervical and lumbosacral subarachnoid space, and artificial Mock CSF buffer, pH 7.35-7.40, containing inulin of 25 mg/dl or 14C-inulin of 1.5-2 muCi/dl as a tracer was perfused in the sacro-cervical direction through the catheter. After a steady state of perfusion was acommplished, the CSF was collected from the outlet catheter. Production and absorption rate of the CSF were calculated after Pappenheimer and Heisey's equation. 1) Effects of CSF pressure on the rate of production (Vf) and absorption (Va) of CSF and on the difference between outflow fluid rate (Vo) and inflow fluid rate (Vi) were studied within the pressure range of -100 to +600 mmH2O. Then, regression lines were calculated by means of the least square method. See Article. Vf was little affected by changes in CSF pressure, while Va increased linearly as CSF pressure elevated. This suggests that the spinal subarachnoid space plays an important role as a site of CSF absorption when the intracranial pressure increases. Vo-Vi, that is difference between absorption and production rate, decreased linearly as the CSF pressure increased. 2) Under a constant CSF pressure of +200 mmH2O, the effects of glucocorticoids (dexamethasone, 0.25 mg/kg and hydrocortisone, 4.15 mg/kg) and a carbonic anhydrase inhibitor (acetazolamide, 10 mg/kg) upon the production and absorption rate of CSF were determined 1/2, 1, 2 and 3 hours after intravenous administration. a) Effect of dexamethasone: The rate of CSF production was reduced to 60.5 +/- 2.4% (p less than 0.001) of the control level. The absorption rate of CSF also decreased to 59.2 +/- 6.09% (p less than 0.001) of the control. b) Effect of hydrocortisone: The production rate of CSF decreased to 67.4 +/- 6.61% (p less than 0.001), and the absorption rate to 76.5 +/- 3.94% (p less than 0.001) of the control level. c) Effect of acetazolamide: The production and absorption rate also decreased to 57.2 +/- 5.61% (p less than 0.001) and to 56.9 +/- 7.02% (p less than 0.001), respectively. 3) Pentration of tritiated dexamethasone and tritiated hydrocortisone from plasma to CSF. The penetration of tritiated dexamethasone and tritiated hydrocortisone from plasma to CSF in the spinal and cranial subarachnoid space was observed after the intravenous administration. The CSF/Plasma ratio of dexamethasone was 30.9% at 15 minutes and gradually increased to 91.5% and 93.5%, respectively, in the cranial and spinal CSF at 3 hours after the injection.\n",
      "The role of sulfhydryl groups on the impaired hepatic 3',3,5-triiodothyronine generation from thyroxine in the hypothyroid, starved, fetal, and neonatal rodent. The role of nonprotein sulfhydryl groups (NPSH) in the decreased in vitro hepatic 3',3,5-triiodothyronine (T(3)) generation from thyroxine (T(4)) in the starved, hypothyroid, fetal and 1- to 4-d-old neonatal rat and dwarf mouse was assessed. NPSH were measured in fresh 25% liver homogenates prepared in 0.1 M PO(4)/10 mM EDTA buffer. As compared with values in adult male rats, NPSH concentration was decreased in the 2-d-starved (1.1+/-0.04 (mean+/-SE) vs. 2.2+/-0.15 mmol/250 g wet liver weight, P &lt; 0.001), fetal (1.0+/-0.04 vs. 3.2+/-0.08, P &lt; 0.001), 1-d-old neonatal (1.1+/-0.03 vs. 2.1+/-0.04, P &lt; 0.001), and hypothyroid (thyroidectomized 60 d) (1.4+/-0.06 vs. 2.2+/-0.15 P &lt; 0.001) rat. NPSH were also decreased in the hypothyroid, hypopituitary dwarf mouse as compared with values in their normal litter mates (1.3+/-0.03 vs. 2.0+/-0.2, P &lt; 0.01). Chronic administration of T(3) (0.5 mug/100 g body wt per d) markedly increased hepatic T(3) generation from T(4) in the thyroidectomized rat and in the dwarf mouse to values similar to those observed in the normal rodent without affecting NPSH concentration. In contrast, T(3) administration to the starved rat did not alter either hepatic T(3) generation from T(4) or NPSH. Reduced glutathione concentration was also markedly decreased in the starved rat (fed; 1.05+/-0.075 mmol/250 g wet tissue vs. starved 0.38+/-0.02, P &lt; 0.001). Dithiothreitol (DTT), a thiol reducing agent, increased hepatic T(3) generation from T(4) in the normal adult male rat by 45+/-5% in six experiments. When compared to DTT-stimulated control homogenates, the addition of DTT completely restored hepatic T(3) generation in starved rats, partially restored T(3) generation in 1- and 4-d-old neonates, but had little or no effect in the fetal and hypothyroid rat and dwarf mouse. Liver homogenates stored for 6 mo at -20 degrees C lost their capacity to generate T(3) from T(4). NPSH concentrations in the frozen homogenates decreased progressively with increasing storage and were absent by 6 mo. 5'-Deiodinase activity correlated with NPSH concentration in the stored homogenates (r = 0.95, P &lt; 0.005). Addition of DTT partially restored hepatic T(3) generation in the frozen homogenate. It is concluded that NPSH are important for the action of the liver 5'-deiodinase. The decreased hepatic T(3) generation in the starved rat is associated with decreased NPSH but not with a decrease in the absolute quantity of 5'-deiodinase because provision of sulfhydryl groups restored hepatic T(3) generation to normal. In contrast, the decreased hepatic T(3) generation in the adult hypothyroid rodent and in the fetal rat is probably due to a decrease in the enzyme concentration per se. In the 1- and 4-d neonatal rat, the decrease in hepatic T(3) generation is secondary to a decrease in NPSH and the deiodinating enzyme.\n",
      "\n",
      "Question: What method allows for the precise genetic analysis of defined DNA sequences, facilitating the investigation of 5S gene function and the effects of mutations in recombinant plasmids?\n",
      "\n",
      "Options:\n",
      "A. The combination of DNA cloning in bacterial plasmids and DNA injection into Xenopus oocyte nuclei enables precise genetic analysis of defined DNA sequences, allowing for the investigation of 5S gene function and the effects of mutations in recombinant plasmids.\n",
      "B. Using CRISPR-Cas9 gene editing to directly modify the 5S gene sequences in vivo.\n",
      "C. Employing RNA interference (RNAi) to silence the expression of the 5S genes in Xenopus oocytes.\n",
      "D. Performing whole genome sequencing to analyze the effects of mutations on the 5S gene function.\n",
      "\n",
      "Answer(pick one between A, B, C and D):\n",
      "Prompt: You are an expert in multiple-choice questions. Your task is to select the best answer from the given options based on the provided context. \n",
      "\n",
      "Context:\n",
      "3,3'-Diiodothyronine production, a major pathway of peripheral iodothyronine metabolism in man. 3,3'-Diiodothyronine (3,3'-T(2)) has been detected in human serum and in thyroglobulin. However, no quantitative assessment of its clearance rate (CR), production rate (PR), or of the importance of extrathyroidal sources of 3,3'-T(2) relative to direct thyroidal secretion is yet available. This study examines these parameters in seven euthyroid subjects, and in eight athyreotic subjects (H) eumetabolic due to thyroxine therapy (HT(4)) (n = 5) or triiodothyronine replacement (HT(3)) (n = 3). A highly specific radioimmunoassay for the measurement of 3,3'-T(2) in whole serum was developed. Serum 3,3'-T(2) concentrations were (mean +/- SD) 6.0+/-1.0 ng/100 ml in 13 normal subjects, 9.0+/-4.6 ng/100 ml in 25 hyperthyroid patients, and 2.7+/-1.1 ng/100 ml in 17 hypothyroid patients. The values in each of the latter two groups were significantly different from normal. 3,3'-T(2) was detected regularly in normal concentrations in 11 hypothyroid patients eumetabolic by treatment with synthetic T(4), in 10 eumetabolic patients suffering from nonthyroidal systemic illness, and in 2 subjects with elevated serum T(4)-binding globulin. The 3,3'-T(2) CR was assessed from data acquired from the (125)I-3,3'-T(2) constant infusion technique. The 3,3'-T(2) PR was calculated from CR and serum concentration of 3,3'-T(2) determined by radio-immunoassay. In the HT(4) subjects the 3,3'-T(2) CR averaged 840+/-377 liters/day and 3,3'-T(2) PR 33.9+/-12.5 mug/day. These results were not significantly different from those in the control group: 3,3'-T(2) CR 628+/-218 liters/day and 3,3'-T(2) PR 39.8+/-19.8 mug/day (all corrected to 70 kg body wt). In addition to 3,3'-T(2) PR, T(3), and reverse triiodothyronine (rT(3)) PR were determined in three of the HT(4) subjects. In each case studied, the 3,3'-T(2) PR was close to the combined triiodothyronine (T(3) + rT(3)) PR. The mean molar ratio of T(2) PR/(T(3) + rT(3)) PR was 1.08+/-0.10. The results obtained in the HT(4) subjects indicate that the production of 3,3'-T(2) is a major route of T(4) metabolism. The combined studies of 3,3'-T(2), T(3) and rT(3) PR in the HT(4) subjects indicate that both T(3) and rT(3) are major precursors of 3,3'-T(2). In the HT(3) subjects, the conversion of T(3) to 3,3'-T(2), determined as the molar ratio of 3,3'-T(2) PR to T(3) PR, ranged from 0.36 to 0.92, providing further evidence that T(3) is a precursor of 3,3'-T(2). From the close agreement between the mean values for 3,3'-T(2) PR in the euthyroid and HT(4) group it is concluded that most, if not all of the 3,3'-T(2) produced in normal humans is derived by extrathyroidal conversion from T(3) and rT(3).\n",
      "Physiological and pharmacological influences on thyroxine to 3,5,3'-triiodothyronine conversion and nuclear 3,5,3'-triiodothyronine binding in rat anterior pituitary. Our recent in vivo studies have suggested that intrapituitary l-thyroxine (T(4)) to 3,5,3'-triiodo-l-thyronine (T(3)) conversion with subsequent nuclear binding of T(3) is an important pathway by which circulating T(4) can inhibit thyrotropin release. The present studies were performed to evaluate various physiological and pharmacological influences on these two processes in rat anterior pituitary tissue. Intact pituitary fragments were incubated in buffer-1% bovine serum albumin containing 0.14 ng/ml [(131)I]T(3) and 3.8 ng/ml [(125)I]T(4). Nuclei were isolated after 3 h of incubation and the bound iodothyronines identified by paper chromatography. There was 0.3-1% [(125)I]T(3) contaminating the medium [(125)I]T(4), and this did not change during incubation. Nuclear [(125)I]T(4) was not decreased by 650-fold excesses of medium T(3) or T(4), suggesting that it was nonspecifically bound. The ratio of nuclear to medium [(131)I]- and [(125)I]T(3) were expressed as nuclear counts per minute per milligram wet weight of tissue:counts per minute per microliter medium. Intrapituitary T(4) to T(3) conversion was evidenced by the fact that the nuclear:medium (N:M) ratio for [(131)I]T(3) was 0.45+/-0.21, whereas that for [(125)I]T(3) was 2.23+/-1.28 (mean+/-SD, n = 51). A ratio (R), the N:M [(125)I]T(3) divided by the N:M [(131)I]T(3), was used as an index of intrapituitary T(4) to T(3) conversion. Increasing medium T(3) concentrations up to 50 ng/ml caused a progressive decrease in the N:M ratio for both T(3) isotopes, but no change in the value for R, indicating that both competed for the same limited-capacity nuclear receptors. Increasing concentrations of medium T(4) caused no change in the N:M [(131)I]T(3) but did cause a significant decrease in R in three of four experiments. These results suggest saturation of T(4)-5'-monodeiodination occurred at lower T(4) concentrations than saturation of nuclear T(3) binding sites. In hypothyroid rats, the N:M ratios for both [(131)I]T(3) and [(125)I]T(3) were increased (P &lt; 0.005), but R was three-fold higher than in controls (P &lt; 0.005). Animals given 10 mug T(4)/100 g body wt per d for 5 d had significantly decreased N:M ratios for both [(131)I]T(3) and [(125)I]T(3), as well as a decreased value for R. In fasted rats, neither N:M ratio was depressed, although hepatic T(4) to T(3) conversion in the same animals was 50% of control (P &lt; 0.005). Iopanoic acid (13 muM), but not 6-n-propylthiouracil (29 muM), decreased the N:M [(125)I]T(3) with a significant decrease in the value for R (P &lt; 0.025 or less). Neither sodium iodide (6 muM) nor thyrotropin-releasing hormone (7-700 nM) affected the T(3) N:M ratios. These results indicate that intrapituitary T(4) to T(3) conversion is stimulated in hypothyroidism and depressed in T(4)-treated animals, whereas opposite changes occur in hepatic T(4)-5'-monodeiodination. Unlike liver, anterior pituitary T(4)-5'-monodeiodination is not affected by fasting or incubation with 6-n-propyl-2-thiouracil, but T(4) to T(3) conversion is inhibited in both by iopanoic acid. These results indicate that there are important differences between anterior pituitary and other tissues in the regulation of T(4)-5'-monodeiodination.\n",
      "Metabolism of resorcinylic compounds by bacteria. Purification and properties of orcinol hydroxylase from Pseudomonas putida 01. Orcinol hydroxylase (EC 1.14.13.6), which catalyzes the first reaction of orcinol catabolism in Pseudomonas putida 01, has been purified to homogeneity, and crystallized. Orcinol hydroxylase catalyzes the hydroxylation of orcinol with equimolar consumption of O2 and NADH (or NADPH) to 2, 3, 5-trihydroxytoluene, which is nonenzymically oxidized to a quinone. The visible absorption spectrum of the enzyme shows maxima at 373 and 454 nm and a shoulder at 480 nm. FAD can be dissociated from the protein. Reconstitution of enzymic activity was achieved with FAD, and to a limited extent by FMN. The enzyme has a molecular weight of 63,000 to 68,000 and contains 1 mol of FAD per mol of protein. K-m values for the three substrates orcinol, NADH, and O2 are 0.03, 0.13, and 0.07mM, RESPECTIVELY. The molecular activity of the crystalline enzyme is 1560 min minus 1. In the absence of orcinol, NADH is only slowly oxidized with formation of H2O2. Several analogs of orcinol also serve as substrates for hydroxylation, namely resorcinol, 4-methylresorcinol, and 4-bromoresorcinol. Other analogs, m-cresol, m-ethylphenol, 4-ethylresorcinol, and phloroglucinol, mimic orcinol as effectors, in that they (a) accelerate electron flow from NADH to the flavin and (b) decrease the apparent K-m for NADH but not to the same extent as the substrates that are hydroxylated. The latter compounds are not hydroxylated. Instead H2O2 accumulates as the only product of O2 reduction. The enzyme therefore behaves either as a hydroxylase or an oxidase. The ratio of hydroxylase to oxidase activities of the enzyme is decreased by an increase in the temperature of incubation; at 60 degrees the reaction with orcinol is almost 50% uncoupled from hydroxylation. The apparent K-m values for the effectors are in good agreement with the D-D values obtained for orcinol, resorcinol, and m-cresol. K-D values were obtained by measurement of the effector-induced perturbations of the visible absorption spectrum of the flavoprotein by difference absorption spectroscopy. The circular dichroism spectrum of orcinol hydroxylase is also altered in the presence of orcinol. The participation of the flavin in the over-all reaction is demonstrated by its rapid reduction under anaerobic conditions by NADH in the presence or orcinol, resorcinol, or m-cresol. Subsequent introduction of oxygen restores the oxidized form and yields H2O2 when m-cresol is the effector, but not when orcinol is the effector. Transfer of reducing equivalents from the reduced flavoprotein to free FAD may also occur. Reduction of orcinol hydroxylase by NADH in the absence of an effector is 10-4-fold slower than in the presence of an effector. The minimal structural requirements for effectors appear to be a 1,3-dihydroxy or 1-alkyl-3-hydorxybenzene, but only the former are substrates for hydroxylation.\n",
      "[Production and absorption rate of cerebrospinal fluid in the spinal subarachnoid space of the dog (author's transl)]. Adult mongrel dogs, weighing 10-17 kg. were anesthetized with Nembutal and cervical and lumbosacral laminectomy was performed. The spinal subarachnoid space was blocked by extradural ligation at the level of the C4 to interrupt CSF communication between the cranial and spinal space. Polyethylene catheters were placed in the cervical and lumbosacral subarachnoid space, and artificial Mock CSF buffer, pH 7.35-7.40, containing inulin of 25 mg/dl or 14C-inulin of 1.5-2 muCi/dl as a tracer was perfused in the sacro-cervical direction through the catheter. After a steady state of perfusion was acommplished, the CSF was collected from the outlet catheter. Production and absorption rate of the CSF were calculated after Pappenheimer and Heisey's equation. 1) Effects of CSF pressure on the rate of production (Vf) and absorption (Va) of CSF and on the difference between outflow fluid rate (Vo) and inflow fluid rate (Vi) were studied within the pressure range of -100 to +600 mmH2O. Then, regression lines were calculated by means of the least square method. See Article. Vf was little affected by changes in CSF pressure, while Va increased linearly as CSF pressure elevated. This suggests that the spinal subarachnoid space plays an important role as a site of CSF absorption when the intracranial pressure increases. Vo-Vi, that is difference between absorption and production rate, decreased linearly as the CSF pressure increased. 2) Under a constant CSF pressure of +200 mmH2O, the effects of glucocorticoids (dexamethasone, 0.25 mg/kg and hydrocortisone, 4.15 mg/kg) and a carbonic anhydrase inhibitor (acetazolamide, 10 mg/kg) upon the production and absorption rate of CSF were determined 1/2, 1, 2 and 3 hours after intravenous administration. a) Effect of dexamethasone: The rate of CSF production was reduced to 60.5 +/- 2.4% (p less than 0.001) of the control level. The absorption rate of CSF also decreased to 59.2 +/- 6.09% (p less than 0.001) of the control. b) Effect of hydrocortisone: The production rate of CSF decreased to 67.4 +/- 6.61% (p less than 0.001), and the absorption rate to 76.5 +/- 3.94% (p less than 0.001) of the control level. c) Effect of acetazolamide: The production and absorption rate also decreased to 57.2 +/- 5.61% (p less than 0.001) and to 56.9 +/- 7.02% (p less than 0.001), respectively. 3) Pentration of tritiated dexamethasone and tritiated hydrocortisone from plasma to CSF. The penetration of tritiated dexamethasone and tritiated hydrocortisone from plasma to CSF in the spinal and cranial subarachnoid space was observed after the intravenous administration. The CSF/Plasma ratio of dexamethasone was 30.9% at 15 minutes and gradually increased to 91.5% and 93.5%, respectively, in the cranial and spinal CSF at 3 hours after the injection.\n",
      "The role of sulfhydryl groups on the impaired hepatic 3',3,5-triiodothyronine generation from thyroxine in the hypothyroid, starved, fetal, and neonatal rodent. The role of nonprotein sulfhydryl groups (NPSH) in the decreased in vitro hepatic 3',3,5-triiodothyronine (T(3)) generation from thyroxine (T(4)) in the starved, hypothyroid, fetal and 1- to 4-d-old neonatal rat and dwarf mouse was assessed. NPSH were measured in fresh 25% liver homogenates prepared in 0.1 M PO(4)/10 mM EDTA buffer. As compared with values in adult male rats, NPSH concentration was decreased in the 2-d-starved (1.1+/-0.04 (mean+/-SE) vs. 2.2+/-0.15 mmol/250 g wet liver weight, P &lt; 0.001), fetal (1.0+/-0.04 vs. 3.2+/-0.08, P &lt; 0.001), 1-d-old neonatal (1.1+/-0.03 vs. 2.1+/-0.04, P &lt; 0.001), and hypothyroid (thyroidectomized 60 d) (1.4+/-0.06 vs. 2.2+/-0.15 P &lt; 0.001) rat. NPSH were also decreased in the hypothyroid, hypopituitary dwarf mouse as compared with values in their normal litter mates (1.3+/-0.03 vs. 2.0+/-0.2, P &lt; 0.01). Chronic administration of T(3) (0.5 mug/100 g body wt per d) markedly increased hepatic T(3) generation from T(4) in the thyroidectomized rat and in the dwarf mouse to values similar to those observed in the normal rodent without affecting NPSH concentration. In contrast, T(3) administration to the starved rat did not alter either hepatic T(3) generation from T(4) or NPSH. Reduced glutathione concentration was also markedly decreased in the starved rat (fed; 1.05+/-0.075 mmol/250 g wet tissue vs. starved 0.38+/-0.02, P &lt; 0.001). Dithiothreitol (DTT), a thiol reducing agent, increased hepatic T(3) generation from T(4) in the normal adult male rat by 45+/-5% in six experiments. When compared to DTT-stimulated control homogenates, the addition of DTT completely restored hepatic T(3) generation in starved rats, partially restored T(3) generation in 1- and 4-d-old neonates, but had little or no effect in the fetal and hypothyroid rat and dwarf mouse. Liver homogenates stored for 6 mo at -20 degrees C lost their capacity to generate T(3) from T(4). NPSH concentrations in the frozen homogenates decreased progressively with increasing storage and were absent by 6 mo. 5'-Deiodinase activity correlated with NPSH concentration in the stored homogenates (r = 0.95, P &lt; 0.005). Addition of DTT partially restored hepatic T(3) generation in the frozen homogenate. It is concluded that NPSH are important for the action of the liver 5'-deiodinase. The decreased hepatic T(3) generation in the starved rat is associated with decreased NPSH but not with a decrease in the absolute quantity of 5'-deiodinase because provision of sulfhydryl groups restored hepatic T(3) generation to normal. In contrast, the decreased hepatic T(3) generation in the adult hypothyroid rodent and in the fetal rat is probably due to a decrease in the enzyme concentration per se. In the 1- and 4-d neonatal rat, the decrease in hepatic T(3) generation is secondary to a decrease in NPSH and the deiodinating enzyme.\n",
      "\n",
      "Question: How did hand blood flow during exercise in 33Â°C heat differ among Europeans without heat acclimation, Europeans acclimatized in India, and Indians in their natural environment?\n",
      "\n",
      "Options:\n",
      "A. The study found that hand blood flow varied significantly among Europeans without heat acclimation, Europeans acclimatized in India, and Indians in their natural environment during exercise in 33Â°C heat, with the highest flow in unacclimated Europeans and the lowest in Indians.\n",
      "B. Hand blood flow was highest in Indians and lowest in Europeans without heat acclimation.\n",
      "C. All groups showed similar hand blood flow levels during exercise regardless of acclimatization.\n",
      "D. Europeans acclimatized in India had the highest hand blood flow, while unacclimated Europeans had the lowest.\n",
      "\n",
      "Answer(pick one between A, B, C and D):\n",
      "Prompt: You are an expert in multiple-choice questions. Your task is to select the best answer from the given options based on the provided context. \n",
      "\n",
      "Context:\n",
      "3,3'-Diiodothyronine production, a major pathway of peripheral iodothyronine metabolism in man. 3,3'-Diiodothyronine (3,3'-T(2)) has been detected in human serum and in thyroglobulin. However, no quantitative assessment of its clearance rate (CR), production rate (PR), or of the importance of extrathyroidal sources of 3,3'-T(2) relative to direct thyroidal secretion is yet available. This study examines these parameters in seven euthyroid subjects, and in eight athyreotic subjects (H) eumetabolic due to thyroxine therapy (HT(4)) (n = 5) or triiodothyronine replacement (HT(3)) (n = 3). A highly specific radioimmunoassay for the measurement of 3,3'-T(2) in whole serum was developed. Serum 3,3'-T(2) concentrations were (mean +/- SD) 6.0+/-1.0 ng/100 ml in 13 normal subjects, 9.0+/-4.6 ng/100 ml in 25 hyperthyroid patients, and 2.7+/-1.1 ng/100 ml in 17 hypothyroid patients. The values in each of the latter two groups were significantly different from normal. 3,3'-T(2) was detected regularly in normal concentrations in 11 hypothyroid patients eumetabolic by treatment with synthetic T(4), in 10 eumetabolic patients suffering from nonthyroidal systemic illness, and in 2 subjects with elevated serum T(4)-binding globulin. The 3,3'-T(2) CR was assessed from data acquired from the (125)I-3,3'-T(2) constant infusion technique. The 3,3'-T(2) PR was calculated from CR and serum concentration of 3,3'-T(2) determined by radio-immunoassay. In the HT(4) subjects the 3,3'-T(2) CR averaged 840+/-377 liters/day and 3,3'-T(2) PR 33.9+/-12.5 mug/day. These results were not significantly different from those in the control group: 3,3'-T(2) CR 628+/-218 liters/day and 3,3'-T(2) PR 39.8+/-19.8 mug/day (all corrected to 70 kg body wt). In addition to 3,3'-T(2) PR, T(3), and reverse triiodothyronine (rT(3)) PR were determined in three of the HT(4) subjects. In each case studied, the 3,3'-T(2) PR was close to the combined triiodothyronine (T(3) + rT(3)) PR. The mean molar ratio of T(2) PR/(T(3) + rT(3)) PR was 1.08+/-0.10. The results obtained in the HT(4) subjects indicate that the production of 3,3'-T(2) is a major route of T(4) metabolism. The combined studies of 3,3'-T(2), T(3) and rT(3) PR in the HT(4) subjects indicate that both T(3) and rT(3) are major precursors of 3,3'-T(2). In the HT(3) subjects, the conversion of T(3) to 3,3'-T(2), determined as the molar ratio of 3,3'-T(2) PR to T(3) PR, ranged from 0.36 to 0.92, providing further evidence that T(3) is a precursor of 3,3'-T(2). From the close agreement between the mean values for 3,3'-T(2) PR in the euthyroid and HT(4) group it is concluded that most, if not all of the 3,3'-T(2) produced in normal humans is derived by extrathyroidal conversion from T(3) and rT(3).\n",
      "Physiological and pharmacological influences on thyroxine to 3,5,3'-triiodothyronine conversion and nuclear 3,5,3'-triiodothyronine binding in rat anterior pituitary. Our recent in vivo studies have suggested that intrapituitary l-thyroxine (T(4)) to 3,5,3'-triiodo-l-thyronine (T(3)) conversion with subsequent nuclear binding of T(3) is an important pathway by which circulating T(4) can inhibit thyrotropin release. The present studies were performed to evaluate various physiological and pharmacological influences on these two processes in rat anterior pituitary tissue. Intact pituitary fragments were incubated in buffer-1% bovine serum albumin containing 0.14 ng/ml [(131)I]T(3) and 3.8 ng/ml [(125)I]T(4). Nuclei were isolated after 3 h of incubation and the bound iodothyronines identified by paper chromatography. There was 0.3-1% [(125)I]T(3) contaminating the medium [(125)I]T(4), and this did not change during incubation. Nuclear [(125)I]T(4) was not decreased by 650-fold excesses of medium T(3) or T(4), suggesting that it was nonspecifically bound. The ratio of nuclear to medium [(131)I]- and [(125)I]T(3) were expressed as nuclear counts per minute per milligram wet weight of tissue:counts per minute per microliter medium. Intrapituitary T(4) to T(3) conversion was evidenced by the fact that the nuclear:medium (N:M) ratio for [(131)I]T(3) was 0.45+/-0.21, whereas that for [(125)I]T(3) was 2.23+/-1.28 (mean+/-SD, n = 51). A ratio (R), the N:M [(125)I]T(3) divided by the N:M [(131)I]T(3), was used as an index of intrapituitary T(4) to T(3) conversion. Increasing medium T(3) concentrations up to 50 ng/ml caused a progressive decrease in the N:M ratio for both T(3) isotopes, but no change in the value for R, indicating that both competed for the same limited-capacity nuclear receptors. Increasing concentrations of medium T(4) caused no change in the N:M [(131)I]T(3) but did cause a significant decrease in R in three of four experiments. These results suggest saturation of T(4)-5'-monodeiodination occurred at lower T(4) concentrations than saturation of nuclear T(3) binding sites. In hypothyroid rats, the N:M ratios for both [(131)I]T(3) and [(125)I]T(3) were increased (P &lt; 0.005), but R was three-fold higher than in controls (P &lt; 0.005). Animals given 10 mug T(4)/100 g body wt per d for 5 d had significantly decreased N:M ratios for both [(131)I]T(3) and [(125)I]T(3), as well as a decreased value for R. In fasted rats, neither N:M ratio was depressed, although hepatic T(4) to T(3) conversion in the same animals was 50% of control (P &lt; 0.005). Iopanoic acid (13 muM), but not 6-n-propylthiouracil (29 muM), decreased the N:M [(125)I]T(3) with a significant decrease in the value for R (P &lt; 0.025 or less). Neither sodium iodide (6 muM) nor thyrotropin-releasing hormone (7-700 nM) affected the T(3) N:M ratios. These results indicate that intrapituitary T(4) to T(3) conversion is stimulated in hypothyroidism and depressed in T(4)-treated animals, whereas opposite changes occur in hepatic T(4)-5'-monodeiodination. Unlike liver, anterior pituitary T(4)-5'-monodeiodination is not affected by fasting or incubation with 6-n-propyl-2-thiouracil, but T(4) to T(3) conversion is inhibited in both by iopanoic acid. These results indicate that there are important differences between anterior pituitary and other tissues in the regulation of T(4)-5'-monodeiodination.\n",
      "Metabolism of resorcinylic compounds by bacteria. Purification and properties of orcinol hydroxylase from Pseudomonas putida 01. Orcinol hydroxylase (EC 1.14.13.6), which catalyzes the first reaction of orcinol catabolism in Pseudomonas putida 01, has been purified to homogeneity, and crystallized. Orcinol hydroxylase catalyzes the hydroxylation of orcinol with equimolar consumption of O2 and NADH (or NADPH) to 2, 3, 5-trihydroxytoluene, which is nonenzymically oxidized to a quinone. The visible absorption spectrum of the enzyme shows maxima at 373 and 454 nm and a shoulder at 480 nm. FAD can be dissociated from the protein. Reconstitution of enzymic activity was achieved with FAD, and to a limited extent by FMN. The enzyme has a molecular weight of 63,000 to 68,000 and contains 1 mol of FAD per mol of protein. K-m values for the three substrates orcinol, NADH, and O2 are 0.03, 0.13, and 0.07mM, RESPECTIVELY. The molecular activity of the crystalline enzyme is 1560 min minus 1. In the absence of orcinol, NADH is only slowly oxidized with formation of H2O2. Several analogs of orcinol also serve as substrates for hydroxylation, namely resorcinol, 4-methylresorcinol, and 4-bromoresorcinol. Other analogs, m-cresol, m-ethylphenol, 4-ethylresorcinol, and phloroglucinol, mimic orcinol as effectors, in that they (a) accelerate electron flow from NADH to the flavin and (b) decrease the apparent K-m for NADH but not to the same extent as the substrates that are hydroxylated. The latter compounds are not hydroxylated. Instead H2O2 accumulates as the only product of O2 reduction. The enzyme therefore behaves either as a hydroxylase or an oxidase. The ratio of hydroxylase to oxidase activities of the enzyme is decreased by an increase in the temperature of incubation; at 60 degrees the reaction with orcinol is almost 50% uncoupled from hydroxylation. The apparent K-m values for the effectors are in good agreement with the D-D values obtained for orcinol, resorcinol, and m-cresol. K-D values were obtained by measurement of the effector-induced perturbations of the visible absorption spectrum of the flavoprotein by difference absorption spectroscopy. The circular dichroism spectrum of orcinol hydroxylase is also altered in the presence of orcinol. The participation of the flavin in the over-all reaction is demonstrated by its rapid reduction under anaerobic conditions by NADH in the presence or orcinol, resorcinol, or m-cresol. Subsequent introduction of oxygen restores the oxidized form and yields H2O2 when m-cresol is the effector, but not when orcinol is the effector. Transfer of reducing equivalents from the reduced flavoprotein to free FAD may also occur. Reduction of orcinol hydroxylase by NADH in the absence of an effector is 10-4-fold slower than in the presence of an effector. The minimal structural requirements for effectors appear to be a 1,3-dihydroxy or 1-alkyl-3-hydorxybenzene, but only the former are substrates for hydroxylation.\n",
      "[Production and absorption rate of cerebrospinal fluid in the spinal subarachnoid space of the dog (author's transl)]. Adult mongrel dogs, weighing 10-17 kg. were anesthetized with Nembutal and cervical and lumbosacral laminectomy was performed. The spinal subarachnoid space was blocked by extradural ligation at the level of the C4 to interrupt CSF communication between the cranial and spinal space. Polyethylene catheters were placed in the cervical and lumbosacral subarachnoid space, and artificial Mock CSF buffer, pH 7.35-7.40, containing inulin of 25 mg/dl or 14C-inulin of 1.5-2 muCi/dl as a tracer was perfused in the sacro-cervical direction through the catheter. After a steady state of perfusion was acommplished, the CSF was collected from the outlet catheter. Production and absorption rate of the CSF were calculated after Pappenheimer and Heisey's equation. 1) Effects of CSF pressure on the rate of production (Vf) and absorption (Va) of CSF and on the difference between outflow fluid rate (Vo) and inflow fluid rate (Vi) were studied within the pressure range of -100 to +600 mmH2O. Then, regression lines were calculated by means of the least square method. See Article. Vf was little affected by changes in CSF pressure, while Va increased linearly as CSF pressure elevated. This suggests that the spinal subarachnoid space plays an important role as a site of CSF absorption when the intracranial pressure increases. Vo-Vi, that is difference between absorption and production rate, decreased linearly as the CSF pressure increased. 2) Under a constant CSF pressure of +200 mmH2O, the effects of glucocorticoids (dexamethasone, 0.25 mg/kg and hydrocortisone, 4.15 mg/kg) and a carbonic anhydrase inhibitor (acetazolamide, 10 mg/kg) upon the production and absorption rate of CSF were determined 1/2, 1, 2 and 3 hours after intravenous administration. a) Effect of dexamethasone: The rate of CSF production was reduced to 60.5 +/- 2.4% (p less than 0.001) of the control level. The absorption rate of CSF also decreased to 59.2 +/- 6.09% (p less than 0.001) of the control. b) Effect of hydrocortisone: The production rate of CSF decreased to 67.4 +/- 6.61% (p less than 0.001), and the absorption rate to 76.5 +/- 3.94% (p less than 0.001) of the control level. c) Effect of acetazolamide: The production and absorption rate also decreased to 57.2 +/- 5.61% (p less than 0.001) and to 56.9 +/- 7.02% (p less than 0.001), respectively. 3) Pentration of tritiated dexamethasone and tritiated hydrocortisone from plasma to CSF. The penetration of tritiated dexamethasone and tritiated hydrocortisone from plasma to CSF in the spinal and cranial subarachnoid space was observed after the intravenous administration. The CSF/Plasma ratio of dexamethasone was 30.9% at 15 minutes and gradually increased to 91.5% and 93.5%, respectively, in the cranial and spinal CSF at 3 hours after the injection.\n",
      "The role of sulfhydryl groups on the impaired hepatic 3',3,5-triiodothyronine generation from thyroxine in the hypothyroid, starved, fetal, and neonatal rodent. The role of nonprotein sulfhydryl groups (NPSH) in the decreased in vitro hepatic 3',3,5-triiodothyronine (T(3)) generation from thyroxine (T(4)) in the starved, hypothyroid, fetal and 1- to 4-d-old neonatal rat and dwarf mouse was assessed. NPSH were measured in fresh 25% liver homogenates prepared in 0.1 M PO(4)/10 mM EDTA buffer. As compared with values in adult male rats, NPSH concentration was decreased in the 2-d-starved (1.1+/-0.04 (mean+/-SE) vs. 2.2+/-0.15 mmol/250 g wet liver weight, P &lt; 0.001), fetal (1.0+/-0.04 vs. 3.2+/-0.08, P &lt; 0.001), 1-d-old neonatal (1.1+/-0.03 vs. 2.1+/-0.04, P &lt; 0.001), and hypothyroid (thyroidectomized 60 d) (1.4+/-0.06 vs. 2.2+/-0.15 P &lt; 0.001) rat. NPSH were also decreased in the hypothyroid, hypopituitary dwarf mouse as compared with values in their normal litter mates (1.3+/-0.03 vs. 2.0+/-0.2, P &lt; 0.01). Chronic administration of T(3) (0.5 mug/100 g body wt per d) markedly increased hepatic T(3) generation from T(4) in the thyroidectomized rat and in the dwarf mouse to values similar to those observed in the normal rodent without affecting NPSH concentration. In contrast, T(3) administration to the starved rat did not alter either hepatic T(3) generation from T(4) or NPSH. Reduced glutathione concentration was also markedly decreased in the starved rat (fed; 1.05+/-0.075 mmol/250 g wet tissue vs. starved 0.38+/-0.02, P &lt; 0.001). Dithiothreitol (DTT), a thiol reducing agent, increased hepatic T(3) generation from T(4) in the normal adult male rat by 45+/-5% in six experiments. When compared to DTT-stimulated control homogenates, the addition of DTT completely restored hepatic T(3) generation in starved rats, partially restored T(3) generation in 1- and 4-d-old neonates, but had little or no effect in the fetal and hypothyroid rat and dwarf mouse. Liver homogenates stored for 6 mo at -20 degrees C lost their capacity to generate T(3) from T(4). NPSH concentrations in the frozen homogenates decreased progressively with increasing storage and were absent by 6 mo. 5'-Deiodinase activity correlated with NPSH concentration in the stored homogenates (r = 0.95, P &lt; 0.005). Addition of DTT partially restored hepatic T(3) generation in the frozen homogenate. It is concluded that NPSH are important for the action of the liver 5'-deiodinase. The decreased hepatic T(3) generation in the starved rat is associated with decreased NPSH but not with a decrease in the absolute quantity of 5'-deiodinase because provision of sulfhydryl groups restored hepatic T(3) generation to normal. In contrast, the decreased hepatic T(3) generation in the adult hypothyroid rodent and in the fetal rat is probably due to a decrease in the enzyme concentration per se. In the 1- and 4-d neonatal rat, the decrease in hepatic T(3) generation is secondary to a decrease in NPSH and the deiodinating enzyme.\n",
      "\n",
      "Question: What were the findings regarding the establishment and effects of the multi-drug-resistant strain BIO-4R of Streptococcus faecalis in germ-free mice over a two-week study period?\n",
      "\n",
      "Options:\n",
      "A. The multi-drug-resistant strain BIO-4R of Streptococcus faecalis caused severe symptoms in the germ-free mice, leading to a high mortality rate during the two-week study period.\n",
      "B. The multi-drug-resistant strain BIO-4R of Streptococcus faecalis was successfully established in the intestinal tract of germ-free mice, maintaining its drug resistance and causing no symptoms in the animals over a two-week study period.\n",
      "C. BIO-4R was not established in the intestinal tract of germ-free mice, and the drug resistance was lost within the first week of the study.\n",
      "D. The study found that BIO-4R significantly reduced the population of beneficial gut bacteria in the germ-free mice, leading to gastrointestinal distress.\n",
      "\n",
      "Answer(pick one between A, B, C and D):\n",
      "Prompt: You are an expert in multiple-choice questions. Your task is to select the best answer from the given options based on the provided context. \n",
      "\n",
      "Context:\n",
      "3,3'-Diiodothyronine production, a major pathway of peripheral iodothyronine metabolism in man. 3,3'-Diiodothyronine (3,3'-T(2)) has been detected in human serum and in thyroglobulin. However, no quantitative assessment of its clearance rate (CR), production rate (PR), or of the importance of extrathyroidal sources of 3,3'-T(2) relative to direct thyroidal secretion is yet available. This study examines these parameters in seven euthyroid subjects, and in eight athyreotic subjects (H) eumetabolic due to thyroxine therapy (HT(4)) (n = 5) or triiodothyronine replacement (HT(3)) (n = 3). A highly specific radioimmunoassay for the measurement of 3,3'-T(2) in whole serum was developed. Serum 3,3'-T(2) concentrations were (mean +/- SD) 6.0+/-1.0 ng/100 ml in 13 normal subjects, 9.0+/-4.6 ng/100 ml in 25 hyperthyroid patients, and 2.7+/-1.1 ng/100 ml in 17 hypothyroid patients. The values in each of the latter two groups were significantly different from normal. 3,3'-T(2) was detected regularly in normal concentrations in 11 hypothyroid patients eumetabolic by treatment with synthetic T(4), in 10 eumetabolic patients suffering from nonthyroidal systemic illness, and in 2 subjects with elevated serum T(4)-binding globulin. The 3,3'-T(2) CR was assessed from data acquired from the (125)I-3,3'-T(2) constant infusion technique. The 3,3'-T(2) PR was calculated from CR and serum concentration of 3,3'-T(2) determined by radio-immunoassay. In the HT(4) subjects the 3,3'-T(2) CR averaged 840+/-377 liters/day and 3,3'-T(2) PR 33.9+/-12.5 mug/day. These results were not significantly different from those in the control group: 3,3'-T(2) CR 628+/-218 liters/day and 3,3'-T(2) PR 39.8+/-19.8 mug/day (all corrected to 70 kg body wt). In addition to 3,3'-T(2) PR, T(3), and reverse triiodothyronine (rT(3)) PR were determined in three of the HT(4) subjects. In each case studied, the 3,3'-T(2) PR was close to the combined triiodothyronine (T(3) + rT(3)) PR. The mean molar ratio of T(2) PR/(T(3) + rT(3)) PR was 1.08+/-0.10. The results obtained in the HT(4) subjects indicate that the production of 3,3'-T(2) is a major route of T(4) metabolism. The combined studies of 3,3'-T(2), T(3) and rT(3) PR in the HT(4) subjects indicate that both T(3) and rT(3) are major precursors of 3,3'-T(2). In the HT(3) subjects, the conversion of T(3) to 3,3'-T(2), determined as the molar ratio of 3,3'-T(2) PR to T(3) PR, ranged from 0.36 to 0.92, providing further evidence that T(3) is a precursor of 3,3'-T(2). From the close agreement between the mean values for 3,3'-T(2) PR in the euthyroid and HT(4) group it is concluded that most, if not all of the 3,3'-T(2) produced in normal humans is derived by extrathyroidal conversion from T(3) and rT(3).\n",
      "Physiological and pharmacological influences on thyroxine to 3,5,3'-triiodothyronine conversion and nuclear 3,5,3'-triiodothyronine binding in rat anterior pituitary. Our recent in vivo studies have suggested that intrapituitary l-thyroxine (T(4)) to 3,5,3'-triiodo-l-thyronine (T(3)) conversion with subsequent nuclear binding of T(3) is an important pathway by which circulating T(4) can inhibit thyrotropin release. The present studies were performed to evaluate various physiological and pharmacological influences on these two processes in rat anterior pituitary tissue. Intact pituitary fragments were incubated in buffer-1% bovine serum albumin containing 0.14 ng/ml [(131)I]T(3) and 3.8 ng/ml [(125)I]T(4). Nuclei were isolated after 3 h of incubation and the bound iodothyronines identified by paper chromatography. There was 0.3-1% [(125)I]T(3) contaminating the medium [(125)I]T(4), and this did not change during incubation. Nuclear [(125)I]T(4) was not decreased by 650-fold excesses of medium T(3) or T(4), suggesting that it was nonspecifically bound. The ratio of nuclear to medium [(131)I]- and [(125)I]T(3) were expressed as nuclear counts per minute per milligram wet weight of tissue:counts per minute per microliter medium. Intrapituitary T(4) to T(3) conversion was evidenced by the fact that the nuclear:medium (N:M) ratio for [(131)I]T(3) was 0.45+/-0.21, whereas that for [(125)I]T(3) was 2.23+/-1.28 (mean+/-SD, n = 51). A ratio (R), the N:M [(125)I]T(3) divided by the N:M [(131)I]T(3), was used as an index of intrapituitary T(4) to T(3) conversion. Increasing medium T(3) concentrations up to 50 ng/ml caused a progressive decrease in the N:M ratio for both T(3) isotopes, but no change in the value for R, indicating that both competed for the same limited-capacity nuclear receptors. Increasing concentrations of medium T(4) caused no change in the N:M [(131)I]T(3) but did cause a significant decrease in R in three of four experiments. These results suggest saturation of T(4)-5'-monodeiodination occurred at lower T(4) concentrations than saturation of nuclear T(3) binding sites. In hypothyroid rats, the N:M ratios for both [(131)I]T(3) and [(125)I]T(3) were increased (P &lt; 0.005), but R was three-fold higher than in controls (P &lt; 0.005). Animals given 10 mug T(4)/100 g body wt per d for 5 d had significantly decreased N:M ratios for both [(131)I]T(3) and [(125)I]T(3), as well as a decreased value for R. In fasted rats, neither N:M ratio was depressed, although hepatic T(4) to T(3) conversion in the same animals was 50% of control (P &lt; 0.005). Iopanoic acid (13 muM), but not 6-n-propylthiouracil (29 muM), decreased the N:M [(125)I]T(3) with a significant decrease in the value for R (P &lt; 0.025 or less). Neither sodium iodide (6 muM) nor thyrotropin-releasing hormone (7-700 nM) affected the T(3) N:M ratios. These results indicate that intrapituitary T(4) to T(3) conversion is stimulated in hypothyroidism and depressed in T(4)-treated animals, whereas opposite changes occur in hepatic T(4)-5'-monodeiodination. Unlike liver, anterior pituitary T(4)-5'-monodeiodination is not affected by fasting or incubation with 6-n-propyl-2-thiouracil, but T(4) to T(3) conversion is inhibited in both by iopanoic acid. These results indicate that there are important differences between anterior pituitary and other tissues in the regulation of T(4)-5'-monodeiodination.\n",
      "Metabolism of resorcinylic compounds by bacteria. Purification and properties of orcinol hydroxylase from Pseudomonas putida 01. Orcinol hydroxylase (EC 1.14.13.6), which catalyzes the first reaction of orcinol catabolism in Pseudomonas putida 01, has been purified to homogeneity, and crystallized. Orcinol hydroxylase catalyzes the hydroxylation of orcinol with equimolar consumption of O2 and NADH (or NADPH) to 2, 3, 5-trihydroxytoluene, which is nonenzymically oxidized to a quinone. The visible absorption spectrum of the enzyme shows maxima at 373 and 454 nm and a shoulder at 480 nm. FAD can be dissociated from the protein. Reconstitution of enzymic activity was achieved with FAD, and to a limited extent by FMN. The enzyme has a molecular weight of 63,000 to 68,000 and contains 1 mol of FAD per mol of protein. K-m values for the three substrates orcinol, NADH, and O2 are 0.03, 0.13, and 0.07mM, RESPECTIVELY. The molecular activity of the crystalline enzyme is 1560 min minus 1. In the absence of orcinol, NADH is only slowly oxidized with formation of H2O2. Several analogs of orcinol also serve as substrates for hydroxylation, namely resorcinol, 4-methylresorcinol, and 4-bromoresorcinol. Other analogs, m-cresol, m-ethylphenol, 4-ethylresorcinol, and phloroglucinol, mimic orcinol as effectors, in that they (a) accelerate electron flow from NADH to the flavin and (b) decrease the apparent K-m for NADH but not to the same extent as the substrates that are hydroxylated. The latter compounds are not hydroxylated. Instead H2O2 accumulates as the only product of O2 reduction. The enzyme therefore behaves either as a hydroxylase or an oxidase. The ratio of hydroxylase to oxidase activities of the enzyme is decreased by an increase in the temperature of incubation; at 60 degrees the reaction with orcinol is almost 50% uncoupled from hydroxylation. The apparent K-m values for the effectors are in good agreement with the D-D values obtained for orcinol, resorcinol, and m-cresol. K-D values were obtained by measurement of the effector-induced perturbations of the visible absorption spectrum of the flavoprotein by difference absorption spectroscopy. The circular dichroism spectrum of orcinol hydroxylase is also altered in the presence of orcinol. The participation of the flavin in the over-all reaction is demonstrated by its rapid reduction under anaerobic conditions by NADH in the presence or orcinol, resorcinol, or m-cresol. Subsequent introduction of oxygen restores the oxidized form and yields H2O2 when m-cresol is the effector, but not when orcinol is the effector. Transfer of reducing equivalents from the reduced flavoprotein to free FAD may also occur. Reduction of orcinol hydroxylase by NADH in the absence of an effector is 10-4-fold slower than in the presence of an effector. The minimal structural requirements for effectors appear to be a 1,3-dihydroxy or 1-alkyl-3-hydorxybenzene, but only the former are substrates for hydroxylation.\n",
      "[Production and absorption rate of cerebrospinal fluid in the spinal subarachnoid space of the dog (author's transl)]. Adult mongrel dogs, weighing 10-17 kg. were anesthetized with Nembutal and cervical and lumbosacral laminectomy was performed. The spinal subarachnoid space was blocked by extradural ligation at the level of the C4 to interrupt CSF communication between the cranial and spinal space. Polyethylene catheters were placed in the cervical and lumbosacral subarachnoid space, and artificial Mock CSF buffer, pH 7.35-7.40, containing inulin of 25 mg/dl or 14C-inulin of 1.5-2 muCi/dl as a tracer was perfused in the sacro-cervical direction through the catheter. After a steady state of perfusion was acommplished, the CSF was collected from the outlet catheter. Production and absorption rate of the CSF were calculated after Pappenheimer and Heisey's equation. 1) Effects of CSF pressure on the rate of production (Vf) and absorption (Va) of CSF and on the difference between outflow fluid rate (Vo) and inflow fluid rate (Vi) were studied within the pressure range of -100 to +600 mmH2O. Then, regression lines were calculated by means of the least square method. See Article. Vf was little affected by changes in CSF pressure, while Va increased linearly as CSF pressure elevated. This suggests that the spinal subarachnoid space plays an important role as a site of CSF absorption when the intracranial pressure increases. Vo-Vi, that is difference between absorption and production rate, decreased linearly as the CSF pressure increased. 2) Under a constant CSF pressure of +200 mmH2O, the effects of glucocorticoids (dexamethasone, 0.25 mg/kg and hydrocortisone, 4.15 mg/kg) and a carbonic anhydrase inhibitor (acetazolamide, 10 mg/kg) upon the production and absorption rate of CSF were determined 1/2, 1, 2 and 3 hours after intravenous administration. a) Effect of dexamethasone: The rate of CSF production was reduced to 60.5 +/- 2.4% (p less than 0.001) of the control level. The absorption rate of CSF also decreased to 59.2 +/- 6.09% (p less than 0.001) of the control. b) Effect of hydrocortisone: The production rate of CSF decreased to 67.4 +/- 6.61% (p less than 0.001), and the absorption rate to 76.5 +/- 3.94% (p less than 0.001) of the control level. c) Effect of acetazolamide: The production and absorption rate also decreased to 57.2 +/- 5.61% (p less than 0.001) and to 56.9 +/- 7.02% (p less than 0.001), respectively. 3) Pentration of tritiated dexamethasone and tritiated hydrocortisone from plasma to CSF. The penetration of tritiated dexamethasone and tritiated hydrocortisone from plasma to CSF in the spinal and cranial subarachnoid space was observed after the intravenous administration. The CSF/Plasma ratio of dexamethasone was 30.9% at 15 minutes and gradually increased to 91.5% and 93.5%, respectively, in the cranial and spinal CSF at 3 hours after the injection.\n",
      "The role of sulfhydryl groups on the impaired hepatic 3',3,5-triiodothyronine generation from thyroxine in the hypothyroid, starved, fetal, and neonatal rodent. The role of nonprotein sulfhydryl groups (NPSH) in the decreased in vitro hepatic 3',3,5-triiodothyronine (T(3)) generation from thyroxine (T(4)) in the starved, hypothyroid, fetal and 1- to 4-d-old neonatal rat and dwarf mouse was assessed. NPSH were measured in fresh 25% liver homogenates prepared in 0.1 M PO(4)/10 mM EDTA buffer. As compared with values in adult male rats, NPSH concentration was decreased in the 2-d-starved (1.1+/-0.04 (mean+/-SE) vs. 2.2+/-0.15 mmol/250 g wet liver weight, P &lt; 0.001), fetal (1.0+/-0.04 vs. 3.2+/-0.08, P &lt; 0.001), 1-d-old neonatal (1.1+/-0.03 vs. 2.1+/-0.04, P &lt; 0.001), and hypothyroid (thyroidectomized 60 d) (1.4+/-0.06 vs. 2.2+/-0.15 P &lt; 0.001) rat. NPSH were also decreased in the hypothyroid, hypopituitary dwarf mouse as compared with values in their normal litter mates (1.3+/-0.03 vs. 2.0+/-0.2, P &lt; 0.01). Chronic administration of T(3) (0.5 mug/100 g body wt per d) markedly increased hepatic T(3) generation from T(4) in the thyroidectomized rat and in the dwarf mouse to values similar to those observed in the normal rodent without affecting NPSH concentration. In contrast, T(3) administration to the starved rat did not alter either hepatic T(3) generation from T(4) or NPSH. Reduced glutathione concentration was also markedly decreased in the starved rat (fed; 1.05+/-0.075 mmol/250 g wet tissue vs. starved 0.38+/-0.02, P &lt; 0.001). Dithiothreitol (DTT), a thiol reducing agent, increased hepatic T(3) generation from T(4) in the normal adult male rat by 45+/-5% in six experiments. When compared to DTT-stimulated control homogenates, the addition of DTT completely restored hepatic T(3) generation in starved rats, partially restored T(3) generation in 1- and 4-d-old neonates, but had little or no effect in the fetal and hypothyroid rat and dwarf mouse. Liver homogenates stored for 6 mo at -20 degrees C lost their capacity to generate T(3) from T(4). NPSH concentrations in the frozen homogenates decreased progressively with increasing storage and were absent by 6 mo. 5'-Deiodinase activity correlated with NPSH concentration in the stored homogenates (r = 0.95, P &lt; 0.005). Addition of DTT partially restored hepatic T(3) generation in the frozen homogenate. It is concluded that NPSH are important for the action of the liver 5'-deiodinase. The decreased hepatic T(3) generation in the starved rat is associated with decreased NPSH but not with a decrease in the absolute quantity of 5'-deiodinase because provision of sulfhydryl groups restored hepatic T(3) generation to normal. In contrast, the decreased hepatic T(3) generation in the adult hypothyroid rodent and in the fetal rat is probably due to a decrease in the enzyme concentration per se. In the 1- and 4-d neonatal rat, the decrease in hepatic T(3) generation is secondary to a decrease in NPSH and the deiodinating enzyme.\n",
      "\n",
      "Question: What is the focus of the critical evaluation regarding the monocyte test in relation to drug allergies?\n",
      "\n",
      "Options:\n",
      "A. The monocyte test's use in diagnosing drug allergies is critically evaluated, with discussions on its further hospital application and assessment.\n",
      "B. The monocyte test is primarily evaluated for its effectiveness in treating drug allergies.\n",
      "C. The focus is on the historical development of the monocyte test and its initial introduction.\n",
      "D. The evaluation centers on the cost-effectiveness of the monocyte test compared to other allergy tests.\n",
      "\n",
      "Answer(pick one between A, B, C and D):\n",
      "Prompt: You are an expert in multiple-choice questions. Your task is to select the best answer from the given options based on the provided context. \n",
      "\n",
      "Context:\n",
      "3,3'-Diiodothyronine production, a major pathway of peripheral iodothyronine metabolism in man. 3,3'-Diiodothyronine (3,3'-T(2)) has been detected in human serum and in thyroglobulin. However, no quantitative assessment of its clearance rate (CR), production rate (PR), or of the importance of extrathyroidal sources of 3,3'-T(2) relative to direct thyroidal secretion is yet available. This study examines these parameters in seven euthyroid subjects, and in eight athyreotic subjects (H) eumetabolic due to thyroxine therapy (HT(4)) (n = 5) or triiodothyronine replacement (HT(3)) (n = 3). A highly specific radioimmunoassay for the measurement of 3,3'-T(2) in whole serum was developed. Serum 3,3'-T(2) concentrations were (mean +/- SD) 6.0+/-1.0 ng/100 ml in 13 normal subjects, 9.0+/-4.6 ng/100 ml in 25 hyperthyroid patients, and 2.7+/-1.1 ng/100 ml in 17 hypothyroid patients. The values in each of the latter two groups were significantly different from normal. 3,3'-T(2) was detected regularly in normal concentrations in 11 hypothyroid patients eumetabolic by treatment with synthetic T(4), in 10 eumetabolic patients suffering from nonthyroidal systemic illness, and in 2 subjects with elevated serum T(4)-binding globulin. The 3,3'-T(2) CR was assessed from data acquired from the (125)I-3,3'-T(2) constant infusion technique. The 3,3'-T(2) PR was calculated from CR and serum concentration of 3,3'-T(2) determined by radio-immunoassay. In the HT(4) subjects the 3,3'-T(2) CR averaged 840+/-377 liters/day and 3,3'-T(2) PR 33.9+/-12.5 mug/day. These results were not significantly different from those in the control group: 3,3'-T(2) CR 628+/-218 liters/day and 3,3'-T(2) PR 39.8+/-19.8 mug/day (all corrected to 70 kg body wt). In addition to 3,3'-T(2) PR, T(3), and reverse triiodothyronine (rT(3)) PR were determined in three of the HT(4) subjects. In each case studied, the 3,3'-T(2) PR was close to the combined triiodothyronine (T(3) + rT(3)) PR. The mean molar ratio of T(2) PR/(T(3) + rT(3)) PR was 1.08+/-0.10. The results obtained in the HT(4) subjects indicate that the production of 3,3'-T(2) is a major route of T(4) metabolism. The combined studies of 3,3'-T(2), T(3) and rT(3) PR in the HT(4) subjects indicate that both T(3) and rT(3) are major precursors of 3,3'-T(2). In the HT(3) subjects, the conversion of T(3) to 3,3'-T(2), determined as the molar ratio of 3,3'-T(2) PR to T(3) PR, ranged from 0.36 to 0.92, providing further evidence that T(3) is a precursor of 3,3'-T(2). From the close agreement between the mean values for 3,3'-T(2) PR in the euthyroid and HT(4) group it is concluded that most, if not all of the 3,3'-T(2) produced in normal humans is derived by extrathyroidal conversion from T(3) and rT(3).\n",
      "Physiological and pharmacological influences on thyroxine to 3,5,3'-triiodothyronine conversion and nuclear 3,5,3'-triiodothyronine binding in rat anterior pituitary. Our recent in vivo studies have suggested that intrapituitary l-thyroxine (T(4)) to 3,5,3'-triiodo-l-thyronine (T(3)) conversion with subsequent nuclear binding of T(3) is an important pathway by which circulating T(4) can inhibit thyrotropin release. The present studies were performed to evaluate various physiological and pharmacological influences on these two processes in rat anterior pituitary tissue. Intact pituitary fragments were incubated in buffer-1% bovine serum albumin containing 0.14 ng/ml [(131)I]T(3) and 3.8 ng/ml [(125)I]T(4). Nuclei were isolated after 3 h of incubation and the bound iodothyronines identified by paper chromatography. There was 0.3-1% [(125)I]T(3) contaminating the medium [(125)I]T(4), and this did not change during incubation. Nuclear [(125)I]T(4) was not decreased by 650-fold excesses of medium T(3) or T(4), suggesting that it was nonspecifically bound. The ratio of nuclear to medium [(131)I]- and [(125)I]T(3) were expressed as nuclear counts per minute per milligram wet weight of tissue:counts per minute per microliter medium. Intrapituitary T(4) to T(3) conversion was evidenced by the fact that the nuclear:medium (N:M) ratio for [(131)I]T(3) was 0.45+/-0.21, whereas that for [(125)I]T(3) was 2.23+/-1.28 (mean+/-SD, n = 51). A ratio (R), the N:M [(125)I]T(3) divided by the N:M [(131)I]T(3), was used as an index of intrapituitary T(4) to T(3) conversion. Increasing medium T(3) concentrations up to 50 ng/ml caused a progressive decrease in the N:M ratio for both T(3) isotopes, but no change in the value for R, indicating that both competed for the same limited-capacity nuclear receptors. Increasing concentrations of medium T(4) caused no change in the N:M [(131)I]T(3) but did cause a significant decrease in R in three of four experiments. These results suggest saturation of T(4)-5'-monodeiodination occurred at lower T(4) concentrations than saturation of nuclear T(3) binding sites. In hypothyroid rats, the N:M ratios for both [(131)I]T(3) and [(125)I]T(3) were increased (P &lt; 0.005), but R was three-fold higher than in controls (P &lt; 0.005). Animals given 10 mug T(4)/100 g body wt per d for 5 d had significantly decreased N:M ratios for both [(131)I]T(3) and [(125)I]T(3), as well as a decreased value for R. In fasted rats, neither N:M ratio was depressed, although hepatic T(4) to T(3) conversion in the same animals was 50% of control (P &lt; 0.005). Iopanoic acid (13 muM), but not 6-n-propylthiouracil (29 muM), decreased the N:M [(125)I]T(3) with a significant decrease in the value for R (P &lt; 0.025 or less). Neither sodium iodide (6 muM) nor thyrotropin-releasing hormone (7-700 nM) affected the T(3) N:M ratios. These results indicate that intrapituitary T(4) to T(3) conversion is stimulated in hypothyroidism and depressed in T(4)-treated animals, whereas opposite changes occur in hepatic T(4)-5'-monodeiodination. Unlike liver, anterior pituitary T(4)-5'-monodeiodination is not affected by fasting or incubation with 6-n-propyl-2-thiouracil, but T(4) to T(3) conversion is inhibited in both by iopanoic acid. These results indicate that there are important differences between anterior pituitary and other tissues in the regulation of T(4)-5'-monodeiodination.\n",
      "Metabolism of resorcinylic compounds by bacteria. Purification and properties of orcinol hydroxylase from Pseudomonas putida 01. Orcinol hydroxylase (EC 1.14.13.6), which catalyzes the first reaction of orcinol catabolism in Pseudomonas putida 01, has been purified to homogeneity, and crystallized. Orcinol hydroxylase catalyzes the hydroxylation of orcinol with equimolar consumption of O2 and NADH (or NADPH) to 2, 3, 5-trihydroxytoluene, which is nonenzymically oxidized to a quinone. The visible absorption spectrum of the enzyme shows maxima at 373 and 454 nm and a shoulder at 480 nm. FAD can be dissociated from the protein. Reconstitution of enzymic activity was achieved with FAD, and to a limited extent by FMN. The enzyme has a molecular weight of 63,000 to 68,000 and contains 1 mol of FAD per mol of protein. K-m values for the three substrates orcinol, NADH, and O2 are 0.03, 0.13, and 0.07mM, RESPECTIVELY. The molecular activity of the crystalline enzyme is 1560 min minus 1. In the absence of orcinol, NADH is only slowly oxidized with formation of H2O2. Several analogs of orcinol also serve as substrates for hydroxylation, namely resorcinol, 4-methylresorcinol, and 4-bromoresorcinol. Other analogs, m-cresol, m-ethylphenol, 4-ethylresorcinol, and phloroglucinol, mimic orcinol as effectors, in that they (a) accelerate electron flow from NADH to the flavin and (b) decrease the apparent K-m for NADH but not to the same extent as the substrates that are hydroxylated. The latter compounds are not hydroxylated. Instead H2O2 accumulates as the only product of O2 reduction. The enzyme therefore behaves either as a hydroxylase or an oxidase. The ratio of hydroxylase to oxidase activities of the enzyme is decreased by an increase in the temperature of incubation; at 60 degrees the reaction with orcinol is almost 50% uncoupled from hydroxylation. The apparent K-m values for the effectors are in good agreement with the D-D values obtained for orcinol, resorcinol, and m-cresol. K-D values were obtained by measurement of the effector-induced perturbations of the visible absorption spectrum of the flavoprotein by difference absorption spectroscopy. The circular dichroism spectrum of orcinol hydroxylase is also altered in the presence of orcinol. The participation of the flavin in the over-all reaction is demonstrated by its rapid reduction under anaerobic conditions by NADH in the presence or orcinol, resorcinol, or m-cresol. Subsequent introduction of oxygen restores the oxidized form and yields H2O2 when m-cresol is the effector, but not when orcinol is the effector. Transfer of reducing equivalents from the reduced flavoprotein to free FAD may also occur. Reduction of orcinol hydroxylase by NADH in the absence of an effector is 10-4-fold slower than in the presence of an effector. The minimal structural requirements for effectors appear to be a 1,3-dihydroxy or 1-alkyl-3-hydorxybenzene, but only the former are substrates for hydroxylation.\n",
      "[Production and absorption rate of cerebrospinal fluid in the spinal subarachnoid space of the dog (author's transl)]. Adult mongrel dogs, weighing 10-17 kg. were anesthetized with Nembutal and cervical and lumbosacral laminectomy was performed. The spinal subarachnoid space was blocked by extradural ligation at the level of the C4 to interrupt CSF communication between the cranial and spinal space. Polyethylene catheters were placed in the cervical and lumbosacral subarachnoid space, and artificial Mock CSF buffer, pH 7.35-7.40, containing inulin of 25 mg/dl or 14C-inulin of 1.5-2 muCi/dl as a tracer was perfused in the sacro-cervical direction through the catheter. After a steady state of perfusion was acommplished, the CSF was collected from the outlet catheter. Production and absorption rate of the CSF were calculated after Pappenheimer and Heisey's equation. 1) Effects of CSF pressure on the rate of production (Vf) and absorption (Va) of CSF and on the difference between outflow fluid rate (Vo) and inflow fluid rate (Vi) were studied within the pressure range of -100 to +600 mmH2O. Then, regression lines were calculated by means of the least square method. See Article. Vf was little affected by changes in CSF pressure, while Va increased linearly as CSF pressure elevated. This suggests that the spinal subarachnoid space plays an important role as a site of CSF absorption when the intracranial pressure increases. Vo-Vi, that is difference between absorption and production rate, decreased linearly as the CSF pressure increased. 2) Under a constant CSF pressure of +200 mmH2O, the effects of glucocorticoids (dexamethasone, 0.25 mg/kg and hydrocortisone, 4.15 mg/kg) and a carbonic anhydrase inhibitor (acetazolamide, 10 mg/kg) upon the production and absorption rate of CSF were determined 1/2, 1, 2 and 3 hours after intravenous administration. a) Effect of dexamethasone: The rate of CSF production was reduced to 60.5 +/- 2.4% (p less than 0.001) of the control level. The absorption rate of CSF also decreased to 59.2 +/- 6.09% (p less than 0.001) of the control. b) Effect of hydrocortisone: The production rate of CSF decreased to 67.4 +/- 6.61% (p less than 0.001), and the absorption rate to 76.5 +/- 3.94% (p less than 0.001) of the control level. c) Effect of acetazolamide: The production and absorption rate also decreased to 57.2 +/- 5.61% (p less than 0.001) and to 56.9 +/- 7.02% (p less than 0.001), respectively. 3) Pentration of tritiated dexamethasone and tritiated hydrocortisone from plasma to CSF. The penetration of tritiated dexamethasone and tritiated hydrocortisone from plasma to CSF in the spinal and cranial subarachnoid space was observed after the intravenous administration. The CSF/Plasma ratio of dexamethasone was 30.9% at 15 minutes and gradually increased to 91.5% and 93.5%, respectively, in the cranial and spinal CSF at 3 hours after the injection.\n",
      "The role of sulfhydryl groups on the impaired hepatic 3',3,5-triiodothyronine generation from thyroxine in the hypothyroid, starved, fetal, and neonatal rodent. The role of nonprotein sulfhydryl groups (NPSH) in the decreased in vitro hepatic 3',3,5-triiodothyronine (T(3)) generation from thyroxine (T(4)) in the starved, hypothyroid, fetal and 1- to 4-d-old neonatal rat and dwarf mouse was assessed. NPSH were measured in fresh 25% liver homogenates prepared in 0.1 M PO(4)/10 mM EDTA buffer. As compared with values in adult male rats, NPSH concentration was decreased in the 2-d-starved (1.1+/-0.04 (mean+/-SE) vs. 2.2+/-0.15 mmol/250 g wet liver weight, P &lt; 0.001), fetal (1.0+/-0.04 vs. 3.2+/-0.08, P &lt; 0.001), 1-d-old neonatal (1.1+/-0.03 vs. 2.1+/-0.04, P &lt; 0.001), and hypothyroid (thyroidectomized 60 d) (1.4+/-0.06 vs. 2.2+/-0.15 P &lt; 0.001) rat. NPSH were also decreased in the hypothyroid, hypopituitary dwarf mouse as compared with values in their normal litter mates (1.3+/-0.03 vs. 2.0+/-0.2, P &lt; 0.01). Chronic administration of T(3) (0.5 mug/100 g body wt per d) markedly increased hepatic T(3) generation from T(4) in the thyroidectomized rat and in the dwarf mouse to values similar to those observed in the normal rodent without affecting NPSH concentration. In contrast, T(3) administration to the starved rat did not alter either hepatic T(3) generation from T(4) or NPSH. Reduced glutathione concentration was also markedly decreased in the starved rat (fed; 1.05+/-0.075 mmol/250 g wet tissue vs. starved 0.38+/-0.02, P &lt; 0.001). Dithiothreitol (DTT), a thiol reducing agent, increased hepatic T(3) generation from T(4) in the normal adult male rat by 45+/-5% in six experiments. When compared to DTT-stimulated control homogenates, the addition of DTT completely restored hepatic T(3) generation in starved rats, partially restored T(3) generation in 1- and 4-d-old neonates, but had little or no effect in the fetal and hypothyroid rat and dwarf mouse. Liver homogenates stored for 6 mo at -20 degrees C lost their capacity to generate T(3) from T(4). NPSH concentrations in the frozen homogenates decreased progressively with increasing storage and were absent by 6 mo. 5'-Deiodinase activity correlated with NPSH concentration in the stored homogenates (r = 0.95, P &lt; 0.005). Addition of DTT partially restored hepatic T(3) generation in the frozen homogenate. It is concluded that NPSH are important for the action of the liver 5'-deiodinase. The decreased hepatic T(3) generation in the starved rat is associated with decreased NPSH but not with a decrease in the absolute quantity of 5'-deiodinase because provision of sulfhydryl groups restored hepatic T(3) generation to normal. In contrast, the decreased hepatic T(3) generation in the adult hypothyroid rodent and in the fetal rat is probably due to a decrease in the enzyme concentration per se. In the 1- and 4-d neonatal rat, the decrease in hepatic T(3) generation is secondary to a decrease in NPSH and the deiodinating enzyme.\n",
      "\n",
      "Question: What were the findings regarding the effectiveness and safety of cefamandole nafate in treating infections in infants and children?\n",
      "\n",
      "Options:\n",
      "A. Cefamandole nafate was found to be ineffective against all types of infections in infants and children.\n",
      "B. Cefamandole nafate caused severe adverse effects, including liver failure and respiratory distress in infants.\n",
      "C. Cefamandole nafate was effective in treating various infections in infants and children, including those caused by Staphylococcus aureus and Haemophilus influenzae, with minimal adverse effects reported.\n",
      "D. Cefamandole nafate was primarily used to treat viral infections in infants and children.\n",
      "\n",
      "Answer(pick one between A, B, C and D):\n",
      "Prompt: You are an expert in multiple-choice questions. Your task is to select the best answer from the given options based on the provided context. \n",
      "\n",
      "Context:\n",
      "3,3'-Diiodothyronine production, a major pathway of peripheral iodothyronine metabolism in man. 3,3'-Diiodothyronine (3,3'-T(2)) has been detected in human serum and in thyroglobulin. However, no quantitative assessment of its clearance rate (CR), production rate (PR), or of the importance of extrathyroidal sources of 3,3'-T(2) relative to direct thyroidal secretion is yet available. This study examines these parameters in seven euthyroid subjects, and in eight athyreotic subjects (H) eumetabolic due to thyroxine therapy (HT(4)) (n = 5) or triiodothyronine replacement (HT(3)) (n = 3). A highly specific radioimmunoassay for the measurement of 3,3'-T(2) in whole serum was developed. Serum 3,3'-T(2) concentrations were (mean +/- SD) 6.0+/-1.0 ng/100 ml in 13 normal subjects, 9.0+/-4.6 ng/100 ml in 25 hyperthyroid patients, and 2.7+/-1.1 ng/100 ml in 17 hypothyroid patients. The values in each of the latter two groups were significantly different from normal. 3,3'-T(2) was detected regularly in normal concentrations in 11 hypothyroid patients eumetabolic by treatment with synthetic T(4), in 10 eumetabolic patients suffering from nonthyroidal systemic illness, and in 2 subjects with elevated serum T(4)-binding globulin. The 3,3'-T(2) CR was assessed from data acquired from the (125)I-3,3'-T(2) constant infusion technique. The 3,3'-T(2) PR was calculated from CR and serum concentration of 3,3'-T(2) determined by radio-immunoassay. In the HT(4) subjects the 3,3'-T(2) CR averaged 840+/-377 liters/day and 3,3'-T(2) PR 33.9+/-12.5 mug/day. These results were not significantly different from those in the control group: 3,3'-T(2) CR 628+/-218 liters/day and 3,3'-T(2) PR 39.8+/-19.8 mug/day (all corrected to 70 kg body wt). In addition to 3,3'-T(2) PR, T(3), and reverse triiodothyronine (rT(3)) PR were determined in three of the HT(4) subjects. In each case studied, the 3,3'-T(2) PR was close to the combined triiodothyronine (T(3) + rT(3)) PR. The mean molar ratio of T(2) PR/(T(3) + rT(3)) PR was 1.08+/-0.10. The results obtained in the HT(4) subjects indicate that the production of 3,3'-T(2) is a major route of T(4) metabolism. The combined studies of 3,3'-T(2), T(3) and rT(3) PR in the HT(4) subjects indicate that both T(3) and rT(3) are major precursors of 3,3'-T(2). In the HT(3) subjects, the conversion of T(3) to 3,3'-T(2), determined as the molar ratio of 3,3'-T(2) PR to T(3) PR, ranged from 0.36 to 0.92, providing further evidence that T(3) is a precursor of 3,3'-T(2). From the close agreement between the mean values for 3,3'-T(2) PR in the euthyroid and HT(4) group it is concluded that most, if not all of the 3,3'-T(2) produced in normal humans is derived by extrathyroidal conversion from T(3) and rT(3).\n",
      "Physiological and pharmacological influences on thyroxine to 3,5,3'-triiodothyronine conversion and nuclear 3,5,3'-triiodothyronine binding in rat anterior pituitary. Our recent in vivo studies have suggested that intrapituitary l-thyroxine (T(4)) to 3,5,3'-triiodo-l-thyronine (T(3)) conversion with subsequent nuclear binding of T(3) is an important pathway by which circulating T(4) can inhibit thyrotropin release. The present studies were performed to evaluate various physiological and pharmacological influences on these two processes in rat anterior pituitary tissue. Intact pituitary fragments were incubated in buffer-1% bovine serum albumin containing 0.14 ng/ml [(131)I]T(3) and 3.8 ng/ml [(125)I]T(4). Nuclei were isolated after 3 h of incubation and the bound iodothyronines identified by paper chromatography. There was 0.3-1% [(125)I]T(3) contaminating the medium [(125)I]T(4), and this did not change during incubation. Nuclear [(125)I]T(4) was not decreased by 650-fold excesses of medium T(3) or T(4), suggesting that it was nonspecifically bound. The ratio of nuclear to medium [(131)I]- and [(125)I]T(3) were expressed as nuclear counts per minute per milligram wet weight of tissue:counts per minute per microliter medium. Intrapituitary T(4) to T(3) conversion was evidenced by the fact that the nuclear:medium (N:M) ratio for [(131)I]T(3) was 0.45+/-0.21, whereas that for [(125)I]T(3) was 2.23+/-1.28 (mean+/-SD, n = 51). A ratio (R), the N:M [(125)I]T(3) divided by the N:M [(131)I]T(3), was used as an index of intrapituitary T(4) to T(3) conversion. Increasing medium T(3) concentrations up to 50 ng/ml caused a progressive decrease in the N:M ratio for both T(3) isotopes, but no change in the value for R, indicating that both competed for the same limited-capacity nuclear receptors. Increasing concentrations of medium T(4) caused no change in the N:M [(131)I]T(3) but did cause a significant decrease in R in three of four experiments. These results suggest saturation of T(4)-5'-monodeiodination occurred at lower T(4) concentrations than saturation of nuclear T(3) binding sites. In hypothyroid rats, the N:M ratios for both [(131)I]T(3) and [(125)I]T(3) were increased (P &lt; 0.005), but R was three-fold higher than in controls (P &lt; 0.005). Animals given 10 mug T(4)/100 g body wt per d for 5 d had significantly decreased N:M ratios for both [(131)I]T(3) and [(125)I]T(3), as well as a decreased value for R. In fasted rats, neither N:M ratio was depressed, although hepatic T(4) to T(3) conversion in the same animals was 50% of control (P &lt; 0.005). Iopanoic acid (13 muM), but not 6-n-propylthiouracil (29 muM), decreased the N:M [(125)I]T(3) with a significant decrease in the value for R (P &lt; 0.025 or less). Neither sodium iodide (6 muM) nor thyrotropin-releasing hormone (7-700 nM) affected the T(3) N:M ratios. These results indicate that intrapituitary T(4) to T(3) conversion is stimulated in hypothyroidism and depressed in T(4)-treated animals, whereas opposite changes occur in hepatic T(4)-5'-monodeiodination. Unlike liver, anterior pituitary T(4)-5'-monodeiodination is not affected by fasting or incubation with 6-n-propyl-2-thiouracil, but T(4) to T(3) conversion is inhibited in both by iopanoic acid. These results indicate that there are important differences between anterior pituitary and other tissues in the regulation of T(4)-5'-monodeiodination.\n",
      "Metabolism of resorcinylic compounds by bacteria. Purification and properties of orcinol hydroxylase from Pseudomonas putida 01. Orcinol hydroxylase (EC 1.14.13.6), which catalyzes the first reaction of orcinol catabolism in Pseudomonas putida 01, has been purified to homogeneity, and crystallized. Orcinol hydroxylase catalyzes the hydroxylation of orcinol with equimolar consumption of O2 and NADH (or NADPH) to 2, 3, 5-trihydroxytoluene, which is nonenzymically oxidized to a quinone. The visible absorption spectrum of the enzyme shows maxima at 373 and 454 nm and a shoulder at 480 nm. FAD can be dissociated from the protein. Reconstitution of enzymic activity was achieved with FAD, and to a limited extent by FMN. The enzyme has a molecular weight of 63,000 to 68,000 and contains 1 mol of FAD per mol of protein. K-m values for the three substrates orcinol, NADH, and O2 are 0.03, 0.13, and 0.07mM, RESPECTIVELY. The molecular activity of the crystalline enzyme is 1560 min minus 1. In the absence of orcinol, NADH is only slowly oxidized with formation of H2O2. Several analogs of orcinol also serve as substrates for hydroxylation, namely resorcinol, 4-methylresorcinol, and 4-bromoresorcinol. Other analogs, m-cresol, m-ethylphenol, 4-ethylresorcinol, and phloroglucinol, mimic orcinol as effectors, in that they (a) accelerate electron flow from NADH to the flavin and (b) decrease the apparent K-m for NADH but not to the same extent as the substrates that are hydroxylated. The latter compounds are not hydroxylated. Instead H2O2 accumulates as the only product of O2 reduction. The enzyme therefore behaves either as a hydroxylase or an oxidase. The ratio of hydroxylase to oxidase activities of the enzyme is decreased by an increase in the temperature of incubation; at 60 degrees the reaction with orcinol is almost 50% uncoupled from hydroxylation. The apparent K-m values for the effectors are in good agreement with the D-D values obtained for orcinol, resorcinol, and m-cresol. K-D values were obtained by measurement of the effector-induced perturbations of the visible absorption spectrum of the flavoprotein by difference absorption spectroscopy. The circular dichroism spectrum of orcinol hydroxylase is also altered in the presence of orcinol. The participation of the flavin in the over-all reaction is demonstrated by its rapid reduction under anaerobic conditions by NADH in the presence or orcinol, resorcinol, or m-cresol. Subsequent introduction of oxygen restores the oxidized form and yields H2O2 when m-cresol is the effector, but not when orcinol is the effector. Transfer of reducing equivalents from the reduced flavoprotein to free FAD may also occur. Reduction of orcinol hydroxylase by NADH in the absence of an effector is 10-4-fold slower than in the presence of an effector. The minimal structural requirements for effectors appear to be a 1,3-dihydroxy or 1-alkyl-3-hydorxybenzene, but only the former are substrates for hydroxylation.\n",
      "[Production and absorption rate of cerebrospinal fluid in the spinal subarachnoid space of the dog (author's transl)]. Adult mongrel dogs, weighing 10-17 kg. were anesthetized with Nembutal and cervical and lumbosacral laminectomy was performed. The spinal subarachnoid space was blocked by extradural ligation at the level of the C4 to interrupt CSF communication between the cranial and spinal space. Polyethylene catheters were placed in the cervical and lumbosacral subarachnoid space, and artificial Mock CSF buffer, pH 7.35-7.40, containing inulin of 25 mg/dl or 14C-inulin of 1.5-2 muCi/dl as a tracer was perfused in the sacro-cervical direction through the catheter. After a steady state of perfusion was acommplished, the CSF was collected from the outlet catheter. Production and absorption rate of the CSF were calculated after Pappenheimer and Heisey's equation. 1) Effects of CSF pressure on the rate of production (Vf) and absorption (Va) of CSF and on the difference between outflow fluid rate (Vo) and inflow fluid rate (Vi) were studied within the pressure range of -100 to +600 mmH2O. Then, regression lines were calculated by means of the least square method. See Article. Vf was little affected by changes in CSF pressure, while Va increased linearly as CSF pressure elevated. This suggests that the spinal subarachnoid space plays an important role as a site of CSF absorption when the intracranial pressure increases. Vo-Vi, that is difference between absorption and production rate, decreased linearly as the CSF pressure increased. 2) Under a constant CSF pressure of +200 mmH2O, the effects of glucocorticoids (dexamethasone, 0.25 mg/kg and hydrocortisone, 4.15 mg/kg) and a carbonic anhydrase inhibitor (acetazolamide, 10 mg/kg) upon the production and absorption rate of CSF were determined 1/2, 1, 2 and 3 hours after intravenous administration. a) Effect of dexamethasone: The rate of CSF production was reduced to 60.5 +/- 2.4% (p less than 0.001) of the control level. The absorption rate of CSF also decreased to 59.2 +/- 6.09% (p less than 0.001) of the control. b) Effect of hydrocortisone: The production rate of CSF decreased to 67.4 +/- 6.61% (p less than 0.001), and the absorption rate to 76.5 +/- 3.94% (p less than 0.001) of the control level. c) Effect of acetazolamide: The production and absorption rate also decreased to 57.2 +/- 5.61% (p less than 0.001) and to 56.9 +/- 7.02% (p less than 0.001), respectively. 3) Pentration of tritiated dexamethasone and tritiated hydrocortisone from plasma to CSF. The penetration of tritiated dexamethasone and tritiated hydrocortisone from plasma to CSF in the spinal and cranial subarachnoid space was observed after the intravenous administration. The CSF/Plasma ratio of dexamethasone was 30.9% at 15 minutes and gradually increased to 91.5% and 93.5%, respectively, in the cranial and spinal CSF at 3 hours after the injection.\n",
      "The role of sulfhydryl groups on the impaired hepatic 3',3,5-triiodothyronine generation from thyroxine in the hypothyroid, starved, fetal, and neonatal rodent. The role of nonprotein sulfhydryl groups (NPSH) in the decreased in vitro hepatic 3',3,5-triiodothyronine (T(3)) generation from thyroxine (T(4)) in the starved, hypothyroid, fetal and 1- to 4-d-old neonatal rat and dwarf mouse was assessed. NPSH were measured in fresh 25% liver homogenates prepared in 0.1 M PO(4)/10 mM EDTA buffer. As compared with values in adult male rats, NPSH concentration was decreased in the 2-d-starved (1.1+/-0.04 (mean+/-SE) vs. 2.2+/-0.15 mmol/250 g wet liver weight, P &lt; 0.001), fetal (1.0+/-0.04 vs. 3.2+/-0.08, P &lt; 0.001), 1-d-old neonatal (1.1+/-0.03 vs. 2.1+/-0.04, P &lt; 0.001), and hypothyroid (thyroidectomized 60 d) (1.4+/-0.06 vs. 2.2+/-0.15 P &lt; 0.001) rat. NPSH were also decreased in the hypothyroid, hypopituitary dwarf mouse as compared with values in their normal litter mates (1.3+/-0.03 vs. 2.0+/-0.2, P &lt; 0.01). Chronic administration of T(3) (0.5 mug/100 g body wt per d) markedly increased hepatic T(3) generation from T(4) in the thyroidectomized rat and in the dwarf mouse to values similar to those observed in the normal rodent without affecting NPSH concentration. In contrast, T(3) administration to the starved rat did not alter either hepatic T(3) generation from T(4) or NPSH. Reduced glutathione concentration was also markedly decreased in the starved rat (fed; 1.05+/-0.075 mmol/250 g wet tissue vs. starved 0.38+/-0.02, P &lt; 0.001). Dithiothreitol (DTT), a thiol reducing agent, increased hepatic T(3) generation from T(4) in the normal adult male rat by 45+/-5% in six experiments. When compared to DTT-stimulated control homogenates, the addition of DTT completely restored hepatic T(3) generation in starved rats, partially restored T(3) generation in 1- and 4-d-old neonates, but had little or no effect in the fetal and hypothyroid rat and dwarf mouse. Liver homogenates stored for 6 mo at -20 degrees C lost their capacity to generate T(3) from T(4). NPSH concentrations in the frozen homogenates decreased progressively with increasing storage and were absent by 6 mo. 5'-Deiodinase activity correlated with NPSH concentration in the stored homogenates (r = 0.95, P &lt; 0.005). Addition of DTT partially restored hepatic T(3) generation in the frozen homogenate. It is concluded that NPSH are important for the action of the liver 5'-deiodinase. The decreased hepatic T(3) generation in the starved rat is associated with decreased NPSH but not with a decrease in the absolute quantity of 5'-deiodinase because provision of sulfhydryl groups restored hepatic T(3) generation to normal. In contrast, the decreased hepatic T(3) generation in the adult hypothyroid rodent and in the fetal rat is probably due to a decrease in the enzyme concentration per se. In the 1- and 4-d neonatal rat, the decrease in hepatic T(3) generation is secondary to a decrease in NPSH and the deiodinating enzyme.\n",
      "\n",
      "Question: What percentage of patients with fibrotic lung disease show collagen-induced migration inhibition factor production and cytotoxicity in their circulating lymphocytes, suggesting a potential autoimmune response related to lung collagen?\n",
      "\n",
      "Options:\n",
      "A. Circulating lymphocytes from 50% of patients with fibrotic lung disease show collagen-induced migration inhibition factor production and cytotoxicity.\n",
      "B. Circulating lymphocytes from over 94% of patients with fibrotic lung disease exhibit collagen-induced migration inhibition factor production and cytotoxicity, indicating a potential autoimmune response linked to lung collagen.\n",
      "C. Less than 30% of patients with fibrotic lung disease exhibit collagen-induced migration inhibition factor production and cytotoxicity in their circulating lymphocytes.\n",
      "D. Collagen-induced migration inhibition factor production and cytotoxicity are observed in 80% of patients with nonfibrotic lung disease.\n",
      "\n",
      "Answer(pick one between A, B, C and D):\n",
      "Prompt: You are an expert in multiple-choice questions. Your task is to select the best answer from the given options based on the provided context. \n",
      "\n",
      "Context:\n",
      "3,3'-Diiodothyronine production, a major pathway of peripheral iodothyronine metabolism in man. 3,3'-Diiodothyronine (3,3'-T(2)) has been detected in human serum and in thyroglobulin. However, no quantitative assessment of its clearance rate (CR), production rate (PR), or of the importance of extrathyroidal sources of 3,3'-T(2) relative to direct thyroidal secretion is yet available. This study examines these parameters in seven euthyroid subjects, and in eight athyreotic subjects (H) eumetabolic due to thyroxine therapy (HT(4)) (n = 5) or triiodothyronine replacement (HT(3)) (n = 3). A highly specific radioimmunoassay for the measurement of 3,3'-T(2) in whole serum was developed. Serum 3,3'-T(2) concentrations were (mean +/- SD) 6.0+/-1.0 ng/100 ml in 13 normal subjects, 9.0+/-4.6 ng/100 ml in 25 hyperthyroid patients, and 2.7+/-1.1 ng/100 ml in 17 hypothyroid patients. The values in each of the latter two groups were significantly different from normal. 3,3'-T(2) was detected regularly in normal concentrations in 11 hypothyroid patients eumetabolic by treatment with synthetic T(4), in 10 eumetabolic patients suffering from nonthyroidal systemic illness, and in 2 subjects with elevated serum T(4)-binding globulin. The 3,3'-T(2) CR was assessed from data acquired from the (125)I-3,3'-T(2) constant infusion technique. The 3,3'-T(2) PR was calculated from CR and serum concentration of 3,3'-T(2) determined by radio-immunoassay. In the HT(4) subjects the 3,3'-T(2) CR averaged 840+/-377 liters/day and 3,3'-T(2) PR 33.9+/-12.5 mug/day. These results were not significantly different from those in the control group: 3,3'-T(2) CR 628+/-218 liters/day and 3,3'-T(2) PR 39.8+/-19.8 mug/day (all corrected to 70 kg body wt). In addition to 3,3'-T(2) PR, T(3), and reverse triiodothyronine (rT(3)) PR were determined in three of the HT(4) subjects. In each case studied, the 3,3'-T(2) PR was close to the combined triiodothyronine (T(3) + rT(3)) PR. The mean molar ratio of T(2) PR/(T(3) + rT(3)) PR was 1.08+/-0.10. The results obtained in the HT(4) subjects indicate that the production of 3,3'-T(2) is a major route of T(4) metabolism. The combined studies of 3,3'-T(2), T(3) and rT(3) PR in the HT(4) subjects indicate that both T(3) and rT(3) are major precursors of 3,3'-T(2). In the HT(3) subjects, the conversion of T(3) to 3,3'-T(2), determined as the molar ratio of 3,3'-T(2) PR to T(3) PR, ranged from 0.36 to 0.92, providing further evidence that T(3) is a precursor of 3,3'-T(2). From the close agreement between the mean values for 3,3'-T(2) PR in the euthyroid and HT(4) group it is concluded that most, if not all of the 3,3'-T(2) produced in normal humans is derived by extrathyroidal conversion from T(3) and rT(3).\n",
      "Physiological and pharmacological influences on thyroxine to 3,5,3'-triiodothyronine conversion and nuclear 3,5,3'-triiodothyronine binding in rat anterior pituitary. Our recent in vivo studies have suggested that intrapituitary l-thyroxine (T(4)) to 3,5,3'-triiodo-l-thyronine (T(3)) conversion with subsequent nuclear binding of T(3) is an important pathway by which circulating T(4) can inhibit thyrotropin release. The present studies were performed to evaluate various physiological and pharmacological influences on these two processes in rat anterior pituitary tissue. Intact pituitary fragments were incubated in buffer-1% bovine serum albumin containing 0.14 ng/ml [(131)I]T(3) and 3.8 ng/ml [(125)I]T(4). Nuclei were isolated after 3 h of incubation and the bound iodothyronines identified by paper chromatography. There was 0.3-1% [(125)I]T(3) contaminating the medium [(125)I]T(4), and this did not change during incubation. Nuclear [(125)I]T(4) was not decreased by 650-fold excesses of medium T(3) or T(4), suggesting that it was nonspecifically bound. The ratio of nuclear to medium [(131)I]- and [(125)I]T(3) were expressed as nuclear counts per minute per milligram wet weight of tissue:counts per minute per microliter medium. Intrapituitary T(4) to T(3) conversion was evidenced by the fact that the nuclear:medium (N:M) ratio for [(131)I]T(3) was 0.45+/-0.21, whereas that for [(125)I]T(3) was 2.23+/-1.28 (mean+/-SD, n = 51). A ratio (R), the N:M [(125)I]T(3) divided by the N:M [(131)I]T(3), was used as an index of intrapituitary T(4) to T(3) conversion. Increasing medium T(3) concentrations up to 50 ng/ml caused a progressive decrease in the N:M ratio for both T(3) isotopes, but no change in the value for R, indicating that both competed for the same limited-capacity nuclear receptors. Increasing concentrations of medium T(4) caused no change in the N:M [(131)I]T(3) but did cause a significant decrease in R in three of four experiments. These results suggest saturation of T(4)-5'-monodeiodination occurred at lower T(4) concentrations than saturation of nuclear T(3) binding sites. In hypothyroid rats, the N:M ratios for both [(131)I]T(3) and [(125)I]T(3) were increased (P &lt; 0.005), but R was three-fold higher than in controls (P &lt; 0.005). Animals given 10 mug T(4)/100 g body wt per d for 5 d had significantly decreased N:M ratios for both [(131)I]T(3) and [(125)I]T(3), as well as a decreased value for R. In fasted rats, neither N:M ratio was depressed, although hepatic T(4) to T(3) conversion in the same animals was 50% of control (P &lt; 0.005). Iopanoic acid (13 muM), but not 6-n-propylthiouracil (29 muM), decreased the N:M [(125)I]T(3) with a significant decrease in the value for R (P &lt; 0.025 or less). Neither sodium iodide (6 muM) nor thyrotropin-releasing hormone (7-700 nM) affected the T(3) N:M ratios. These results indicate that intrapituitary T(4) to T(3) conversion is stimulated in hypothyroidism and depressed in T(4)-treated animals, whereas opposite changes occur in hepatic T(4)-5'-monodeiodination. Unlike liver, anterior pituitary T(4)-5'-monodeiodination is not affected by fasting or incubation with 6-n-propyl-2-thiouracil, but T(4) to T(3) conversion is inhibited in both by iopanoic acid. These results indicate that there are important differences between anterior pituitary and other tissues in the regulation of T(4)-5'-monodeiodination.\n",
      "Metabolism of resorcinylic compounds by bacteria. Purification and properties of orcinol hydroxylase from Pseudomonas putida 01. Orcinol hydroxylase (EC 1.14.13.6), which catalyzes the first reaction of orcinol catabolism in Pseudomonas putida 01, has been purified to homogeneity, and crystallized. Orcinol hydroxylase catalyzes the hydroxylation of orcinol with equimolar consumption of O2 and NADH (or NADPH) to 2, 3, 5-trihydroxytoluene, which is nonenzymically oxidized to a quinone. The visible absorption spectrum of the enzyme shows maxima at 373 and 454 nm and a shoulder at 480 nm. FAD can be dissociated from the protein. Reconstitution of enzymic activity was achieved with FAD, and to a limited extent by FMN. The enzyme has a molecular weight of 63,000 to 68,000 and contains 1 mol of FAD per mol of protein. K-m values for the three substrates orcinol, NADH, and O2 are 0.03, 0.13, and 0.07mM, RESPECTIVELY. The molecular activity of the crystalline enzyme is 1560 min minus 1. In the absence of orcinol, NADH is only slowly oxidized with formation of H2O2. Several analogs of orcinol also serve as substrates for hydroxylation, namely resorcinol, 4-methylresorcinol, and 4-bromoresorcinol. Other analogs, m-cresol, m-ethylphenol, 4-ethylresorcinol, and phloroglucinol, mimic orcinol as effectors, in that they (a) accelerate electron flow from NADH to the flavin and (b) decrease the apparent K-m for NADH but not to the same extent as the substrates that are hydroxylated. The latter compounds are not hydroxylated. Instead H2O2 accumulates as the only product of O2 reduction. The enzyme therefore behaves either as a hydroxylase or an oxidase. The ratio of hydroxylase to oxidase activities of the enzyme is decreased by an increase in the temperature of incubation; at 60 degrees the reaction with orcinol is almost 50% uncoupled from hydroxylation. The apparent K-m values for the effectors are in good agreement with the D-D values obtained for orcinol, resorcinol, and m-cresol. K-D values were obtained by measurement of the effector-induced perturbations of the visible absorption spectrum of the flavoprotein by difference absorption spectroscopy. The circular dichroism spectrum of orcinol hydroxylase is also altered in the presence of orcinol. The participation of the flavin in the over-all reaction is demonstrated by its rapid reduction under anaerobic conditions by NADH in the presence or orcinol, resorcinol, or m-cresol. Subsequent introduction of oxygen restores the oxidized form and yields H2O2 when m-cresol is the effector, but not when orcinol is the effector. Transfer of reducing equivalents from the reduced flavoprotein to free FAD may also occur. Reduction of orcinol hydroxylase by NADH in the absence of an effector is 10-4-fold slower than in the presence of an effector. The minimal structural requirements for effectors appear to be a 1,3-dihydroxy or 1-alkyl-3-hydorxybenzene, but only the former are substrates for hydroxylation.\n",
      "[Production and absorption rate of cerebrospinal fluid in the spinal subarachnoid space of the dog (author's transl)]. Adult mongrel dogs, weighing 10-17 kg. were anesthetized with Nembutal and cervical and lumbosacral laminectomy was performed. The spinal subarachnoid space was blocked by extradural ligation at the level of the C4 to interrupt CSF communication between the cranial and spinal space. Polyethylene catheters were placed in the cervical and lumbosacral subarachnoid space, and artificial Mock CSF buffer, pH 7.35-7.40, containing inulin of 25 mg/dl or 14C-inulin of 1.5-2 muCi/dl as a tracer was perfused in the sacro-cervical direction through the catheter. After a steady state of perfusion was acommplished, the CSF was collected from the outlet catheter. Production and absorption rate of the CSF were calculated after Pappenheimer and Heisey's equation. 1) Effects of CSF pressure on the rate of production (Vf) and absorption (Va) of CSF and on the difference between outflow fluid rate (Vo) and inflow fluid rate (Vi) were studied within the pressure range of -100 to +600 mmH2O. Then, regression lines were calculated by means of the least square method. See Article. Vf was little affected by changes in CSF pressure, while Va increased linearly as CSF pressure elevated. This suggests that the spinal subarachnoid space plays an important role as a site of CSF absorption when the intracranial pressure increases. Vo-Vi, that is difference between absorption and production rate, decreased linearly as the CSF pressure increased. 2) Under a constant CSF pressure of +200 mmH2O, the effects of glucocorticoids (dexamethasone, 0.25 mg/kg and hydrocortisone, 4.15 mg/kg) and a carbonic anhydrase inhibitor (acetazolamide, 10 mg/kg) upon the production and absorption rate of CSF were determined 1/2, 1, 2 and 3 hours after intravenous administration. a) Effect of dexamethasone: The rate of CSF production was reduced to 60.5 +/- 2.4% (p less than 0.001) of the control level. The absorption rate of CSF also decreased to 59.2 +/- 6.09% (p less than 0.001) of the control. b) Effect of hydrocortisone: The production rate of CSF decreased to 67.4 +/- 6.61% (p less than 0.001), and the absorption rate to 76.5 +/- 3.94% (p less than 0.001) of the control level. c) Effect of acetazolamide: The production and absorption rate also decreased to 57.2 +/- 5.61% (p less than 0.001) and to 56.9 +/- 7.02% (p less than 0.001), respectively. 3) Pentration of tritiated dexamethasone and tritiated hydrocortisone from plasma to CSF. The penetration of tritiated dexamethasone and tritiated hydrocortisone from plasma to CSF in the spinal and cranial subarachnoid space was observed after the intravenous administration. The CSF/Plasma ratio of dexamethasone was 30.9% at 15 minutes and gradually increased to 91.5% and 93.5%, respectively, in the cranial and spinal CSF at 3 hours after the injection.\n",
      "The role of sulfhydryl groups on the impaired hepatic 3',3,5-triiodothyronine generation from thyroxine in the hypothyroid, starved, fetal, and neonatal rodent. The role of nonprotein sulfhydryl groups (NPSH) in the decreased in vitro hepatic 3',3,5-triiodothyronine (T(3)) generation from thyroxine (T(4)) in the starved, hypothyroid, fetal and 1- to 4-d-old neonatal rat and dwarf mouse was assessed. NPSH were measured in fresh 25% liver homogenates prepared in 0.1 M PO(4)/10 mM EDTA buffer. As compared with values in adult male rats, NPSH concentration was decreased in the 2-d-starved (1.1+/-0.04 (mean+/-SE) vs. 2.2+/-0.15 mmol/250 g wet liver weight, P &lt; 0.001), fetal (1.0+/-0.04 vs. 3.2+/-0.08, P &lt; 0.001), 1-d-old neonatal (1.1+/-0.03 vs. 2.1+/-0.04, P &lt; 0.001), and hypothyroid (thyroidectomized 60 d) (1.4+/-0.06 vs. 2.2+/-0.15 P &lt; 0.001) rat. NPSH were also decreased in the hypothyroid, hypopituitary dwarf mouse as compared with values in their normal litter mates (1.3+/-0.03 vs. 2.0+/-0.2, P &lt; 0.01). Chronic administration of T(3) (0.5 mug/100 g body wt per d) markedly increased hepatic T(3) generation from T(4) in the thyroidectomized rat and in the dwarf mouse to values similar to those observed in the normal rodent without affecting NPSH concentration. In contrast, T(3) administration to the starved rat did not alter either hepatic T(3) generation from T(4) or NPSH. Reduced glutathione concentration was also markedly decreased in the starved rat (fed; 1.05+/-0.075 mmol/250 g wet tissue vs. starved 0.38+/-0.02, P &lt; 0.001). Dithiothreitol (DTT), a thiol reducing agent, increased hepatic T(3) generation from T(4) in the normal adult male rat by 45+/-5% in six experiments. When compared to DTT-stimulated control homogenates, the addition of DTT completely restored hepatic T(3) generation in starved rats, partially restored T(3) generation in 1- and 4-d-old neonates, but had little or no effect in the fetal and hypothyroid rat and dwarf mouse. Liver homogenates stored for 6 mo at -20 degrees C lost their capacity to generate T(3) from T(4). NPSH concentrations in the frozen homogenates decreased progressively with increasing storage and were absent by 6 mo. 5'-Deiodinase activity correlated with NPSH concentration in the stored homogenates (r = 0.95, P &lt; 0.005). Addition of DTT partially restored hepatic T(3) generation in the frozen homogenate. It is concluded that NPSH are important for the action of the liver 5'-deiodinase. The decreased hepatic T(3) generation in the starved rat is associated with decreased NPSH but not with a decrease in the absolute quantity of 5'-deiodinase because provision of sulfhydryl groups restored hepatic T(3) generation to normal. In contrast, the decreased hepatic T(3) generation in the adult hypothyroid rodent and in the fetal rat is probably due to a decrease in the enzyme concentration per se. In the 1- and 4-d neonatal rat, the decrease in hepatic T(3) generation is secondary to a decrease in NPSH and the deiodinating enzyme.\n",
      "\n",
      "Question: What were the findings regarding transferrin concentration in normal adult Zambians in terms of gender differences and diffusion times?\n",
      "\n",
      "Options:\n",
      "A. Transferrin concentration in normal adult Zambians shows significant gender differences, with males having higher levels than females.\n",
      "B. The study found that transferrin values are consistent regardless of diffusion times, with no variation observed.\n",
      "C. Transferrin concentration in normal adult Zambians varies only with age, not with diffusion times or gender.\n",
      "D. A study on transferrin concentration in normal adult Zambians shows no gender differences, with values varying based on diffusion times of 4, 16, and 48 hours.\n",
      "\n",
      "Answer(pick one between A, B, C and D):\n",
      "Prompt: You are an expert in multiple-choice questions. Your task is to select the best answer from the given options based on the provided context. \n",
      "\n",
      "Context:\n",
      "3,3'-Diiodothyronine production, a major pathway of peripheral iodothyronine metabolism in man. 3,3'-Diiodothyronine (3,3'-T(2)) has been detected in human serum and in thyroglobulin. However, no quantitative assessment of its clearance rate (CR), production rate (PR), or of the importance of extrathyroidal sources of 3,3'-T(2) relative to direct thyroidal secretion is yet available. This study examines these parameters in seven euthyroid subjects, and in eight athyreotic subjects (H) eumetabolic due to thyroxine therapy (HT(4)) (n = 5) or triiodothyronine replacement (HT(3)) (n = 3). A highly specific radioimmunoassay for the measurement of 3,3'-T(2) in whole serum was developed. Serum 3,3'-T(2) concentrations were (mean +/- SD) 6.0+/-1.0 ng/100 ml in 13 normal subjects, 9.0+/-4.6 ng/100 ml in 25 hyperthyroid patients, and 2.7+/-1.1 ng/100 ml in 17 hypothyroid patients. The values in each of the latter two groups were significantly different from normal. 3,3'-T(2) was detected regularly in normal concentrations in 11 hypothyroid patients eumetabolic by treatment with synthetic T(4), in 10 eumetabolic patients suffering from nonthyroidal systemic illness, and in 2 subjects with elevated serum T(4)-binding globulin. The 3,3'-T(2) CR was assessed from data acquired from the (125)I-3,3'-T(2) constant infusion technique. The 3,3'-T(2) PR was calculated from CR and serum concentration of 3,3'-T(2) determined by radio-immunoassay. In the HT(4) subjects the 3,3'-T(2) CR averaged 840+/-377 liters/day and 3,3'-T(2) PR 33.9+/-12.5 mug/day. These results were not significantly different from those in the control group: 3,3'-T(2) CR 628+/-218 liters/day and 3,3'-T(2) PR 39.8+/-19.8 mug/day (all corrected to 70 kg body wt). In addition to 3,3'-T(2) PR, T(3), and reverse triiodothyronine (rT(3)) PR were determined in three of the HT(4) subjects. In each case studied, the 3,3'-T(2) PR was close to the combined triiodothyronine (T(3) + rT(3)) PR. The mean molar ratio of T(2) PR/(T(3) + rT(3)) PR was 1.08+/-0.10. The results obtained in the HT(4) subjects indicate that the production of 3,3'-T(2) is a major route of T(4) metabolism. The combined studies of 3,3'-T(2), T(3) and rT(3) PR in the HT(4) subjects indicate that both T(3) and rT(3) are major precursors of 3,3'-T(2). In the HT(3) subjects, the conversion of T(3) to 3,3'-T(2), determined as the molar ratio of 3,3'-T(2) PR to T(3) PR, ranged from 0.36 to 0.92, providing further evidence that T(3) is a precursor of 3,3'-T(2). From the close agreement between the mean values for 3,3'-T(2) PR in the euthyroid and HT(4) group it is concluded that most, if not all of the 3,3'-T(2) produced in normal humans is derived by extrathyroidal conversion from T(3) and rT(3).\n",
      "Physiological and pharmacological influences on thyroxine to 3,5,3'-triiodothyronine conversion and nuclear 3,5,3'-triiodothyronine binding in rat anterior pituitary. Our recent in vivo studies have suggested that intrapituitary l-thyroxine (T(4)) to 3,5,3'-triiodo-l-thyronine (T(3)) conversion with subsequent nuclear binding of T(3) is an important pathway by which circulating T(4) can inhibit thyrotropin release. The present studies were performed to evaluate various physiological and pharmacological influences on these two processes in rat anterior pituitary tissue. Intact pituitary fragments were incubated in buffer-1% bovine serum albumin containing 0.14 ng/ml [(131)I]T(3) and 3.8 ng/ml [(125)I]T(4). Nuclei were isolated after 3 h of incubation and the bound iodothyronines identified by paper chromatography. There was 0.3-1% [(125)I]T(3) contaminating the medium [(125)I]T(4), and this did not change during incubation. Nuclear [(125)I]T(4) was not decreased by 650-fold excesses of medium T(3) or T(4), suggesting that it was nonspecifically bound. The ratio of nuclear to medium [(131)I]- and [(125)I]T(3) were expressed as nuclear counts per minute per milligram wet weight of tissue:counts per minute per microliter medium. Intrapituitary T(4) to T(3) conversion was evidenced by the fact that the nuclear:medium (N:M) ratio for [(131)I]T(3) was 0.45+/-0.21, whereas that for [(125)I]T(3) was 2.23+/-1.28 (mean+/-SD, n = 51). A ratio (R), the N:M [(125)I]T(3) divided by the N:M [(131)I]T(3), was used as an index of intrapituitary T(4) to T(3) conversion. Increasing medium T(3) concentrations up to 50 ng/ml caused a progressive decrease in the N:M ratio for both T(3) isotopes, but no change in the value for R, indicating that both competed for the same limited-capacity nuclear receptors. Increasing concentrations of medium T(4) caused no change in the N:M [(131)I]T(3) but did cause a significant decrease in R in three of four experiments. These results suggest saturation of T(4)-5'-monodeiodination occurred at lower T(4) concentrations than saturation of nuclear T(3) binding sites. In hypothyroid rats, the N:M ratios for both [(131)I]T(3) and [(125)I]T(3) were increased (P &lt; 0.005), but R was three-fold higher than in controls (P &lt; 0.005). Animals given 10 mug T(4)/100 g body wt per d for 5 d had significantly decreased N:M ratios for both [(131)I]T(3) and [(125)I]T(3), as well as a decreased value for R. In fasted rats, neither N:M ratio was depressed, although hepatic T(4) to T(3) conversion in the same animals was 50% of control (P &lt; 0.005). Iopanoic acid (13 muM), but not 6-n-propylthiouracil (29 muM), decreased the N:M [(125)I]T(3) with a significant decrease in the value for R (P &lt; 0.025 or less). Neither sodium iodide (6 muM) nor thyrotropin-releasing hormone (7-700 nM) affected the T(3) N:M ratios. These results indicate that intrapituitary T(4) to T(3) conversion is stimulated in hypothyroidism and depressed in T(4)-treated animals, whereas opposite changes occur in hepatic T(4)-5'-monodeiodination. Unlike liver, anterior pituitary T(4)-5'-monodeiodination is not affected by fasting or incubation with 6-n-propyl-2-thiouracil, but T(4) to T(3) conversion is inhibited in both by iopanoic acid. These results indicate that there are important differences between anterior pituitary and other tissues in the regulation of T(4)-5'-monodeiodination.\n",
      "Metabolism of resorcinylic compounds by bacteria. Purification and properties of orcinol hydroxylase from Pseudomonas putida 01. Orcinol hydroxylase (EC 1.14.13.6), which catalyzes the first reaction of orcinol catabolism in Pseudomonas putida 01, has been purified to homogeneity, and crystallized. Orcinol hydroxylase catalyzes the hydroxylation of orcinol with equimolar consumption of O2 and NADH (or NADPH) to 2, 3, 5-trihydroxytoluene, which is nonenzymically oxidized to a quinone. The visible absorption spectrum of the enzyme shows maxima at 373 and 454 nm and a shoulder at 480 nm. FAD can be dissociated from the protein. Reconstitution of enzymic activity was achieved with FAD, and to a limited extent by FMN. The enzyme has a molecular weight of 63,000 to 68,000 and contains 1 mol of FAD per mol of protein. K-m values for the three substrates orcinol, NADH, and O2 are 0.03, 0.13, and 0.07mM, RESPECTIVELY. The molecular activity of the crystalline enzyme is 1560 min minus 1. In the absence of orcinol, NADH is only slowly oxidized with formation of H2O2. Several analogs of orcinol also serve as substrates for hydroxylation, namely resorcinol, 4-methylresorcinol, and 4-bromoresorcinol. Other analogs, m-cresol, m-ethylphenol, 4-ethylresorcinol, and phloroglucinol, mimic orcinol as effectors, in that they (a) accelerate electron flow from NADH to the flavin and (b) decrease the apparent K-m for NADH but not to the same extent as the substrates that are hydroxylated. The latter compounds are not hydroxylated. Instead H2O2 accumulates as the only product of O2 reduction. The enzyme therefore behaves either as a hydroxylase or an oxidase. The ratio of hydroxylase to oxidase activities of the enzyme is decreased by an increase in the temperature of incubation; at 60 degrees the reaction with orcinol is almost 50% uncoupled from hydroxylation. The apparent K-m values for the effectors are in good agreement with the D-D values obtained for orcinol, resorcinol, and m-cresol. K-D values were obtained by measurement of the effector-induced perturbations of the visible absorption spectrum of the flavoprotein by difference absorption spectroscopy. The circular dichroism spectrum of orcinol hydroxylase is also altered in the presence of orcinol. The participation of the flavin in the over-all reaction is demonstrated by its rapid reduction under anaerobic conditions by NADH in the presence or orcinol, resorcinol, or m-cresol. Subsequent introduction of oxygen restores the oxidized form and yields H2O2 when m-cresol is the effector, but not when orcinol is the effector. Transfer of reducing equivalents from the reduced flavoprotein to free FAD may also occur. Reduction of orcinol hydroxylase by NADH in the absence of an effector is 10-4-fold slower than in the presence of an effector. The minimal structural requirements for effectors appear to be a 1,3-dihydroxy or 1-alkyl-3-hydorxybenzene, but only the former are substrates for hydroxylation.\n",
      "[Production and absorption rate of cerebrospinal fluid in the spinal subarachnoid space of the dog (author's transl)]. Adult mongrel dogs, weighing 10-17 kg. were anesthetized with Nembutal and cervical and lumbosacral laminectomy was performed. The spinal subarachnoid space was blocked by extradural ligation at the level of the C4 to interrupt CSF communication between the cranial and spinal space. Polyethylene catheters were placed in the cervical and lumbosacral subarachnoid space, and artificial Mock CSF buffer, pH 7.35-7.40, containing inulin of 25 mg/dl or 14C-inulin of 1.5-2 muCi/dl as a tracer was perfused in the sacro-cervical direction through the catheter. After a steady state of perfusion was acommplished, the CSF was collected from the outlet catheter. Production and absorption rate of the CSF were calculated after Pappenheimer and Heisey's equation. 1) Effects of CSF pressure on the rate of production (Vf) and absorption (Va) of CSF and on the difference between outflow fluid rate (Vo) and inflow fluid rate (Vi) were studied within the pressure range of -100 to +600 mmH2O. Then, regression lines were calculated by means of the least square method. See Article. Vf was little affected by changes in CSF pressure, while Va increased linearly as CSF pressure elevated. This suggests that the spinal subarachnoid space plays an important role as a site of CSF absorption when the intracranial pressure increases. Vo-Vi, that is difference between absorption and production rate, decreased linearly as the CSF pressure increased. 2) Under a constant CSF pressure of +200 mmH2O, the effects of glucocorticoids (dexamethasone, 0.25 mg/kg and hydrocortisone, 4.15 mg/kg) and a carbonic anhydrase inhibitor (acetazolamide, 10 mg/kg) upon the production and absorption rate of CSF were determined 1/2, 1, 2 and 3 hours after intravenous administration. a) Effect of dexamethasone: The rate of CSF production was reduced to 60.5 +/- 2.4% (p less than 0.001) of the control level. The absorption rate of CSF also decreased to 59.2 +/- 6.09% (p less than 0.001) of the control. b) Effect of hydrocortisone: The production rate of CSF decreased to 67.4 +/- 6.61% (p less than 0.001), and the absorption rate to 76.5 +/- 3.94% (p less than 0.001) of the control level. c) Effect of acetazolamide: The production and absorption rate also decreased to 57.2 +/- 5.61% (p less than 0.001) and to 56.9 +/- 7.02% (p less than 0.001), respectively. 3) Pentration of tritiated dexamethasone and tritiated hydrocortisone from plasma to CSF. The penetration of tritiated dexamethasone and tritiated hydrocortisone from plasma to CSF in the spinal and cranial subarachnoid space was observed after the intravenous administration. The CSF/Plasma ratio of dexamethasone was 30.9% at 15 minutes and gradually increased to 91.5% and 93.5%, respectively, in the cranial and spinal CSF at 3 hours after the injection.\n",
      "The role of sulfhydryl groups on the impaired hepatic 3',3,5-triiodothyronine generation from thyroxine in the hypothyroid, starved, fetal, and neonatal rodent. The role of nonprotein sulfhydryl groups (NPSH) in the decreased in vitro hepatic 3',3,5-triiodothyronine (T(3)) generation from thyroxine (T(4)) in the starved, hypothyroid, fetal and 1- to 4-d-old neonatal rat and dwarf mouse was assessed. NPSH were measured in fresh 25% liver homogenates prepared in 0.1 M PO(4)/10 mM EDTA buffer. As compared with values in adult male rats, NPSH concentration was decreased in the 2-d-starved (1.1+/-0.04 (mean+/-SE) vs. 2.2+/-0.15 mmol/250 g wet liver weight, P &lt; 0.001), fetal (1.0+/-0.04 vs. 3.2+/-0.08, P &lt; 0.001), 1-d-old neonatal (1.1+/-0.03 vs. 2.1+/-0.04, P &lt; 0.001), and hypothyroid (thyroidectomized 60 d) (1.4+/-0.06 vs. 2.2+/-0.15 P &lt; 0.001) rat. NPSH were also decreased in the hypothyroid, hypopituitary dwarf mouse as compared with values in their normal litter mates (1.3+/-0.03 vs. 2.0+/-0.2, P &lt; 0.01). Chronic administration of T(3) (0.5 mug/100 g body wt per d) markedly increased hepatic T(3) generation from T(4) in the thyroidectomized rat and in the dwarf mouse to values similar to those observed in the normal rodent without affecting NPSH concentration. In contrast, T(3) administration to the starved rat did not alter either hepatic T(3) generation from T(4) or NPSH. Reduced glutathione concentration was also markedly decreased in the starved rat (fed; 1.05+/-0.075 mmol/250 g wet tissue vs. starved 0.38+/-0.02, P &lt; 0.001). Dithiothreitol (DTT), a thiol reducing agent, increased hepatic T(3) generation from T(4) in the normal adult male rat by 45+/-5% in six experiments. When compared to DTT-stimulated control homogenates, the addition of DTT completely restored hepatic T(3) generation in starved rats, partially restored T(3) generation in 1- and 4-d-old neonates, but had little or no effect in the fetal and hypothyroid rat and dwarf mouse. Liver homogenates stored for 6 mo at -20 degrees C lost their capacity to generate T(3) from T(4). NPSH concentrations in the frozen homogenates decreased progressively with increasing storage and were absent by 6 mo. 5'-Deiodinase activity correlated with NPSH concentration in the stored homogenates (r = 0.95, P &lt; 0.005). Addition of DTT partially restored hepatic T(3) generation in the frozen homogenate. It is concluded that NPSH are important for the action of the liver 5'-deiodinase. The decreased hepatic T(3) generation in the starved rat is associated with decreased NPSH but not with a decrease in the absolute quantity of 5'-deiodinase because provision of sulfhydryl groups restored hepatic T(3) generation to normal. In contrast, the decreased hepatic T(3) generation in the adult hypothyroid rodent and in the fetal rat is probably due to a decrease in the enzyme concentration per se. In the 1- and 4-d neonatal rat, the decrease in hepatic T(3) generation is secondary to a decrease in NPSH and the deiodinating enzyme.\n",
      "\n",
      "Question: What hormonal changes were observed in a lactating woman during amenorrhea compared to after the resumption of menses?\n",
      "\n",
      "Options:\n",
      "A. In a lactating woman, higher prolactin levels and lower LH and FSH concentrations were observed during amenorrhea compared to after the resumption of menses.\n",
      "B. Higher LH levels and lower prolactin levels during amenorrhea compared to after menses.\n",
      "C. No significant hormonal changes observed during amenorrhea compared to after menses.\n",
      "D. Lower FSH levels and higher estrogen levels during amenorrhea compared to after menses.\n",
      "\n",
      "Answer(pick one between A, B, C and D):\n",
      "Right answer: 0, picked: 0\n",
      "Prompt: You are an expert in multiple-choice questions. Your task is to select the best answer from the given options based on the provided context. \n",
      "\n",
      "Context:\n",
      "3,3'-Diiodothyronine production, a major pathway of peripheral iodothyronine metabolism in man. 3,3'-Diiodothyronine (3,3'-T(2)) has been detected in human serum and in thyroglobulin. However, no quantitative assessment of its clearance rate (CR), production rate (PR), or of the importance of extrathyroidal sources of 3,3'-T(2) relative to direct thyroidal secretion is yet available. This study examines these parameters in seven euthyroid subjects, and in eight athyreotic subjects (H) eumetabolic due to thyroxine therapy (HT(4)) (n = 5) or triiodothyronine replacement (HT(3)) (n = 3). A highly specific radioimmunoassay for the measurement of 3,3'-T(2) in whole serum was developed. Serum 3,3'-T(2) concentrations were (mean +/- SD) 6.0+/-1.0 ng/100 ml in 13 normal subjects, 9.0+/-4.6 ng/100 ml in 25 hyperthyroid patients, and 2.7+/-1.1 ng/100 ml in 17 hypothyroid patients. The values in each of the latter two groups were significantly different from normal. 3,3'-T(2) was detected regularly in normal concentrations in 11 hypothyroid patients eumetabolic by treatment with synthetic T(4), in 10 eumetabolic patients suffering from nonthyroidal systemic illness, and in 2 subjects with elevated serum T(4)-binding globulin. The 3,3'-T(2) CR was assessed from data acquired from the (125)I-3,3'-T(2) constant infusion technique. The 3,3'-T(2) PR was calculated from CR and serum concentration of 3,3'-T(2) determined by radio-immunoassay. In the HT(4) subjects the 3,3'-T(2) CR averaged 840+/-377 liters/day and 3,3'-T(2) PR 33.9+/-12.5 mug/day. These results were not significantly different from those in the control group: 3,3'-T(2) CR 628+/-218 liters/day and 3,3'-T(2) PR 39.8+/-19.8 mug/day (all corrected to 70 kg body wt). In addition to 3,3'-T(2) PR, T(3), and reverse triiodothyronine (rT(3)) PR were determined in three of the HT(4) subjects. In each case studied, the 3,3'-T(2) PR was close to the combined triiodothyronine (T(3) + rT(3)) PR. The mean molar ratio of T(2) PR/(T(3) + rT(3)) PR was 1.08+/-0.10. The results obtained in the HT(4) subjects indicate that the production of 3,3'-T(2) is a major route of T(4) metabolism. The combined studies of 3,3'-T(2), T(3) and rT(3) PR in the HT(4) subjects indicate that both T(3) and rT(3) are major precursors of 3,3'-T(2). In the HT(3) subjects, the conversion of T(3) to 3,3'-T(2), determined as the molar ratio of 3,3'-T(2) PR to T(3) PR, ranged from 0.36 to 0.92, providing further evidence that T(3) is a precursor of 3,3'-T(2). From the close agreement between the mean values for 3,3'-T(2) PR in the euthyroid and HT(4) group it is concluded that most, if not all of the 3,3'-T(2) produced in normal humans is derived by extrathyroidal conversion from T(3) and rT(3).\n",
      "Physiological and pharmacological influences on thyroxine to 3,5,3'-triiodothyronine conversion and nuclear 3,5,3'-triiodothyronine binding in rat anterior pituitary. Our recent in vivo studies have suggested that intrapituitary l-thyroxine (T(4)) to 3,5,3'-triiodo-l-thyronine (T(3)) conversion with subsequent nuclear binding of T(3) is an important pathway by which circulating T(4) can inhibit thyrotropin release. The present studies were performed to evaluate various physiological and pharmacological influences on these two processes in rat anterior pituitary tissue. Intact pituitary fragments were incubated in buffer-1% bovine serum albumin containing 0.14 ng/ml [(131)I]T(3) and 3.8 ng/ml [(125)I]T(4). Nuclei were isolated after 3 h of incubation and the bound iodothyronines identified by paper chromatography. There was 0.3-1% [(125)I]T(3) contaminating the medium [(125)I]T(4), and this did not change during incubation. Nuclear [(125)I]T(4) was not decreased by 650-fold excesses of medium T(3) or T(4), suggesting that it was nonspecifically bound. The ratio of nuclear to medium [(131)I]- and [(125)I]T(3) were expressed as nuclear counts per minute per milligram wet weight of tissue:counts per minute per microliter medium. Intrapituitary T(4) to T(3) conversion was evidenced by the fact that the nuclear:medium (N:M) ratio for [(131)I]T(3) was 0.45+/-0.21, whereas that for [(125)I]T(3) was 2.23+/-1.28 (mean+/-SD, n = 51). A ratio (R), the N:M [(125)I]T(3) divided by the N:M [(131)I]T(3), was used as an index of intrapituitary T(4) to T(3) conversion. Increasing medium T(3) concentrations up to 50 ng/ml caused a progressive decrease in the N:M ratio for both T(3) isotopes, but no change in the value for R, indicating that both competed for the same limited-capacity nuclear receptors. Increasing concentrations of medium T(4) caused no change in the N:M [(131)I]T(3) but did cause a significant decrease in R in three of four experiments. These results suggest saturation of T(4)-5'-monodeiodination occurred at lower T(4) concentrations than saturation of nuclear T(3) binding sites. In hypothyroid rats, the N:M ratios for both [(131)I]T(3) and [(125)I]T(3) were increased (P &lt; 0.005), but R was three-fold higher than in controls (P &lt; 0.005). Animals given 10 mug T(4)/100 g body wt per d for 5 d had significantly decreased N:M ratios for both [(131)I]T(3) and [(125)I]T(3), as well as a decreased value for R. In fasted rats, neither N:M ratio was depressed, although hepatic T(4) to T(3) conversion in the same animals was 50% of control (P &lt; 0.005). Iopanoic acid (13 muM), but not 6-n-propylthiouracil (29 muM), decreased the N:M [(125)I]T(3) with a significant decrease in the value for R (P &lt; 0.025 or less). Neither sodium iodide (6 muM) nor thyrotropin-releasing hormone (7-700 nM) affected the T(3) N:M ratios. These results indicate that intrapituitary T(4) to T(3) conversion is stimulated in hypothyroidism and depressed in T(4)-treated animals, whereas opposite changes occur in hepatic T(4)-5'-monodeiodination. Unlike liver, anterior pituitary T(4)-5'-monodeiodination is not affected by fasting or incubation with 6-n-propyl-2-thiouracil, but T(4) to T(3) conversion is inhibited in both by iopanoic acid. These results indicate that there are important differences between anterior pituitary and other tissues in the regulation of T(4)-5'-monodeiodination.\n",
      "Metabolism of resorcinylic compounds by bacteria. Purification and properties of orcinol hydroxylase from Pseudomonas putida 01. Orcinol hydroxylase (EC 1.14.13.6), which catalyzes the first reaction of orcinol catabolism in Pseudomonas putida 01, has been purified to homogeneity, and crystallized. Orcinol hydroxylase catalyzes the hydroxylation of orcinol with equimolar consumption of O2 and NADH (or NADPH) to 2, 3, 5-trihydroxytoluene, which is nonenzymically oxidized to a quinone. The visible absorption spectrum of the enzyme shows maxima at 373 and 454 nm and a shoulder at 480 nm. FAD can be dissociated from the protein. Reconstitution of enzymic activity was achieved with FAD, and to a limited extent by FMN. The enzyme has a molecular weight of 63,000 to 68,000 and contains 1 mol of FAD per mol of protein. K-m values for the three substrates orcinol, NADH, and O2 are 0.03, 0.13, and 0.07mM, RESPECTIVELY. The molecular activity of the crystalline enzyme is 1560 min minus 1. In the absence of orcinol, NADH is only slowly oxidized with formation of H2O2. Several analogs of orcinol also serve as substrates for hydroxylation, namely resorcinol, 4-methylresorcinol, and 4-bromoresorcinol. Other analogs, m-cresol, m-ethylphenol, 4-ethylresorcinol, and phloroglucinol, mimic orcinol as effectors, in that they (a) accelerate electron flow from NADH to the flavin and (b) decrease the apparent K-m for NADH but not to the same extent as the substrates that are hydroxylated. The latter compounds are not hydroxylated. Instead H2O2 accumulates as the only product of O2 reduction. The enzyme therefore behaves either as a hydroxylase or an oxidase. The ratio of hydroxylase to oxidase activities of the enzyme is decreased by an increase in the temperature of incubation; at 60 degrees the reaction with orcinol is almost 50% uncoupled from hydroxylation. The apparent K-m values for the effectors are in good agreement with the D-D values obtained for orcinol, resorcinol, and m-cresol. K-D values were obtained by measurement of the effector-induced perturbations of the visible absorption spectrum of the flavoprotein by difference absorption spectroscopy. The circular dichroism spectrum of orcinol hydroxylase is also altered in the presence of orcinol. The participation of the flavin in the over-all reaction is demonstrated by its rapid reduction under anaerobic conditions by NADH in the presence or orcinol, resorcinol, or m-cresol. Subsequent introduction of oxygen restores the oxidized form and yields H2O2 when m-cresol is the effector, but not when orcinol is the effector. Transfer of reducing equivalents from the reduced flavoprotein to free FAD may also occur. Reduction of orcinol hydroxylase by NADH in the absence of an effector is 10-4-fold slower than in the presence of an effector. The minimal structural requirements for effectors appear to be a 1,3-dihydroxy or 1-alkyl-3-hydorxybenzene, but only the former are substrates for hydroxylation.\n",
      "[Production and absorption rate of cerebrospinal fluid in the spinal subarachnoid space of the dog (author's transl)]. Adult mongrel dogs, weighing 10-17 kg. were anesthetized with Nembutal and cervical and lumbosacral laminectomy was performed. The spinal subarachnoid space was blocked by extradural ligation at the level of the C4 to interrupt CSF communication between the cranial and spinal space. Polyethylene catheters were placed in the cervical and lumbosacral subarachnoid space, and artificial Mock CSF buffer, pH 7.35-7.40, containing inulin of 25 mg/dl or 14C-inulin of 1.5-2 muCi/dl as a tracer was perfused in the sacro-cervical direction through the catheter. After a steady state of perfusion was acommplished, the CSF was collected from the outlet catheter. Production and absorption rate of the CSF were calculated after Pappenheimer and Heisey's equation. 1) Effects of CSF pressure on the rate of production (Vf) and absorption (Va) of CSF and on the difference between outflow fluid rate (Vo) and inflow fluid rate (Vi) were studied within the pressure range of -100 to +600 mmH2O. Then, regression lines were calculated by means of the least square method. See Article. Vf was little affected by changes in CSF pressure, while Va increased linearly as CSF pressure elevated. This suggests that the spinal subarachnoid space plays an important role as a site of CSF absorption when the intracranial pressure increases. Vo-Vi, that is difference between absorption and production rate, decreased linearly as the CSF pressure increased. 2) Under a constant CSF pressure of +200 mmH2O, the effects of glucocorticoids (dexamethasone, 0.25 mg/kg and hydrocortisone, 4.15 mg/kg) and a carbonic anhydrase inhibitor (acetazolamide, 10 mg/kg) upon the production and absorption rate of CSF were determined 1/2, 1, 2 and 3 hours after intravenous administration. a) Effect of dexamethasone: The rate of CSF production was reduced to 60.5 +/- 2.4% (p less than 0.001) of the control level. The absorption rate of CSF also decreased to 59.2 +/- 6.09% (p less than 0.001) of the control. b) Effect of hydrocortisone: The production rate of CSF decreased to 67.4 +/- 6.61% (p less than 0.001), and the absorption rate to 76.5 +/- 3.94% (p less than 0.001) of the control level. c) Effect of acetazolamide: The production and absorption rate also decreased to 57.2 +/- 5.61% (p less than 0.001) and to 56.9 +/- 7.02% (p less than 0.001), respectively. 3) Pentration of tritiated dexamethasone and tritiated hydrocortisone from plasma to CSF. The penetration of tritiated dexamethasone and tritiated hydrocortisone from plasma to CSF in the spinal and cranial subarachnoid space was observed after the intravenous administration. The CSF/Plasma ratio of dexamethasone was 30.9% at 15 minutes and gradually increased to 91.5% and 93.5%, respectively, in the cranial and spinal CSF at 3 hours after the injection.\n",
      "The role of sulfhydryl groups on the impaired hepatic 3',3,5-triiodothyronine generation from thyroxine in the hypothyroid, starved, fetal, and neonatal rodent. The role of nonprotein sulfhydryl groups (NPSH) in the decreased in vitro hepatic 3',3,5-triiodothyronine (T(3)) generation from thyroxine (T(4)) in the starved, hypothyroid, fetal and 1- to 4-d-old neonatal rat and dwarf mouse was assessed. NPSH were measured in fresh 25% liver homogenates prepared in 0.1 M PO(4)/10 mM EDTA buffer. As compared with values in adult male rats, NPSH concentration was decreased in the 2-d-starved (1.1+/-0.04 (mean+/-SE) vs. 2.2+/-0.15 mmol/250 g wet liver weight, P &lt; 0.001), fetal (1.0+/-0.04 vs. 3.2+/-0.08, P &lt; 0.001), 1-d-old neonatal (1.1+/-0.03 vs. 2.1+/-0.04, P &lt; 0.001), and hypothyroid (thyroidectomized 60 d) (1.4+/-0.06 vs. 2.2+/-0.15 P &lt; 0.001) rat. NPSH were also decreased in the hypothyroid, hypopituitary dwarf mouse as compared with values in their normal litter mates (1.3+/-0.03 vs. 2.0+/-0.2, P &lt; 0.01). Chronic administration of T(3) (0.5 mug/100 g body wt per d) markedly increased hepatic T(3) generation from T(4) in the thyroidectomized rat and in the dwarf mouse to values similar to those observed in the normal rodent without affecting NPSH concentration. In contrast, T(3) administration to the starved rat did not alter either hepatic T(3) generation from T(4) or NPSH. Reduced glutathione concentration was also markedly decreased in the starved rat (fed; 1.05+/-0.075 mmol/250 g wet tissue vs. starved 0.38+/-0.02, P &lt; 0.001). Dithiothreitol (DTT), a thiol reducing agent, increased hepatic T(3) generation from T(4) in the normal adult male rat by 45+/-5% in six experiments. When compared to DTT-stimulated control homogenates, the addition of DTT completely restored hepatic T(3) generation in starved rats, partially restored T(3) generation in 1- and 4-d-old neonates, but had little or no effect in the fetal and hypothyroid rat and dwarf mouse. Liver homogenates stored for 6 mo at -20 degrees C lost their capacity to generate T(3) from T(4). NPSH concentrations in the frozen homogenates decreased progressively with increasing storage and were absent by 6 mo. 5'-Deiodinase activity correlated with NPSH concentration in the stored homogenates (r = 0.95, P &lt; 0.005). Addition of DTT partially restored hepatic T(3) generation in the frozen homogenate. It is concluded that NPSH are important for the action of the liver 5'-deiodinase. The decreased hepatic T(3) generation in the starved rat is associated with decreased NPSH but not with a decrease in the absolute quantity of 5'-deiodinase because provision of sulfhydryl groups restored hepatic T(3) generation to normal. In contrast, the decreased hepatic T(3) generation in the adult hypothyroid rodent and in the fetal rat is probably due to a decrease in the enzyme concentration per se. In the 1- and 4-d neonatal rat, the decrease in hepatic T(3) generation is secondary to a decrease in NPSH and the deiodinating enzyme.\n",
      "\n",
      "Question: What can short-term plasma renin activity responses to salt depletion and propranolol predict regarding long-term plasma renin levels and blood pressure reduction during treatment?\n",
      "\n",
      "Options:\n",
      "A. Short-term plasma renin activity responses can predict both long-term plasma renin levels and blood pressure reduction during treatment.\n",
      "B. Short-term plasma renin activity responses do not correlate with long-term plasma renin levels but predict significant blood pressure reduction.\n",
      "C. Short-term plasma renin activity responses to propranolol alone can predict long-term blood pressure reduction without considering salt depletion.\n",
      "D. Short-term plasma renin activity responses to salt depletion and propranolol can predict long-term plasma renin levels but do not predict blood pressure reduction during treatment.\n",
      "\n",
      "Answer(pick one between A, B, C and D):\n",
      "Prompt: You are an expert in multiple-choice questions. Your task is to select the best answer from the given options based on the provided context. \n",
      "\n",
      "Context:\n",
      "3,3'-Diiodothyronine production, a major pathway of peripheral iodothyronine metabolism in man. 3,3'-Diiodothyronine (3,3'-T(2)) has been detected in human serum and in thyroglobulin. However, no quantitative assessment of its clearance rate (CR), production rate (PR), or of the importance of extrathyroidal sources of 3,3'-T(2) relative to direct thyroidal secretion is yet available. This study examines these parameters in seven euthyroid subjects, and in eight athyreotic subjects (H) eumetabolic due to thyroxine therapy (HT(4)) (n = 5) or triiodothyronine replacement (HT(3)) (n = 3). A highly specific radioimmunoassay for the measurement of 3,3'-T(2) in whole serum was developed. Serum 3,3'-T(2) concentrations were (mean +/- SD) 6.0+/-1.0 ng/100 ml in 13 normal subjects, 9.0+/-4.6 ng/100 ml in 25 hyperthyroid patients, and 2.7+/-1.1 ng/100 ml in 17 hypothyroid patients. The values in each of the latter two groups were significantly different from normal. 3,3'-T(2) was detected regularly in normal concentrations in 11 hypothyroid patients eumetabolic by treatment with synthetic T(4), in 10 eumetabolic patients suffering from nonthyroidal systemic illness, and in 2 subjects with elevated serum T(4)-binding globulin. The 3,3'-T(2) CR was assessed from data acquired from the (125)I-3,3'-T(2) constant infusion technique. The 3,3'-T(2) PR was calculated from CR and serum concentration of 3,3'-T(2) determined by radio-immunoassay. In the HT(4) subjects the 3,3'-T(2) CR averaged 840+/-377 liters/day and 3,3'-T(2) PR 33.9+/-12.5 mug/day. These results were not significantly different from those in the control group: 3,3'-T(2) CR 628+/-218 liters/day and 3,3'-T(2) PR 39.8+/-19.8 mug/day (all corrected to 70 kg body wt). In addition to 3,3'-T(2) PR, T(3), and reverse triiodothyronine (rT(3)) PR were determined in three of the HT(4) subjects. In each case studied, the 3,3'-T(2) PR was close to the combined triiodothyronine (T(3) + rT(3)) PR. The mean molar ratio of T(2) PR/(T(3) + rT(3)) PR was 1.08+/-0.10. The results obtained in the HT(4) subjects indicate that the production of 3,3'-T(2) is a major route of T(4) metabolism. The combined studies of 3,3'-T(2), T(3) and rT(3) PR in the HT(4) subjects indicate that both T(3) and rT(3) are major precursors of 3,3'-T(2). In the HT(3) subjects, the conversion of T(3) to 3,3'-T(2), determined as the molar ratio of 3,3'-T(2) PR to T(3) PR, ranged from 0.36 to 0.92, providing further evidence that T(3) is a precursor of 3,3'-T(2). From the close agreement between the mean values for 3,3'-T(2) PR in the euthyroid and HT(4) group it is concluded that most, if not all of the 3,3'-T(2) produced in normal humans is derived by extrathyroidal conversion from T(3) and rT(3).\n",
      "Physiological and pharmacological influences on thyroxine to 3,5,3'-triiodothyronine conversion and nuclear 3,5,3'-triiodothyronine binding in rat anterior pituitary. Our recent in vivo studies have suggested that intrapituitary l-thyroxine (T(4)) to 3,5,3'-triiodo-l-thyronine (T(3)) conversion with subsequent nuclear binding of T(3) is an important pathway by which circulating T(4) can inhibit thyrotropin release. The present studies were performed to evaluate various physiological and pharmacological influences on these two processes in rat anterior pituitary tissue. Intact pituitary fragments were incubated in buffer-1% bovine serum albumin containing 0.14 ng/ml [(131)I]T(3) and 3.8 ng/ml [(125)I]T(4). Nuclei were isolated after 3 h of incubation and the bound iodothyronines identified by paper chromatography. There was 0.3-1% [(125)I]T(3) contaminating the medium [(125)I]T(4), and this did not change during incubation. Nuclear [(125)I]T(4) was not decreased by 650-fold excesses of medium T(3) or T(4), suggesting that it was nonspecifically bound. The ratio of nuclear to medium [(131)I]- and [(125)I]T(3) were expressed as nuclear counts per minute per milligram wet weight of tissue:counts per minute per microliter medium. Intrapituitary T(4) to T(3) conversion was evidenced by the fact that the nuclear:medium (N:M) ratio for [(131)I]T(3) was 0.45+/-0.21, whereas that for [(125)I]T(3) was 2.23+/-1.28 (mean+/-SD, n = 51). A ratio (R), the N:M [(125)I]T(3) divided by the N:M [(131)I]T(3), was used as an index of intrapituitary T(4) to T(3) conversion. Increasing medium T(3) concentrations up to 50 ng/ml caused a progressive decrease in the N:M ratio for both T(3) isotopes, but no change in the value for R, indicating that both competed for the same limited-capacity nuclear receptors. Increasing concentrations of medium T(4) caused no change in the N:M [(131)I]T(3) but did cause a significant decrease in R in three of four experiments. These results suggest saturation of T(4)-5'-monodeiodination occurred at lower T(4) concentrations than saturation of nuclear T(3) binding sites. In hypothyroid rats, the N:M ratios for both [(131)I]T(3) and [(125)I]T(3) were increased (P &lt; 0.005), but R was three-fold higher than in controls (P &lt; 0.005). Animals given 10 mug T(4)/100 g body wt per d for 5 d had significantly decreased N:M ratios for both [(131)I]T(3) and [(125)I]T(3), as well as a decreased value for R. In fasted rats, neither N:M ratio was depressed, although hepatic T(4) to T(3) conversion in the same animals was 50% of control (P &lt; 0.005). Iopanoic acid (13 muM), but not 6-n-propylthiouracil (29 muM), decreased the N:M [(125)I]T(3) with a significant decrease in the value for R (P &lt; 0.025 or less). Neither sodium iodide (6 muM) nor thyrotropin-releasing hormone (7-700 nM) affected the T(3) N:M ratios. These results indicate that intrapituitary T(4) to T(3) conversion is stimulated in hypothyroidism and depressed in T(4)-treated animals, whereas opposite changes occur in hepatic T(4)-5'-monodeiodination. Unlike liver, anterior pituitary T(4)-5'-monodeiodination is not affected by fasting or incubation with 6-n-propyl-2-thiouracil, but T(4) to T(3) conversion is inhibited in both by iopanoic acid. These results indicate that there are important differences between anterior pituitary and other tissues in the regulation of T(4)-5'-monodeiodination.\n",
      "Metabolism of resorcinylic compounds by bacteria. Purification and properties of orcinol hydroxylase from Pseudomonas putida 01. Orcinol hydroxylase (EC 1.14.13.6), which catalyzes the first reaction of orcinol catabolism in Pseudomonas putida 01, has been purified to homogeneity, and crystallized. Orcinol hydroxylase catalyzes the hydroxylation of orcinol with equimolar consumption of O2 and NADH (or NADPH) to 2, 3, 5-trihydroxytoluene, which is nonenzymically oxidized to a quinone. The visible absorption spectrum of the enzyme shows maxima at 373 and 454 nm and a shoulder at 480 nm. FAD can be dissociated from the protein. Reconstitution of enzymic activity was achieved with FAD, and to a limited extent by FMN. The enzyme has a molecular weight of 63,000 to 68,000 and contains 1 mol of FAD per mol of protein. K-m values for the three substrates orcinol, NADH, and O2 are 0.03, 0.13, and 0.07mM, RESPECTIVELY. The molecular activity of the crystalline enzyme is 1560 min minus 1. In the absence of orcinol, NADH is only slowly oxidized with formation of H2O2. Several analogs of orcinol also serve as substrates for hydroxylation, namely resorcinol, 4-methylresorcinol, and 4-bromoresorcinol. Other analogs, m-cresol, m-ethylphenol, 4-ethylresorcinol, and phloroglucinol, mimic orcinol as effectors, in that they (a) accelerate electron flow from NADH to the flavin and (b) decrease the apparent K-m for NADH but not to the same extent as the substrates that are hydroxylated. The latter compounds are not hydroxylated. Instead H2O2 accumulates as the only product of O2 reduction. The enzyme therefore behaves either as a hydroxylase or an oxidase. The ratio of hydroxylase to oxidase activities of the enzyme is decreased by an increase in the temperature of incubation; at 60 degrees the reaction with orcinol is almost 50% uncoupled from hydroxylation. The apparent K-m values for the effectors are in good agreement with the D-D values obtained for orcinol, resorcinol, and m-cresol. K-D values were obtained by measurement of the effector-induced perturbations of the visible absorption spectrum of the flavoprotein by difference absorption spectroscopy. The circular dichroism spectrum of orcinol hydroxylase is also altered in the presence of orcinol. The participation of the flavin in the over-all reaction is demonstrated by its rapid reduction under anaerobic conditions by NADH in the presence or orcinol, resorcinol, or m-cresol. Subsequent introduction of oxygen restores the oxidized form and yields H2O2 when m-cresol is the effector, but not when orcinol is the effector. Transfer of reducing equivalents from the reduced flavoprotein to free FAD may also occur. Reduction of orcinol hydroxylase by NADH in the absence of an effector is 10-4-fold slower than in the presence of an effector. The minimal structural requirements for effectors appear to be a 1,3-dihydroxy or 1-alkyl-3-hydorxybenzene, but only the former are substrates for hydroxylation.\n",
      "[Production and absorption rate of cerebrospinal fluid in the spinal subarachnoid space of the dog (author's transl)]. Adult mongrel dogs, weighing 10-17 kg. were anesthetized with Nembutal and cervical and lumbosacral laminectomy was performed. The spinal subarachnoid space was blocked by extradural ligation at the level of the C4 to interrupt CSF communication between the cranial and spinal space. Polyethylene catheters were placed in the cervical and lumbosacral subarachnoid space, and artificial Mock CSF buffer, pH 7.35-7.40, containing inulin of 25 mg/dl or 14C-inulin of 1.5-2 muCi/dl as a tracer was perfused in the sacro-cervical direction through the catheter. After a steady state of perfusion was acommplished, the CSF was collected from the outlet catheter. Production and absorption rate of the CSF were calculated after Pappenheimer and Heisey's equation. 1) Effects of CSF pressure on the rate of production (Vf) and absorption (Va) of CSF and on the difference between outflow fluid rate (Vo) and inflow fluid rate (Vi) were studied within the pressure range of -100 to +600 mmH2O. Then, regression lines were calculated by means of the least square method. See Article. Vf was little affected by changes in CSF pressure, while Va increased linearly as CSF pressure elevated. This suggests that the spinal subarachnoid space plays an important role as a site of CSF absorption when the intracranial pressure increases. Vo-Vi, that is difference between absorption and production rate, decreased linearly as the CSF pressure increased. 2) Under a constant CSF pressure of +200 mmH2O, the effects of glucocorticoids (dexamethasone, 0.25 mg/kg and hydrocortisone, 4.15 mg/kg) and a carbonic anhydrase inhibitor (acetazolamide, 10 mg/kg) upon the production and absorption rate of CSF were determined 1/2, 1, 2 and 3 hours after intravenous administration. a) Effect of dexamethasone: The rate of CSF production was reduced to 60.5 +/- 2.4% (p less than 0.001) of the control level. The absorption rate of CSF also decreased to 59.2 +/- 6.09% (p less than 0.001) of the control. b) Effect of hydrocortisone: The production rate of CSF decreased to 67.4 +/- 6.61% (p less than 0.001), and the absorption rate to 76.5 +/- 3.94% (p less than 0.001) of the control level. c) Effect of acetazolamide: The production and absorption rate also decreased to 57.2 +/- 5.61% (p less than 0.001) and to 56.9 +/- 7.02% (p less than 0.001), respectively. 3) Pentration of tritiated dexamethasone and tritiated hydrocortisone from plasma to CSF. The penetration of tritiated dexamethasone and tritiated hydrocortisone from plasma to CSF in the spinal and cranial subarachnoid space was observed after the intravenous administration. The CSF/Plasma ratio of dexamethasone was 30.9% at 15 minutes and gradually increased to 91.5% and 93.5%, respectively, in the cranial and spinal CSF at 3 hours after the injection.\n",
      "The role of sulfhydryl groups on the impaired hepatic 3',3,5-triiodothyronine generation from thyroxine in the hypothyroid, starved, fetal, and neonatal rodent. The role of nonprotein sulfhydryl groups (NPSH) in the decreased in vitro hepatic 3',3,5-triiodothyronine (T(3)) generation from thyroxine (T(4)) in the starved, hypothyroid, fetal and 1- to 4-d-old neonatal rat and dwarf mouse was assessed. NPSH were measured in fresh 25% liver homogenates prepared in 0.1 M PO(4)/10 mM EDTA buffer. As compared with values in adult male rats, NPSH concentration was decreased in the 2-d-starved (1.1+/-0.04 (mean+/-SE) vs. 2.2+/-0.15 mmol/250 g wet liver weight, P &lt; 0.001), fetal (1.0+/-0.04 vs. 3.2+/-0.08, P &lt; 0.001), 1-d-old neonatal (1.1+/-0.03 vs. 2.1+/-0.04, P &lt; 0.001), and hypothyroid (thyroidectomized 60 d) (1.4+/-0.06 vs. 2.2+/-0.15 P &lt; 0.001) rat. NPSH were also decreased in the hypothyroid, hypopituitary dwarf mouse as compared with values in their normal litter mates (1.3+/-0.03 vs. 2.0+/-0.2, P &lt; 0.01). Chronic administration of T(3) (0.5 mug/100 g body wt per d) markedly increased hepatic T(3) generation from T(4) in the thyroidectomized rat and in the dwarf mouse to values similar to those observed in the normal rodent without affecting NPSH concentration. In contrast, T(3) administration to the starved rat did not alter either hepatic T(3) generation from T(4) or NPSH. Reduced glutathione concentration was also markedly decreased in the starved rat (fed; 1.05+/-0.075 mmol/250 g wet tissue vs. starved 0.38+/-0.02, P &lt; 0.001). Dithiothreitol (DTT), a thiol reducing agent, increased hepatic T(3) generation from T(4) in the normal adult male rat by 45+/-5% in six experiments. When compared to DTT-stimulated control homogenates, the addition of DTT completely restored hepatic T(3) generation in starved rats, partially restored T(3) generation in 1- and 4-d-old neonates, but had little or no effect in the fetal and hypothyroid rat and dwarf mouse. Liver homogenates stored for 6 mo at -20 degrees C lost their capacity to generate T(3) from T(4). NPSH concentrations in the frozen homogenates decreased progressively with increasing storage and were absent by 6 mo. 5'-Deiodinase activity correlated with NPSH concentration in the stored homogenates (r = 0.95, P &lt; 0.005). Addition of DTT partially restored hepatic T(3) generation in the frozen homogenate. It is concluded that NPSH are important for the action of the liver 5'-deiodinase. The decreased hepatic T(3) generation in the starved rat is associated with decreased NPSH but not with a decrease in the absolute quantity of 5'-deiodinase because provision of sulfhydryl groups restored hepatic T(3) generation to normal. In contrast, the decreased hepatic T(3) generation in the adult hypothyroid rodent and in the fetal rat is probably due to a decrease in the enzyme concentration per se. In the 1- and 4-d neonatal rat, the decrease in hepatic T(3) generation is secondary to a decrease in NPSH and the deiodinating enzyme.\n",
      "\n",
      "Question: What effect does heat sensitivity have on the reverse transcriptase of replication-defective avian sarcoma viruses in certain temperature-sensitive mutants?\n",
      "\n",
      "Options:\n",
      "A. Heat sensitivity enhances the binding of tryptophanyl-tRNA to reverse transcriptase.\n",
      "B. The reverse transcriptase becomes more active at higher temperatures in temperature-sensitive mutants.\n",
      "C. The reverse transcriptase of replication-defective avian sarcoma viruses exhibits heat sensitivity in certain temperature-sensitive mutants, affecting both tryptophanyl-tRNA binding and DNA polymerase activities.\n",
      "D. Heat sensitivity has no effect on the DNA polymerase activities of reverse transcriptase.\n",
      "\n",
      "Answer(pick one between A, B, C and D):\n",
      "Prompt: You are an expert in multiple-choice questions. Your task is to select the best answer from the given options based on the provided context. \n",
      "\n",
      "Context:\n",
      "3,3'-Diiodothyronine production, a major pathway of peripheral iodothyronine metabolism in man. 3,3'-Diiodothyronine (3,3'-T(2)) has been detected in human serum and in thyroglobulin. However, no quantitative assessment of its clearance rate (CR), production rate (PR), or of the importance of extrathyroidal sources of 3,3'-T(2) relative to direct thyroidal secretion is yet available. This study examines these parameters in seven euthyroid subjects, and in eight athyreotic subjects (H) eumetabolic due to thyroxine therapy (HT(4)) (n = 5) or triiodothyronine replacement (HT(3)) (n = 3). A highly specific radioimmunoassay for the measurement of 3,3'-T(2) in whole serum was developed. Serum 3,3'-T(2) concentrations were (mean +/- SD) 6.0+/-1.0 ng/100 ml in 13 normal subjects, 9.0+/-4.6 ng/100 ml in 25 hyperthyroid patients, and 2.7+/-1.1 ng/100 ml in 17 hypothyroid patients. The values in each of the latter two groups were significantly different from normal. 3,3'-T(2) was detected regularly in normal concentrations in 11 hypothyroid patients eumetabolic by treatment with synthetic T(4), in 10 eumetabolic patients suffering from nonthyroidal systemic illness, and in 2 subjects with elevated serum T(4)-binding globulin. The 3,3'-T(2) CR was assessed from data acquired from the (125)I-3,3'-T(2) constant infusion technique. The 3,3'-T(2) PR was calculated from CR and serum concentration of 3,3'-T(2) determined by radio-immunoassay. In the HT(4) subjects the 3,3'-T(2) CR averaged 840+/-377 liters/day and 3,3'-T(2) PR 33.9+/-12.5 mug/day. These results were not significantly different from those in the control group: 3,3'-T(2) CR 628+/-218 liters/day and 3,3'-T(2) PR 39.8+/-19.8 mug/day (all corrected to 70 kg body wt). In addition to 3,3'-T(2) PR, T(3), and reverse triiodothyronine (rT(3)) PR were determined in three of the HT(4) subjects. In each case studied, the 3,3'-T(2) PR was close to the combined triiodothyronine (T(3) + rT(3)) PR. The mean molar ratio of T(2) PR/(T(3) + rT(3)) PR was 1.08+/-0.10. The results obtained in the HT(4) subjects indicate that the production of 3,3'-T(2) is a major route of T(4) metabolism. The combined studies of 3,3'-T(2), T(3) and rT(3) PR in the HT(4) subjects indicate that both T(3) and rT(3) are major precursors of 3,3'-T(2). In the HT(3) subjects, the conversion of T(3) to 3,3'-T(2), determined as the molar ratio of 3,3'-T(2) PR to T(3) PR, ranged from 0.36 to 0.92, providing further evidence that T(3) is a precursor of 3,3'-T(2). From the close agreement between the mean values for 3,3'-T(2) PR in the euthyroid and HT(4) group it is concluded that most, if not all of the 3,3'-T(2) produced in normal humans is derived by extrathyroidal conversion from T(3) and rT(3).\n",
      "Physiological and pharmacological influences on thyroxine to 3,5,3'-triiodothyronine conversion and nuclear 3,5,3'-triiodothyronine binding in rat anterior pituitary. Our recent in vivo studies have suggested that intrapituitary l-thyroxine (T(4)) to 3,5,3'-triiodo-l-thyronine (T(3)) conversion with subsequent nuclear binding of T(3) is an important pathway by which circulating T(4) can inhibit thyrotropin release. The present studies were performed to evaluate various physiological and pharmacological influences on these two processes in rat anterior pituitary tissue. Intact pituitary fragments were incubated in buffer-1% bovine serum albumin containing 0.14 ng/ml [(131)I]T(3) and 3.8 ng/ml [(125)I]T(4). Nuclei were isolated after 3 h of incubation and the bound iodothyronines identified by paper chromatography. There was 0.3-1% [(125)I]T(3) contaminating the medium [(125)I]T(4), and this did not change during incubation. Nuclear [(125)I]T(4) was not decreased by 650-fold excesses of medium T(3) or T(4), suggesting that it was nonspecifically bound. The ratio of nuclear to medium [(131)I]- and [(125)I]T(3) were expressed as nuclear counts per minute per milligram wet weight of tissue:counts per minute per microliter medium. Intrapituitary T(4) to T(3) conversion was evidenced by the fact that the nuclear:medium (N:M) ratio for [(131)I]T(3) was 0.45+/-0.21, whereas that for [(125)I]T(3) was 2.23+/-1.28 (mean+/-SD, n = 51). A ratio (R), the N:M [(125)I]T(3) divided by the N:M [(131)I]T(3), was used as an index of intrapituitary T(4) to T(3) conversion. Increasing medium T(3) concentrations up to 50 ng/ml caused a progressive decrease in the N:M ratio for both T(3) isotopes, but no change in the value for R, indicating that both competed for the same limited-capacity nuclear receptors. Increasing concentrations of medium T(4) caused no change in the N:M [(131)I]T(3) but did cause a significant decrease in R in three of four experiments. These results suggest saturation of T(4)-5'-monodeiodination occurred at lower T(4) concentrations than saturation of nuclear T(3) binding sites. In hypothyroid rats, the N:M ratios for both [(131)I]T(3) and [(125)I]T(3) were increased (P &lt; 0.005), but R was three-fold higher than in controls (P &lt; 0.005). Animals given 10 mug T(4)/100 g body wt per d for 5 d had significantly decreased N:M ratios for both [(131)I]T(3) and [(125)I]T(3), as well as a decreased value for R. In fasted rats, neither N:M ratio was depressed, although hepatic T(4) to T(3) conversion in the same animals was 50% of control (P &lt; 0.005). Iopanoic acid (13 muM), but not 6-n-propylthiouracil (29 muM), decreased the N:M [(125)I]T(3) with a significant decrease in the value for R (P &lt; 0.025 or less). Neither sodium iodide (6 muM) nor thyrotropin-releasing hormone (7-700 nM) affected the T(3) N:M ratios. These results indicate that intrapituitary T(4) to T(3) conversion is stimulated in hypothyroidism and depressed in T(4)-treated animals, whereas opposite changes occur in hepatic T(4)-5'-monodeiodination. Unlike liver, anterior pituitary T(4)-5'-monodeiodination is not affected by fasting or incubation with 6-n-propyl-2-thiouracil, but T(4) to T(3) conversion is inhibited in both by iopanoic acid. These results indicate that there are important differences between anterior pituitary and other tissues in the regulation of T(4)-5'-monodeiodination.\n",
      "Metabolism of resorcinylic compounds by bacteria. Purification and properties of orcinol hydroxylase from Pseudomonas putida 01. Orcinol hydroxylase (EC 1.14.13.6), which catalyzes the first reaction of orcinol catabolism in Pseudomonas putida 01, has been purified to homogeneity, and crystallized. Orcinol hydroxylase catalyzes the hydroxylation of orcinol with equimolar consumption of O2 and NADH (or NADPH) to 2, 3, 5-trihydroxytoluene, which is nonenzymically oxidized to a quinone. The visible absorption spectrum of the enzyme shows maxima at 373 and 454 nm and a shoulder at 480 nm. FAD can be dissociated from the protein. Reconstitution of enzymic activity was achieved with FAD, and to a limited extent by FMN. The enzyme has a molecular weight of 63,000 to 68,000 and contains 1 mol of FAD per mol of protein. K-m values for the three substrates orcinol, NADH, and O2 are 0.03, 0.13, and 0.07mM, RESPECTIVELY. The molecular activity of the crystalline enzyme is 1560 min minus 1. In the absence of orcinol, NADH is only slowly oxidized with formation of H2O2. Several analogs of orcinol also serve as substrates for hydroxylation, namely resorcinol, 4-methylresorcinol, and 4-bromoresorcinol. Other analogs, m-cresol, m-ethylphenol, 4-ethylresorcinol, and phloroglucinol, mimic orcinol as effectors, in that they (a) accelerate electron flow from NADH to the flavin and (b) decrease the apparent K-m for NADH but not to the same extent as the substrates that are hydroxylated. The latter compounds are not hydroxylated. Instead H2O2 accumulates as the only product of O2 reduction. The enzyme therefore behaves either as a hydroxylase or an oxidase. The ratio of hydroxylase to oxidase activities of the enzyme is decreased by an increase in the temperature of incubation; at 60 degrees the reaction with orcinol is almost 50% uncoupled from hydroxylation. The apparent K-m values for the effectors are in good agreement with the D-D values obtained for orcinol, resorcinol, and m-cresol. K-D values were obtained by measurement of the effector-induced perturbations of the visible absorption spectrum of the flavoprotein by difference absorption spectroscopy. The circular dichroism spectrum of orcinol hydroxylase is also altered in the presence of orcinol. The participation of the flavin in the over-all reaction is demonstrated by its rapid reduction under anaerobic conditions by NADH in the presence or orcinol, resorcinol, or m-cresol. Subsequent introduction of oxygen restores the oxidized form and yields H2O2 when m-cresol is the effector, but not when orcinol is the effector. Transfer of reducing equivalents from the reduced flavoprotein to free FAD may also occur. Reduction of orcinol hydroxylase by NADH in the absence of an effector is 10-4-fold slower than in the presence of an effector. The minimal structural requirements for effectors appear to be a 1,3-dihydroxy or 1-alkyl-3-hydorxybenzene, but only the former are substrates for hydroxylation.\n",
      "[Production and absorption rate of cerebrospinal fluid in the spinal subarachnoid space of the dog (author's transl)]. Adult mongrel dogs, weighing 10-17 kg. were anesthetized with Nembutal and cervical and lumbosacral laminectomy was performed. The spinal subarachnoid space was blocked by extradural ligation at the level of the C4 to interrupt CSF communication between the cranial and spinal space. Polyethylene catheters were placed in the cervical and lumbosacral subarachnoid space, and artificial Mock CSF buffer, pH 7.35-7.40, containing inulin of 25 mg/dl or 14C-inulin of 1.5-2 muCi/dl as a tracer was perfused in the sacro-cervical direction through the catheter. After a steady state of perfusion was acommplished, the CSF was collected from the outlet catheter. Production and absorption rate of the CSF were calculated after Pappenheimer and Heisey's equation. 1) Effects of CSF pressure on the rate of production (Vf) and absorption (Va) of CSF and on the difference between outflow fluid rate (Vo) and inflow fluid rate (Vi) were studied within the pressure range of -100 to +600 mmH2O. Then, regression lines were calculated by means of the least square method. See Article. Vf was little affected by changes in CSF pressure, while Va increased linearly as CSF pressure elevated. This suggests that the spinal subarachnoid space plays an important role as a site of CSF absorption when the intracranial pressure increases. Vo-Vi, that is difference between absorption and production rate, decreased linearly as the CSF pressure increased. 2) Under a constant CSF pressure of +200 mmH2O, the effects of glucocorticoids (dexamethasone, 0.25 mg/kg and hydrocortisone, 4.15 mg/kg) and a carbonic anhydrase inhibitor (acetazolamide, 10 mg/kg) upon the production and absorption rate of CSF were determined 1/2, 1, 2 and 3 hours after intravenous administration. a) Effect of dexamethasone: The rate of CSF production was reduced to 60.5 +/- 2.4% (p less than 0.001) of the control level. The absorption rate of CSF also decreased to 59.2 +/- 6.09% (p less than 0.001) of the control. b) Effect of hydrocortisone: The production rate of CSF decreased to 67.4 +/- 6.61% (p less than 0.001), and the absorption rate to 76.5 +/- 3.94% (p less than 0.001) of the control level. c) Effect of acetazolamide: The production and absorption rate also decreased to 57.2 +/- 5.61% (p less than 0.001) and to 56.9 +/- 7.02% (p less than 0.001), respectively. 3) Pentration of tritiated dexamethasone and tritiated hydrocortisone from plasma to CSF. The penetration of tritiated dexamethasone and tritiated hydrocortisone from plasma to CSF in the spinal and cranial subarachnoid space was observed after the intravenous administration. The CSF/Plasma ratio of dexamethasone was 30.9% at 15 minutes and gradually increased to 91.5% and 93.5%, respectively, in the cranial and spinal CSF at 3 hours after the injection.\n",
      "The role of sulfhydryl groups on the impaired hepatic 3',3,5-triiodothyronine generation from thyroxine in the hypothyroid, starved, fetal, and neonatal rodent. The role of nonprotein sulfhydryl groups (NPSH) in the decreased in vitro hepatic 3',3,5-triiodothyronine (T(3)) generation from thyroxine (T(4)) in the starved, hypothyroid, fetal and 1- to 4-d-old neonatal rat and dwarf mouse was assessed. NPSH were measured in fresh 25% liver homogenates prepared in 0.1 M PO(4)/10 mM EDTA buffer. As compared with values in adult male rats, NPSH concentration was decreased in the 2-d-starved (1.1+/-0.04 (mean+/-SE) vs. 2.2+/-0.15 mmol/250 g wet liver weight, P &lt; 0.001), fetal (1.0+/-0.04 vs. 3.2+/-0.08, P &lt; 0.001), 1-d-old neonatal (1.1+/-0.03 vs. 2.1+/-0.04, P &lt; 0.001), and hypothyroid (thyroidectomized 60 d) (1.4+/-0.06 vs. 2.2+/-0.15 P &lt; 0.001) rat. NPSH were also decreased in the hypothyroid, hypopituitary dwarf mouse as compared with values in their normal litter mates (1.3+/-0.03 vs. 2.0+/-0.2, P &lt; 0.01). Chronic administration of T(3) (0.5 mug/100 g body wt per d) markedly increased hepatic T(3) generation from T(4) in the thyroidectomized rat and in the dwarf mouse to values similar to those observed in the normal rodent without affecting NPSH concentration. In contrast, T(3) administration to the starved rat did not alter either hepatic T(3) generation from T(4) or NPSH. Reduced glutathione concentration was also markedly decreased in the starved rat (fed; 1.05+/-0.075 mmol/250 g wet tissue vs. starved 0.38+/-0.02, P &lt; 0.001). Dithiothreitol (DTT), a thiol reducing agent, increased hepatic T(3) generation from T(4) in the normal adult male rat by 45+/-5% in six experiments. When compared to DTT-stimulated control homogenates, the addition of DTT completely restored hepatic T(3) generation in starved rats, partially restored T(3) generation in 1- and 4-d-old neonates, but had little or no effect in the fetal and hypothyroid rat and dwarf mouse. Liver homogenates stored for 6 mo at -20 degrees C lost their capacity to generate T(3) from T(4). NPSH concentrations in the frozen homogenates decreased progressively with increasing storage and were absent by 6 mo. 5'-Deiodinase activity correlated with NPSH concentration in the stored homogenates (r = 0.95, P &lt; 0.005). Addition of DTT partially restored hepatic T(3) generation in the frozen homogenate. It is concluded that NPSH are important for the action of the liver 5'-deiodinase. The decreased hepatic T(3) generation in the starved rat is associated with decreased NPSH but not with a decrease in the absolute quantity of 5'-deiodinase because provision of sulfhydryl groups restored hepatic T(3) generation to normal. In contrast, the decreased hepatic T(3) generation in the adult hypothyroid rodent and in the fetal rat is probably due to a decrease in the enzyme concentration per se. In the 1- and 4-d neonatal rat, the decrease in hepatic T(3) generation is secondary to a decrease in NPSH and the deiodinating enzyme.\n",
      "\n",
      "Question: What are the effects of morphine and dopamine on contractions in guinea-pig ileum, and how does naloxone interact with these substances?\n",
      "\n",
      "Options:\n",
      "A. Morphine increases contractions in guinea-pig ileum, while dopamine has no effect on these contractions.\n",
      "B. Naloxone enhances the depressant effect of morphine and also inhibits dopamine's action on contractions.\n",
      "C. Morphine decreases contractions in guinea-pig ileum, an effect that can be partially reversed by low concentrations of dopamine, while naloxone specifically antagonizes morphine's depressant action without affecting dopamine.\n",
      "D. Dopamine completely reverses the effects of morphine, while naloxone has no interaction with either substance.\n",
      "\n",
      "Answer(pick one between A, B, C and D):\n",
      "Prompt: You are an expert in multiple-choice questions. Your task is to select the best answer from the given options based on the provided context. \n",
      "\n",
      "Context:\n",
      "3,3'-Diiodothyronine production, a major pathway of peripheral iodothyronine metabolism in man. 3,3'-Diiodothyronine (3,3'-T(2)) has been detected in human serum and in thyroglobulin. However, no quantitative assessment of its clearance rate (CR), production rate (PR), or of the importance of extrathyroidal sources of 3,3'-T(2) relative to direct thyroidal secretion is yet available. This study examines these parameters in seven euthyroid subjects, and in eight athyreotic subjects (H) eumetabolic due to thyroxine therapy (HT(4)) (n = 5) or triiodothyronine replacement (HT(3)) (n = 3). A highly specific radioimmunoassay for the measurement of 3,3'-T(2) in whole serum was developed. Serum 3,3'-T(2) concentrations were (mean +/- SD) 6.0+/-1.0 ng/100 ml in 13 normal subjects, 9.0+/-4.6 ng/100 ml in 25 hyperthyroid patients, and 2.7+/-1.1 ng/100 ml in 17 hypothyroid patients. The values in each of the latter two groups were significantly different from normal. 3,3'-T(2) was detected regularly in normal concentrations in 11 hypothyroid patients eumetabolic by treatment with synthetic T(4), in 10 eumetabolic patients suffering from nonthyroidal systemic illness, and in 2 subjects with elevated serum T(4)-binding globulin. The 3,3'-T(2) CR was assessed from data acquired from the (125)I-3,3'-T(2) constant infusion technique. The 3,3'-T(2) PR was calculated from CR and serum concentration of 3,3'-T(2) determined by radio-immunoassay. In the HT(4) subjects the 3,3'-T(2) CR averaged 840+/-377 liters/day and 3,3'-T(2) PR 33.9+/-12.5 mug/day. These results were not significantly different from those in the control group: 3,3'-T(2) CR 628+/-218 liters/day and 3,3'-T(2) PR 39.8+/-19.8 mug/day (all corrected to 70 kg body wt). In addition to 3,3'-T(2) PR, T(3), and reverse triiodothyronine (rT(3)) PR were determined in three of the HT(4) subjects. In each case studied, the 3,3'-T(2) PR was close to the combined triiodothyronine (T(3) + rT(3)) PR. The mean molar ratio of T(2) PR/(T(3) + rT(3)) PR was 1.08+/-0.10. The results obtained in the HT(4) subjects indicate that the production of 3,3'-T(2) is a major route of T(4) metabolism. The combined studies of 3,3'-T(2), T(3) and rT(3) PR in the HT(4) subjects indicate that both T(3) and rT(3) are major precursors of 3,3'-T(2). In the HT(3) subjects, the conversion of T(3) to 3,3'-T(2), determined as the molar ratio of 3,3'-T(2) PR to T(3) PR, ranged from 0.36 to 0.92, providing further evidence that T(3) is a precursor of 3,3'-T(2). From the close agreement between the mean values for 3,3'-T(2) PR in the euthyroid and HT(4) group it is concluded that most, if not all of the 3,3'-T(2) produced in normal humans is derived by extrathyroidal conversion from T(3) and rT(3).\n",
      "Physiological and pharmacological influences on thyroxine to 3,5,3'-triiodothyronine conversion and nuclear 3,5,3'-triiodothyronine binding in rat anterior pituitary. Our recent in vivo studies have suggested that intrapituitary l-thyroxine (T(4)) to 3,5,3'-triiodo-l-thyronine (T(3)) conversion with subsequent nuclear binding of T(3) is an important pathway by which circulating T(4) can inhibit thyrotropin release. The present studies were performed to evaluate various physiological and pharmacological influences on these two processes in rat anterior pituitary tissue. Intact pituitary fragments were incubated in buffer-1% bovine serum albumin containing 0.14 ng/ml [(131)I]T(3) and 3.8 ng/ml [(125)I]T(4). Nuclei were isolated after 3 h of incubation and the bound iodothyronines identified by paper chromatography. There was 0.3-1% [(125)I]T(3) contaminating the medium [(125)I]T(4), and this did not change during incubation. Nuclear [(125)I]T(4) was not decreased by 650-fold excesses of medium T(3) or T(4), suggesting that it was nonspecifically bound. The ratio of nuclear to medium [(131)I]- and [(125)I]T(3) were expressed as nuclear counts per minute per milligram wet weight of tissue:counts per minute per microliter medium. Intrapituitary T(4) to T(3) conversion was evidenced by the fact that the nuclear:medium (N:M) ratio for [(131)I]T(3) was 0.45+/-0.21, whereas that for [(125)I]T(3) was 2.23+/-1.28 (mean+/-SD, n = 51). A ratio (R), the N:M [(125)I]T(3) divided by the N:M [(131)I]T(3), was used as an index of intrapituitary T(4) to T(3) conversion. Increasing medium T(3) concentrations up to 50 ng/ml caused a progressive decrease in the N:M ratio for both T(3) isotopes, but no change in the value for R, indicating that both competed for the same limited-capacity nuclear receptors. Increasing concentrations of medium T(4) caused no change in the N:M [(131)I]T(3) but did cause a significant decrease in R in three of four experiments. These results suggest saturation of T(4)-5'-monodeiodination occurred at lower T(4) concentrations than saturation of nuclear T(3) binding sites. In hypothyroid rats, the N:M ratios for both [(131)I]T(3) and [(125)I]T(3) were increased (P &lt; 0.005), but R was three-fold higher than in controls (P &lt; 0.005). Animals given 10 mug T(4)/100 g body wt per d for 5 d had significantly decreased N:M ratios for both [(131)I]T(3) and [(125)I]T(3), as well as a decreased value for R. In fasted rats, neither N:M ratio was depressed, although hepatic T(4) to T(3) conversion in the same animals was 50% of control (P &lt; 0.005). Iopanoic acid (13 muM), but not 6-n-propylthiouracil (29 muM), decreased the N:M [(125)I]T(3) with a significant decrease in the value for R (P &lt; 0.025 or less). Neither sodium iodide (6 muM) nor thyrotropin-releasing hormone (7-700 nM) affected the T(3) N:M ratios. These results indicate that intrapituitary T(4) to T(3) conversion is stimulated in hypothyroidism and depressed in T(4)-treated animals, whereas opposite changes occur in hepatic T(4)-5'-monodeiodination. Unlike liver, anterior pituitary T(4)-5'-monodeiodination is not affected by fasting or incubation with 6-n-propyl-2-thiouracil, but T(4) to T(3) conversion is inhibited in both by iopanoic acid. These results indicate that there are important differences between anterior pituitary and other tissues in the regulation of T(4)-5'-monodeiodination.\n",
      "Metabolism of resorcinylic compounds by bacteria. Purification and properties of orcinol hydroxylase from Pseudomonas putida 01. Orcinol hydroxylase (EC 1.14.13.6), which catalyzes the first reaction of orcinol catabolism in Pseudomonas putida 01, has been purified to homogeneity, and crystallized. Orcinol hydroxylase catalyzes the hydroxylation of orcinol with equimolar consumption of O2 and NADH (or NADPH) to 2, 3, 5-trihydroxytoluene, which is nonenzymically oxidized to a quinone. The visible absorption spectrum of the enzyme shows maxima at 373 and 454 nm and a shoulder at 480 nm. FAD can be dissociated from the protein. Reconstitution of enzymic activity was achieved with FAD, and to a limited extent by FMN. The enzyme has a molecular weight of 63,000 to 68,000 and contains 1 mol of FAD per mol of protein. K-m values for the three substrates orcinol, NADH, and O2 are 0.03, 0.13, and 0.07mM, RESPECTIVELY. The molecular activity of the crystalline enzyme is 1560 min minus 1. In the absence of orcinol, NADH is only slowly oxidized with formation of H2O2. Several analogs of orcinol also serve as substrates for hydroxylation, namely resorcinol, 4-methylresorcinol, and 4-bromoresorcinol. Other analogs, m-cresol, m-ethylphenol, 4-ethylresorcinol, and phloroglucinol, mimic orcinol as effectors, in that they (a) accelerate electron flow from NADH to the flavin and (b) decrease the apparent K-m for NADH but not to the same extent as the substrates that are hydroxylated. The latter compounds are not hydroxylated. Instead H2O2 accumulates as the only product of O2 reduction. The enzyme therefore behaves either as a hydroxylase or an oxidase. The ratio of hydroxylase to oxidase activities of the enzyme is decreased by an increase in the temperature of incubation; at 60 degrees the reaction with orcinol is almost 50% uncoupled from hydroxylation. The apparent K-m values for the effectors are in good agreement with the D-D values obtained for orcinol, resorcinol, and m-cresol. K-D values were obtained by measurement of the effector-induced perturbations of the visible absorption spectrum of the flavoprotein by difference absorption spectroscopy. The circular dichroism spectrum of orcinol hydroxylase is also altered in the presence of orcinol. The participation of the flavin in the over-all reaction is demonstrated by its rapid reduction under anaerobic conditions by NADH in the presence or orcinol, resorcinol, or m-cresol. Subsequent introduction of oxygen restores the oxidized form and yields H2O2 when m-cresol is the effector, but not when orcinol is the effector. Transfer of reducing equivalents from the reduced flavoprotein to free FAD may also occur. Reduction of orcinol hydroxylase by NADH in the absence of an effector is 10-4-fold slower than in the presence of an effector. The minimal structural requirements for effectors appear to be a 1,3-dihydroxy or 1-alkyl-3-hydorxybenzene, but only the former are substrates for hydroxylation.\n",
      "[Production and absorption rate of cerebrospinal fluid in the spinal subarachnoid space of the dog (author's transl)]. Adult mongrel dogs, weighing 10-17 kg. were anesthetized with Nembutal and cervical and lumbosacral laminectomy was performed. The spinal subarachnoid space was blocked by extradural ligation at the level of the C4 to interrupt CSF communication between the cranial and spinal space. Polyethylene catheters were placed in the cervical and lumbosacral subarachnoid space, and artificial Mock CSF buffer, pH 7.35-7.40, containing inulin of 25 mg/dl or 14C-inulin of 1.5-2 muCi/dl as a tracer was perfused in the sacro-cervical direction through the catheter. After a steady state of perfusion was acommplished, the CSF was collected from the outlet catheter. Production and absorption rate of the CSF were calculated after Pappenheimer and Heisey's equation. 1) Effects of CSF pressure on the rate of production (Vf) and absorption (Va) of CSF and on the difference between outflow fluid rate (Vo) and inflow fluid rate (Vi) were studied within the pressure range of -100 to +600 mmH2O. Then, regression lines were calculated by means of the least square method. See Article. Vf was little affected by changes in CSF pressure, while Va increased linearly as CSF pressure elevated. This suggests that the spinal subarachnoid space plays an important role as a site of CSF absorption when the intracranial pressure increases. Vo-Vi, that is difference between absorption and production rate, decreased linearly as the CSF pressure increased. 2) Under a constant CSF pressure of +200 mmH2O, the effects of glucocorticoids (dexamethasone, 0.25 mg/kg and hydrocortisone, 4.15 mg/kg) and a carbonic anhydrase inhibitor (acetazolamide, 10 mg/kg) upon the production and absorption rate of CSF were determined 1/2, 1, 2 and 3 hours after intravenous administration. a) Effect of dexamethasone: The rate of CSF production was reduced to 60.5 +/- 2.4% (p less than 0.001) of the control level. The absorption rate of CSF also decreased to 59.2 +/- 6.09% (p less than 0.001) of the control. b) Effect of hydrocortisone: The production rate of CSF decreased to 67.4 +/- 6.61% (p less than 0.001), and the absorption rate to 76.5 +/- 3.94% (p less than 0.001) of the control level. c) Effect of acetazolamide: The production and absorption rate also decreased to 57.2 +/- 5.61% (p less than 0.001) and to 56.9 +/- 7.02% (p less than 0.001), respectively. 3) Pentration of tritiated dexamethasone and tritiated hydrocortisone from plasma to CSF. The penetration of tritiated dexamethasone and tritiated hydrocortisone from plasma to CSF in the spinal and cranial subarachnoid space was observed after the intravenous administration. The CSF/Plasma ratio of dexamethasone was 30.9% at 15 minutes and gradually increased to 91.5% and 93.5%, respectively, in the cranial and spinal CSF at 3 hours after the injection.\n",
      "The role of sulfhydryl groups on the impaired hepatic 3',3,5-triiodothyronine generation from thyroxine in the hypothyroid, starved, fetal, and neonatal rodent. The role of nonprotein sulfhydryl groups (NPSH) in the decreased in vitro hepatic 3',3,5-triiodothyronine (T(3)) generation from thyroxine (T(4)) in the starved, hypothyroid, fetal and 1- to 4-d-old neonatal rat and dwarf mouse was assessed. NPSH were measured in fresh 25% liver homogenates prepared in 0.1 M PO(4)/10 mM EDTA buffer. As compared with values in adult male rats, NPSH concentration was decreased in the 2-d-starved (1.1+/-0.04 (mean+/-SE) vs. 2.2+/-0.15 mmol/250 g wet liver weight, P &lt; 0.001), fetal (1.0+/-0.04 vs. 3.2+/-0.08, P &lt; 0.001), 1-d-old neonatal (1.1+/-0.03 vs. 2.1+/-0.04, P &lt; 0.001), and hypothyroid (thyroidectomized 60 d) (1.4+/-0.06 vs. 2.2+/-0.15 P &lt; 0.001) rat. NPSH were also decreased in the hypothyroid, hypopituitary dwarf mouse as compared with values in their normal litter mates (1.3+/-0.03 vs. 2.0+/-0.2, P &lt; 0.01). Chronic administration of T(3) (0.5 mug/100 g body wt per d) markedly increased hepatic T(3) generation from T(4) in the thyroidectomized rat and in the dwarf mouse to values similar to those observed in the normal rodent without affecting NPSH concentration. In contrast, T(3) administration to the starved rat did not alter either hepatic T(3) generation from T(4) or NPSH. Reduced glutathione concentration was also markedly decreased in the starved rat (fed; 1.05+/-0.075 mmol/250 g wet tissue vs. starved 0.38+/-0.02, P &lt; 0.001). Dithiothreitol (DTT), a thiol reducing agent, increased hepatic T(3) generation from T(4) in the normal adult male rat by 45+/-5% in six experiments. When compared to DTT-stimulated control homogenates, the addition of DTT completely restored hepatic T(3) generation in starved rats, partially restored T(3) generation in 1- and 4-d-old neonates, but had little or no effect in the fetal and hypothyroid rat and dwarf mouse. Liver homogenates stored for 6 mo at -20 degrees C lost their capacity to generate T(3) from T(4). NPSH concentrations in the frozen homogenates decreased progressively with increasing storage and were absent by 6 mo. 5'-Deiodinase activity correlated with NPSH concentration in the stored homogenates (r = 0.95, P &lt; 0.005). Addition of DTT partially restored hepatic T(3) generation in the frozen homogenate. It is concluded that NPSH are important for the action of the liver 5'-deiodinase. The decreased hepatic T(3) generation in the starved rat is associated with decreased NPSH but not with a decrease in the absolute quantity of 5'-deiodinase because provision of sulfhydryl groups restored hepatic T(3) generation to normal. In contrast, the decreased hepatic T(3) generation in the adult hypothyroid rodent and in the fetal rat is probably due to a decrease in the enzyme concentration per se. In the 1- and 4-d neonatal rat, the decrease in hepatic T(3) generation is secondary to a decrease in NPSH and the deiodinating enzyme.\n",
      "\n",
      "Question: What role does increased lipoprotein lipase activity in the adipose tissue of genetically obese rats play in fat cell development and obesity prediction?\n",
      "\n",
      "Options:\n",
      "A. Increased lipoprotein lipase activity in the adipose tissue of genetically obese rats leads to reduced fat cell size and weight.\n",
      "B. Increased lipoprotein lipase activity in the adipose tissue of genetically obese rats contributes to early fat cell hypertrophy and may serve as a predictor for the onset of obesity.\n",
      "C. Increased lipoprotein lipase activity in the adipose tissue of genetically obese rats is primarily responsible for muscle development and strength.\n",
      "D. Increased lipoprotein lipase activity in the adipose tissue of genetically obese rats decreases the risk of developing obesity later in life.\n",
      "\n",
      "Answer(pick one between A, B, C and D):\n",
      "Prompt: You are an expert in multiple-choice questions. Your task is to select the best answer from the given options based on the provided context. \n",
      "\n",
      "Context:\n",
      "3,3'-Diiodothyronine production, a major pathway of peripheral iodothyronine metabolism in man. 3,3'-Diiodothyronine (3,3'-T(2)) has been detected in human serum and in thyroglobulin. However, no quantitative assessment of its clearance rate (CR), production rate (PR), or of the importance of extrathyroidal sources of 3,3'-T(2) relative to direct thyroidal secretion is yet available. This study examines these parameters in seven euthyroid subjects, and in eight athyreotic subjects (H) eumetabolic due to thyroxine therapy (HT(4)) (n = 5) or triiodothyronine replacement (HT(3)) (n = 3). A highly specific radioimmunoassay for the measurement of 3,3'-T(2) in whole serum was developed. Serum 3,3'-T(2) concentrations were (mean +/- SD) 6.0+/-1.0 ng/100 ml in 13 normal subjects, 9.0+/-4.6 ng/100 ml in 25 hyperthyroid patients, and 2.7+/-1.1 ng/100 ml in 17 hypothyroid patients. The values in each of the latter two groups were significantly different from normal. 3,3'-T(2) was detected regularly in normal concentrations in 11 hypothyroid patients eumetabolic by treatment with synthetic T(4), in 10 eumetabolic patients suffering from nonthyroidal systemic illness, and in 2 subjects with elevated serum T(4)-binding globulin. The 3,3'-T(2) CR was assessed from data acquired from the (125)I-3,3'-T(2) constant infusion technique. The 3,3'-T(2) PR was calculated from CR and serum concentration of 3,3'-T(2) determined by radio-immunoassay. In the HT(4) subjects the 3,3'-T(2) CR averaged 840+/-377 liters/day and 3,3'-T(2) PR 33.9+/-12.5 mug/day. These results were not significantly different from those in the control group: 3,3'-T(2) CR 628+/-218 liters/day and 3,3'-T(2) PR 39.8+/-19.8 mug/day (all corrected to 70 kg body wt). In addition to 3,3'-T(2) PR, T(3), and reverse triiodothyronine (rT(3)) PR were determined in three of the HT(4) subjects. In each case studied, the 3,3'-T(2) PR was close to the combined triiodothyronine (T(3) + rT(3)) PR. The mean molar ratio of T(2) PR/(T(3) + rT(3)) PR was 1.08+/-0.10. The results obtained in the HT(4) subjects indicate that the production of 3,3'-T(2) is a major route of T(4) metabolism. The combined studies of 3,3'-T(2), T(3) and rT(3) PR in the HT(4) subjects indicate that both T(3) and rT(3) are major precursors of 3,3'-T(2). In the HT(3) subjects, the conversion of T(3) to 3,3'-T(2), determined as the molar ratio of 3,3'-T(2) PR to T(3) PR, ranged from 0.36 to 0.92, providing further evidence that T(3) is a precursor of 3,3'-T(2). From the close agreement between the mean values for 3,3'-T(2) PR in the euthyroid and HT(4) group it is concluded that most, if not all of the 3,3'-T(2) produced in normal humans is derived by extrathyroidal conversion from T(3) and rT(3).\n",
      "Physiological and pharmacological influences on thyroxine to 3,5,3'-triiodothyronine conversion and nuclear 3,5,3'-triiodothyronine binding in rat anterior pituitary. Our recent in vivo studies have suggested that intrapituitary l-thyroxine (T(4)) to 3,5,3'-triiodo-l-thyronine (T(3)) conversion with subsequent nuclear binding of T(3) is an important pathway by which circulating T(4) can inhibit thyrotropin release. The present studies were performed to evaluate various physiological and pharmacological influences on these two processes in rat anterior pituitary tissue. Intact pituitary fragments were incubated in buffer-1% bovine serum albumin containing 0.14 ng/ml [(131)I]T(3) and 3.8 ng/ml [(125)I]T(4). Nuclei were isolated after 3 h of incubation and the bound iodothyronines identified by paper chromatography. There was 0.3-1% [(125)I]T(3) contaminating the medium [(125)I]T(4), and this did not change during incubation. Nuclear [(125)I]T(4) was not decreased by 650-fold excesses of medium T(3) or T(4), suggesting that it was nonspecifically bound. The ratio of nuclear to medium [(131)I]- and [(125)I]T(3) were expressed as nuclear counts per minute per milligram wet weight of tissue:counts per minute per microliter medium. Intrapituitary T(4) to T(3) conversion was evidenced by the fact that the nuclear:medium (N:M) ratio for [(131)I]T(3) was 0.45+/-0.21, whereas that for [(125)I]T(3) was 2.23+/-1.28 (mean+/-SD, n = 51). A ratio (R), the N:M [(125)I]T(3) divided by the N:M [(131)I]T(3), was used as an index of intrapituitary T(4) to T(3) conversion. Increasing medium T(3) concentrations up to 50 ng/ml caused a progressive decrease in the N:M ratio for both T(3) isotopes, but no change in the value for R, indicating that both competed for the same limited-capacity nuclear receptors. Increasing concentrations of medium T(4) caused no change in the N:M [(131)I]T(3) but did cause a significant decrease in R in three of four experiments. These results suggest saturation of T(4)-5'-monodeiodination occurred at lower T(4) concentrations than saturation of nuclear T(3) binding sites. In hypothyroid rats, the N:M ratios for both [(131)I]T(3) and [(125)I]T(3) were increased (P &lt; 0.005), but R was three-fold higher than in controls (P &lt; 0.005). Animals given 10 mug T(4)/100 g body wt per d for 5 d had significantly decreased N:M ratios for both [(131)I]T(3) and [(125)I]T(3), as well as a decreased value for R. In fasted rats, neither N:M ratio was depressed, although hepatic T(4) to T(3) conversion in the same animals was 50% of control (P &lt; 0.005). Iopanoic acid (13 muM), but not 6-n-propylthiouracil (29 muM), decreased the N:M [(125)I]T(3) with a significant decrease in the value for R (P &lt; 0.025 or less). Neither sodium iodide (6 muM) nor thyrotropin-releasing hormone (7-700 nM) affected the T(3) N:M ratios. These results indicate that intrapituitary T(4) to T(3) conversion is stimulated in hypothyroidism and depressed in T(4)-treated animals, whereas opposite changes occur in hepatic T(4)-5'-monodeiodination. Unlike liver, anterior pituitary T(4)-5'-monodeiodination is not affected by fasting or incubation with 6-n-propyl-2-thiouracil, but T(4) to T(3) conversion is inhibited in both by iopanoic acid. These results indicate that there are important differences between anterior pituitary and other tissues in the regulation of T(4)-5'-monodeiodination.\n",
      "Metabolism of resorcinylic compounds by bacteria. Purification and properties of orcinol hydroxylase from Pseudomonas putida 01. Orcinol hydroxylase (EC 1.14.13.6), which catalyzes the first reaction of orcinol catabolism in Pseudomonas putida 01, has been purified to homogeneity, and crystallized. Orcinol hydroxylase catalyzes the hydroxylation of orcinol with equimolar consumption of O2 and NADH (or NADPH) to 2, 3, 5-trihydroxytoluene, which is nonenzymically oxidized to a quinone. The visible absorption spectrum of the enzyme shows maxima at 373 and 454 nm and a shoulder at 480 nm. FAD can be dissociated from the protein. Reconstitution of enzymic activity was achieved with FAD, and to a limited extent by FMN. The enzyme has a molecular weight of 63,000 to 68,000 and contains 1 mol of FAD per mol of protein. K-m values for the three substrates orcinol, NADH, and O2 are 0.03, 0.13, and 0.07mM, RESPECTIVELY. The molecular activity of the crystalline enzyme is 1560 min minus 1. In the absence of orcinol, NADH is only slowly oxidized with formation of H2O2. Several analogs of orcinol also serve as substrates for hydroxylation, namely resorcinol, 4-methylresorcinol, and 4-bromoresorcinol. Other analogs, m-cresol, m-ethylphenol, 4-ethylresorcinol, and phloroglucinol, mimic orcinol as effectors, in that they (a) accelerate electron flow from NADH to the flavin and (b) decrease the apparent K-m for NADH but not to the same extent as the substrates that are hydroxylated. The latter compounds are not hydroxylated. Instead H2O2 accumulates as the only product of O2 reduction. The enzyme therefore behaves either as a hydroxylase or an oxidase. The ratio of hydroxylase to oxidase activities of the enzyme is decreased by an increase in the temperature of incubation; at 60 degrees the reaction with orcinol is almost 50% uncoupled from hydroxylation. The apparent K-m values for the effectors are in good agreement with the D-D values obtained for orcinol, resorcinol, and m-cresol. K-D values were obtained by measurement of the effector-induced perturbations of the visible absorption spectrum of the flavoprotein by difference absorption spectroscopy. The circular dichroism spectrum of orcinol hydroxylase is also altered in the presence of orcinol. The participation of the flavin in the over-all reaction is demonstrated by its rapid reduction under anaerobic conditions by NADH in the presence or orcinol, resorcinol, or m-cresol. Subsequent introduction of oxygen restores the oxidized form and yields H2O2 when m-cresol is the effector, but not when orcinol is the effector. Transfer of reducing equivalents from the reduced flavoprotein to free FAD may also occur. Reduction of orcinol hydroxylase by NADH in the absence of an effector is 10-4-fold slower than in the presence of an effector. The minimal structural requirements for effectors appear to be a 1,3-dihydroxy or 1-alkyl-3-hydorxybenzene, but only the former are substrates for hydroxylation.\n",
      "[Production and absorption rate of cerebrospinal fluid in the spinal subarachnoid space of the dog (author's transl)]. Adult mongrel dogs, weighing 10-17 kg. were anesthetized with Nembutal and cervical and lumbosacral laminectomy was performed. The spinal subarachnoid space was blocked by extradural ligation at the level of the C4 to interrupt CSF communication between the cranial and spinal space. Polyethylene catheters were placed in the cervical and lumbosacral subarachnoid space, and artificial Mock CSF buffer, pH 7.35-7.40, containing inulin of 25 mg/dl or 14C-inulin of 1.5-2 muCi/dl as a tracer was perfused in the sacro-cervical direction through the catheter. After a steady state of perfusion was acommplished, the CSF was collected from the outlet catheter. Production and absorption rate of the CSF were calculated after Pappenheimer and Heisey's equation. 1) Effects of CSF pressure on the rate of production (Vf) and absorption (Va) of CSF and on the difference between outflow fluid rate (Vo) and inflow fluid rate (Vi) were studied within the pressure range of -100 to +600 mmH2O. Then, regression lines were calculated by means of the least square method. See Article. Vf was little affected by changes in CSF pressure, while Va increased linearly as CSF pressure elevated. This suggests that the spinal subarachnoid space plays an important role as a site of CSF absorption when the intracranial pressure increases. Vo-Vi, that is difference between absorption and production rate, decreased linearly as the CSF pressure increased. 2) Under a constant CSF pressure of +200 mmH2O, the effects of glucocorticoids (dexamethasone, 0.25 mg/kg and hydrocortisone, 4.15 mg/kg) and a carbonic anhydrase inhibitor (acetazolamide, 10 mg/kg) upon the production and absorption rate of CSF were determined 1/2, 1, 2 and 3 hours after intravenous administration. a) Effect of dexamethasone: The rate of CSF production was reduced to 60.5 +/- 2.4% (p less than 0.001) of the control level. The absorption rate of CSF also decreased to 59.2 +/- 6.09% (p less than 0.001) of the control. b) Effect of hydrocortisone: The production rate of CSF decreased to 67.4 +/- 6.61% (p less than 0.001), and the absorption rate to 76.5 +/- 3.94% (p less than 0.001) of the control level. c) Effect of acetazolamide: The production and absorption rate also decreased to 57.2 +/- 5.61% (p less than 0.001) and to 56.9 +/- 7.02% (p less than 0.001), respectively. 3) Pentration of tritiated dexamethasone and tritiated hydrocortisone from plasma to CSF. The penetration of tritiated dexamethasone and tritiated hydrocortisone from plasma to CSF in the spinal and cranial subarachnoid space was observed after the intravenous administration. The CSF/Plasma ratio of dexamethasone was 30.9% at 15 minutes and gradually increased to 91.5% and 93.5%, respectively, in the cranial and spinal CSF at 3 hours after the injection.\n",
      "The role of sulfhydryl groups on the impaired hepatic 3',3,5-triiodothyronine generation from thyroxine in the hypothyroid, starved, fetal, and neonatal rodent. The role of nonprotein sulfhydryl groups (NPSH) in the decreased in vitro hepatic 3',3,5-triiodothyronine (T(3)) generation from thyroxine (T(4)) in the starved, hypothyroid, fetal and 1- to 4-d-old neonatal rat and dwarf mouse was assessed. NPSH were measured in fresh 25% liver homogenates prepared in 0.1 M PO(4)/10 mM EDTA buffer. As compared with values in adult male rats, NPSH concentration was decreased in the 2-d-starved (1.1+/-0.04 (mean+/-SE) vs. 2.2+/-0.15 mmol/250 g wet liver weight, P &lt; 0.001), fetal (1.0+/-0.04 vs. 3.2+/-0.08, P &lt; 0.001), 1-d-old neonatal (1.1+/-0.03 vs. 2.1+/-0.04, P &lt; 0.001), and hypothyroid (thyroidectomized 60 d) (1.4+/-0.06 vs. 2.2+/-0.15 P &lt; 0.001) rat. NPSH were also decreased in the hypothyroid, hypopituitary dwarf mouse as compared with values in their normal litter mates (1.3+/-0.03 vs. 2.0+/-0.2, P &lt; 0.01). Chronic administration of T(3) (0.5 mug/100 g body wt per d) markedly increased hepatic T(3) generation from T(4) in the thyroidectomized rat and in the dwarf mouse to values similar to those observed in the normal rodent without affecting NPSH concentration. In contrast, T(3) administration to the starved rat did not alter either hepatic T(3) generation from T(4) or NPSH. Reduced glutathione concentration was also markedly decreased in the starved rat (fed; 1.05+/-0.075 mmol/250 g wet tissue vs. starved 0.38+/-0.02, P &lt; 0.001). Dithiothreitol (DTT), a thiol reducing agent, increased hepatic T(3) generation from T(4) in the normal adult male rat by 45+/-5% in six experiments. When compared to DTT-stimulated control homogenates, the addition of DTT completely restored hepatic T(3) generation in starved rats, partially restored T(3) generation in 1- and 4-d-old neonates, but had little or no effect in the fetal and hypothyroid rat and dwarf mouse. Liver homogenates stored for 6 mo at -20 degrees C lost their capacity to generate T(3) from T(4). NPSH concentrations in the frozen homogenates decreased progressively with increasing storage and were absent by 6 mo. 5'-Deiodinase activity correlated with NPSH concentration in the stored homogenates (r = 0.95, P &lt; 0.005). Addition of DTT partially restored hepatic T(3) generation in the frozen homogenate. It is concluded that NPSH are important for the action of the liver 5'-deiodinase. The decreased hepatic T(3) generation in the starved rat is associated with decreased NPSH but not with a decrease in the absolute quantity of 5'-deiodinase because provision of sulfhydryl groups restored hepatic T(3) generation to normal. In contrast, the decreased hepatic T(3) generation in the adult hypothyroid rodent and in the fetal rat is probably due to a decrease in the enzyme concentration per se. In the 1- and 4-d neonatal rat, the decrease in hepatic T(3) generation is secondary to a decrease in NPSH and the deiodinating enzyme.\n",
      "\n",
      "Question: What do cell-free extracts from antibiotic-negative mutants of Cephalosporium acremonium convert delta-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine into, and what are the properties of this antibiotic?\n",
      "\n",
      "Options:\n",
      "A. Cell-free extracts convert delta-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine into an antibiotic resembling ampicillin, which is resistant to penicillinase.\n",
      "B. Cell-free extracts from antibiotic-negative mutants of Cephalosporium acremonium convert delta-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine into an antibiotic resembling isopenicillin N, which is sensitive to penicillinase.\n",
      "C. Cell-free extracts convert delta-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine into an antibiotic resembling cephalexin, which is sensitive to heat.\n",
      "D. Cell-free extracts convert delta-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine into an antibiotic resembling vancomycin, which has no effect from penicillinase.\n",
      "\n",
      "Answer(pick one between A, B, C and D):\n",
      "Prompt: You are an expert in multiple-choice questions. Your task is to select the best answer from the given options based on the provided context. \n",
      "\n",
      "Context:\n",
      "3,3'-Diiodothyronine production, a major pathway of peripheral iodothyronine metabolism in man. 3,3'-Diiodothyronine (3,3'-T(2)) has been detected in human serum and in thyroglobulin. However, no quantitative assessment of its clearance rate (CR), production rate (PR), or of the importance of extrathyroidal sources of 3,3'-T(2) relative to direct thyroidal secretion is yet available. This study examines these parameters in seven euthyroid subjects, and in eight athyreotic subjects (H) eumetabolic due to thyroxine therapy (HT(4)) (n = 5) or triiodothyronine replacement (HT(3)) (n = 3). A highly specific radioimmunoassay for the measurement of 3,3'-T(2) in whole serum was developed. Serum 3,3'-T(2) concentrations were (mean +/- SD) 6.0+/-1.0 ng/100 ml in 13 normal subjects, 9.0+/-4.6 ng/100 ml in 25 hyperthyroid patients, and 2.7+/-1.1 ng/100 ml in 17 hypothyroid patients. The values in each of the latter two groups were significantly different from normal. 3,3'-T(2) was detected regularly in normal concentrations in 11 hypothyroid patients eumetabolic by treatment with synthetic T(4), in 10 eumetabolic patients suffering from nonthyroidal systemic illness, and in 2 subjects with elevated serum T(4)-binding globulin. The 3,3'-T(2) CR was assessed from data acquired from the (125)I-3,3'-T(2) constant infusion technique. The 3,3'-T(2) PR was calculated from CR and serum concentration of 3,3'-T(2) determined by radio-immunoassay. In the HT(4) subjects the 3,3'-T(2) CR averaged 840+/-377 liters/day and 3,3'-T(2) PR 33.9+/-12.5 mug/day. These results were not significantly different from those in the control group: 3,3'-T(2) CR 628+/-218 liters/day and 3,3'-T(2) PR 39.8+/-19.8 mug/day (all corrected to 70 kg body wt). In addition to 3,3'-T(2) PR, T(3), and reverse triiodothyronine (rT(3)) PR were determined in three of the HT(4) subjects. In each case studied, the 3,3'-T(2) PR was close to the combined triiodothyronine (T(3) + rT(3)) PR. The mean molar ratio of T(2) PR/(T(3) + rT(3)) PR was 1.08+/-0.10. The results obtained in the HT(4) subjects indicate that the production of 3,3'-T(2) is a major route of T(4) metabolism. The combined studies of 3,3'-T(2), T(3) and rT(3) PR in the HT(4) subjects indicate that both T(3) and rT(3) are major precursors of 3,3'-T(2). In the HT(3) subjects, the conversion of T(3) to 3,3'-T(2), determined as the molar ratio of 3,3'-T(2) PR to T(3) PR, ranged from 0.36 to 0.92, providing further evidence that T(3) is a precursor of 3,3'-T(2). From the close agreement between the mean values for 3,3'-T(2) PR in the euthyroid and HT(4) group it is concluded that most, if not all of the 3,3'-T(2) produced in normal humans is derived by extrathyroidal conversion from T(3) and rT(3).\n",
      "Physiological and pharmacological influences on thyroxine to 3,5,3'-triiodothyronine conversion and nuclear 3,5,3'-triiodothyronine binding in rat anterior pituitary. Our recent in vivo studies have suggested that intrapituitary l-thyroxine (T(4)) to 3,5,3'-triiodo-l-thyronine (T(3)) conversion with subsequent nuclear binding of T(3) is an important pathway by which circulating T(4) can inhibit thyrotropin release. The present studies were performed to evaluate various physiological and pharmacological influences on these two processes in rat anterior pituitary tissue. Intact pituitary fragments were incubated in buffer-1% bovine serum albumin containing 0.14 ng/ml [(131)I]T(3) and 3.8 ng/ml [(125)I]T(4). Nuclei were isolated after 3 h of incubation and the bound iodothyronines identified by paper chromatography. There was 0.3-1% [(125)I]T(3) contaminating the medium [(125)I]T(4), and this did not change during incubation. Nuclear [(125)I]T(4) was not decreased by 650-fold excesses of medium T(3) or T(4), suggesting that it was nonspecifically bound. The ratio of nuclear to medium [(131)I]- and [(125)I]T(3) were expressed as nuclear counts per minute per milligram wet weight of tissue:counts per minute per microliter medium. Intrapituitary T(4) to T(3) conversion was evidenced by the fact that the nuclear:medium (N:M) ratio for [(131)I]T(3) was 0.45+/-0.21, whereas that for [(125)I]T(3) was 2.23+/-1.28 (mean+/-SD, n = 51). A ratio (R), the N:M [(125)I]T(3) divided by the N:M [(131)I]T(3), was used as an index of intrapituitary T(4) to T(3) conversion. Increasing medium T(3) concentrations up to 50 ng/ml caused a progressive decrease in the N:M ratio for both T(3) isotopes, but no change in the value for R, indicating that both competed for the same limited-capacity nuclear receptors. Increasing concentrations of medium T(4) caused no change in the N:M [(131)I]T(3) but did cause a significant decrease in R in three of four experiments. These results suggest saturation of T(4)-5'-monodeiodination occurred at lower T(4) concentrations than saturation of nuclear T(3) binding sites. In hypothyroid rats, the N:M ratios for both [(131)I]T(3) and [(125)I]T(3) were increased (P &lt; 0.005), but R was three-fold higher than in controls (P &lt; 0.005). Animals given 10 mug T(4)/100 g body wt per d for 5 d had significantly decreased N:M ratios for both [(131)I]T(3) and [(125)I]T(3), as well as a decreased value for R. In fasted rats, neither N:M ratio was depressed, although hepatic T(4) to T(3) conversion in the same animals was 50% of control (P &lt; 0.005). Iopanoic acid (13 muM), but not 6-n-propylthiouracil (29 muM), decreased the N:M [(125)I]T(3) with a significant decrease in the value for R (P &lt; 0.025 or less). Neither sodium iodide (6 muM) nor thyrotropin-releasing hormone (7-700 nM) affected the T(3) N:M ratios. These results indicate that intrapituitary T(4) to T(3) conversion is stimulated in hypothyroidism and depressed in T(4)-treated animals, whereas opposite changes occur in hepatic T(4)-5'-monodeiodination. Unlike liver, anterior pituitary T(4)-5'-monodeiodination is not affected by fasting or incubation with 6-n-propyl-2-thiouracil, but T(4) to T(3) conversion is inhibited in both by iopanoic acid. These results indicate that there are important differences between anterior pituitary and other tissues in the regulation of T(4)-5'-monodeiodination.\n",
      "Metabolism of resorcinylic compounds by bacteria. Purification and properties of orcinol hydroxylase from Pseudomonas putida 01. Orcinol hydroxylase (EC 1.14.13.6), which catalyzes the first reaction of orcinol catabolism in Pseudomonas putida 01, has been purified to homogeneity, and crystallized. Orcinol hydroxylase catalyzes the hydroxylation of orcinol with equimolar consumption of O2 and NADH (or NADPH) to 2, 3, 5-trihydroxytoluene, which is nonenzymically oxidized to a quinone. The visible absorption spectrum of the enzyme shows maxima at 373 and 454 nm and a shoulder at 480 nm. FAD can be dissociated from the protein. Reconstitution of enzymic activity was achieved with FAD, and to a limited extent by FMN. The enzyme has a molecular weight of 63,000 to 68,000 and contains 1 mol of FAD per mol of protein. K-m values for the three substrates orcinol, NADH, and O2 are 0.03, 0.13, and 0.07mM, RESPECTIVELY. The molecular activity of the crystalline enzyme is 1560 min minus 1. In the absence of orcinol, NADH is only slowly oxidized with formation of H2O2. Several analogs of orcinol also serve as substrates for hydroxylation, namely resorcinol, 4-methylresorcinol, and 4-bromoresorcinol. Other analogs, m-cresol, m-ethylphenol, 4-ethylresorcinol, and phloroglucinol, mimic orcinol as effectors, in that they (a) accelerate electron flow from NADH to the flavin and (b) decrease the apparent K-m for NADH but not to the same extent as the substrates that are hydroxylated. The latter compounds are not hydroxylated. Instead H2O2 accumulates as the only product of O2 reduction. The enzyme therefore behaves either as a hydroxylase or an oxidase. The ratio of hydroxylase to oxidase activities of the enzyme is decreased by an increase in the temperature of incubation; at 60 degrees the reaction with orcinol is almost 50% uncoupled from hydroxylation. The apparent K-m values for the effectors are in good agreement with the D-D values obtained for orcinol, resorcinol, and m-cresol. K-D values were obtained by measurement of the effector-induced perturbations of the visible absorption spectrum of the flavoprotein by difference absorption spectroscopy. The circular dichroism spectrum of orcinol hydroxylase is also altered in the presence of orcinol. The participation of the flavin in the over-all reaction is demonstrated by its rapid reduction under anaerobic conditions by NADH in the presence or orcinol, resorcinol, or m-cresol. Subsequent introduction of oxygen restores the oxidized form and yields H2O2 when m-cresol is the effector, but not when orcinol is the effector. Transfer of reducing equivalents from the reduced flavoprotein to free FAD may also occur. Reduction of orcinol hydroxylase by NADH in the absence of an effector is 10-4-fold slower than in the presence of an effector. The minimal structural requirements for effectors appear to be a 1,3-dihydroxy or 1-alkyl-3-hydorxybenzene, but only the former are substrates for hydroxylation.\n",
      "[Production and absorption rate of cerebrospinal fluid in the spinal subarachnoid space of the dog (author's transl)]. Adult mongrel dogs, weighing 10-17 kg. were anesthetized with Nembutal and cervical and lumbosacral laminectomy was performed. The spinal subarachnoid space was blocked by extradural ligation at the level of the C4 to interrupt CSF communication between the cranial and spinal space. Polyethylene catheters were placed in the cervical and lumbosacral subarachnoid space, and artificial Mock CSF buffer, pH 7.35-7.40, containing inulin of 25 mg/dl or 14C-inulin of 1.5-2 muCi/dl as a tracer was perfused in the sacro-cervical direction through the catheter. After a steady state of perfusion was acommplished, the CSF was collected from the outlet catheter. Production and absorption rate of the CSF were calculated after Pappenheimer and Heisey's equation. 1) Effects of CSF pressure on the rate of production (Vf) and absorption (Va) of CSF and on the difference between outflow fluid rate (Vo) and inflow fluid rate (Vi) were studied within the pressure range of -100 to +600 mmH2O. Then, regression lines were calculated by means of the least square method. See Article. Vf was little affected by changes in CSF pressure, while Va increased linearly as CSF pressure elevated. This suggests that the spinal subarachnoid space plays an important role as a site of CSF absorption when the intracranial pressure increases. Vo-Vi, that is difference between absorption and production rate, decreased linearly as the CSF pressure increased. 2) Under a constant CSF pressure of +200 mmH2O, the effects of glucocorticoids (dexamethasone, 0.25 mg/kg and hydrocortisone, 4.15 mg/kg) and a carbonic anhydrase inhibitor (acetazolamide, 10 mg/kg) upon the production and absorption rate of CSF were determined 1/2, 1, 2 and 3 hours after intravenous administration. a) Effect of dexamethasone: The rate of CSF production was reduced to 60.5 +/- 2.4% (p less than 0.001) of the control level. The absorption rate of CSF also decreased to 59.2 +/- 6.09% (p less than 0.001) of the control. b) Effect of hydrocortisone: The production rate of CSF decreased to 67.4 +/- 6.61% (p less than 0.001), and the absorption rate to 76.5 +/- 3.94% (p less than 0.001) of the control level. c) Effect of acetazolamide: The production and absorption rate also decreased to 57.2 +/- 5.61% (p less than 0.001) and to 56.9 +/- 7.02% (p less than 0.001), respectively. 3) Pentration of tritiated dexamethasone and tritiated hydrocortisone from plasma to CSF. The penetration of tritiated dexamethasone and tritiated hydrocortisone from plasma to CSF in the spinal and cranial subarachnoid space was observed after the intravenous administration. The CSF/Plasma ratio of dexamethasone was 30.9% at 15 minutes and gradually increased to 91.5% and 93.5%, respectively, in the cranial and spinal CSF at 3 hours after the injection.\n",
      "The role of sulfhydryl groups on the impaired hepatic 3',3,5-triiodothyronine generation from thyroxine in the hypothyroid, starved, fetal, and neonatal rodent. The role of nonprotein sulfhydryl groups (NPSH) in the decreased in vitro hepatic 3',3,5-triiodothyronine (T(3)) generation from thyroxine (T(4)) in the starved, hypothyroid, fetal and 1- to 4-d-old neonatal rat and dwarf mouse was assessed. NPSH were measured in fresh 25% liver homogenates prepared in 0.1 M PO(4)/10 mM EDTA buffer. As compared with values in adult male rats, NPSH concentration was decreased in the 2-d-starved (1.1+/-0.04 (mean+/-SE) vs. 2.2+/-0.15 mmol/250 g wet liver weight, P &lt; 0.001), fetal (1.0+/-0.04 vs. 3.2+/-0.08, P &lt; 0.001), 1-d-old neonatal (1.1+/-0.03 vs. 2.1+/-0.04, P &lt; 0.001), and hypothyroid (thyroidectomized 60 d) (1.4+/-0.06 vs. 2.2+/-0.15 P &lt; 0.001) rat. NPSH were also decreased in the hypothyroid, hypopituitary dwarf mouse as compared with values in their normal litter mates (1.3+/-0.03 vs. 2.0+/-0.2, P &lt; 0.01). Chronic administration of T(3) (0.5 mug/100 g body wt per d) markedly increased hepatic T(3) generation from T(4) in the thyroidectomized rat and in the dwarf mouse to values similar to those observed in the normal rodent without affecting NPSH concentration. In contrast, T(3) administration to the starved rat did not alter either hepatic T(3) generation from T(4) or NPSH. Reduced glutathione concentration was also markedly decreased in the starved rat (fed; 1.05+/-0.075 mmol/250 g wet tissue vs. starved 0.38+/-0.02, P &lt; 0.001). Dithiothreitol (DTT), a thiol reducing agent, increased hepatic T(3) generation from T(4) in the normal adult male rat by 45+/-5% in six experiments. When compared to DTT-stimulated control homogenates, the addition of DTT completely restored hepatic T(3) generation in starved rats, partially restored T(3) generation in 1- and 4-d-old neonates, but had little or no effect in the fetal and hypothyroid rat and dwarf mouse. Liver homogenates stored for 6 mo at -20 degrees C lost their capacity to generate T(3) from T(4). NPSH concentrations in the frozen homogenates decreased progressively with increasing storage and were absent by 6 mo. 5'-Deiodinase activity correlated with NPSH concentration in the stored homogenates (r = 0.95, P &lt; 0.005). Addition of DTT partially restored hepatic T(3) generation in the frozen homogenate. It is concluded that NPSH are important for the action of the liver 5'-deiodinase. The decreased hepatic T(3) generation in the starved rat is associated with decreased NPSH but not with a decrease in the absolute quantity of 5'-deiodinase because provision of sulfhydryl groups restored hepatic T(3) generation to normal. In contrast, the decreased hepatic T(3) generation in the adult hypothyroid rodent and in the fetal rat is probably due to a decrease in the enzyme concentration per se. In the 1- and 4-d neonatal rat, the decrease in hepatic T(3) generation is secondary to a decrease in NPSH and the deiodinating enzyme.\n",
      "\n",
      "Question: What are the characteristics and composition of glycoprotein B isolated from cow's milk fat globule membrane?\n",
      "\n",
      "Options:\n",
      "A. Glycoprotein B is a fat-soluble protein with a molecular weight of 30,000 and contains 20% carbohydrates, primarily consisting of glucose and fructose, with an amino acid composition featuring alanine at the amino terminal and valine at the carboxyl terminal.\n",
      "B. Glycoprotein B, a salt-soluble protein from cow's milk fat globule membrane, was purified to a single band with a molecular weight of 49,500 and contains 14% carbohydrates, including sialic acid and various sugars, along with an amino acid composition featuring serine at the amino terminal and leucine at the carboxyl terminal.\n",
      "C. Glycoprotein B is a water-soluble protein with a molecular weight of 60,000 and contains 10% carbohydrates, including only glucose, with an amino acid composition featuring glycine at the amino terminal and phenylalanine at the carboxyl terminal.\n",
      "D. Glycoprotein B is a salt-soluble protein with a molecular weight of 45,000 and contains 18% carbohydrates, including mannose and ribose, with an amino acid composition featuring threonine at the amino terminal and isoleucine at the carboxyl terminal.\n",
      "\n",
      "Answer(pick one between A, B, C and D):\n",
      "Prompt: You are an expert in multiple-choice questions. Your task is to select the best answer from the given options based on the provided context. \n",
      "\n",
      "Context:\n",
      "3,3'-Diiodothyronine production, a major pathway of peripheral iodothyronine metabolism in man. 3,3'-Diiodothyronine (3,3'-T(2)) has been detected in human serum and in thyroglobulin. However, no quantitative assessment of its clearance rate (CR), production rate (PR), or of the importance of extrathyroidal sources of 3,3'-T(2) relative to direct thyroidal secretion is yet available. This study examines these parameters in seven euthyroid subjects, and in eight athyreotic subjects (H) eumetabolic due to thyroxine therapy (HT(4)) (n = 5) or triiodothyronine replacement (HT(3)) (n = 3). A highly specific radioimmunoassay for the measurement of 3,3'-T(2) in whole serum was developed. Serum 3,3'-T(2) concentrations were (mean +/- SD) 6.0+/-1.0 ng/100 ml in 13 normal subjects, 9.0+/-4.6 ng/100 ml in 25 hyperthyroid patients, and 2.7+/-1.1 ng/100 ml in 17 hypothyroid patients. The values in each of the latter two groups were significantly different from normal. 3,3'-T(2) was detected regularly in normal concentrations in 11 hypothyroid patients eumetabolic by treatment with synthetic T(4), in 10 eumetabolic patients suffering from nonthyroidal systemic illness, and in 2 subjects with elevated serum T(4)-binding globulin. The 3,3'-T(2) CR was assessed from data acquired from the (125)I-3,3'-T(2) constant infusion technique. The 3,3'-T(2) PR was calculated from CR and serum concentration of 3,3'-T(2) determined by radio-immunoassay. In the HT(4) subjects the 3,3'-T(2) CR averaged 840+/-377 liters/day and 3,3'-T(2) PR 33.9+/-12.5 mug/day. These results were not significantly different from those in the control group: 3,3'-T(2) CR 628+/-218 liters/day and 3,3'-T(2) PR 39.8+/-19.8 mug/day (all corrected to 70 kg body wt). In addition to 3,3'-T(2) PR, T(3), and reverse triiodothyronine (rT(3)) PR were determined in three of the HT(4) subjects. In each case studied, the 3,3'-T(2) PR was close to the combined triiodothyronine (T(3) + rT(3)) PR. The mean molar ratio of T(2) PR/(T(3) + rT(3)) PR was 1.08+/-0.10. The results obtained in the HT(4) subjects indicate that the production of 3,3'-T(2) is a major route of T(4) metabolism. The combined studies of 3,3'-T(2), T(3) and rT(3) PR in the HT(4) subjects indicate that both T(3) and rT(3) are major precursors of 3,3'-T(2). In the HT(3) subjects, the conversion of T(3) to 3,3'-T(2), determined as the molar ratio of 3,3'-T(2) PR to T(3) PR, ranged from 0.36 to 0.92, providing further evidence that T(3) is a precursor of 3,3'-T(2). From the close agreement between the mean values for 3,3'-T(2) PR in the euthyroid and HT(4) group it is concluded that most, if not all of the 3,3'-T(2) produced in normal humans is derived by extrathyroidal conversion from T(3) and rT(3).\n",
      "Physiological and pharmacological influences on thyroxine to 3,5,3'-triiodothyronine conversion and nuclear 3,5,3'-triiodothyronine binding in rat anterior pituitary. Our recent in vivo studies have suggested that intrapituitary l-thyroxine (T(4)) to 3,5,3'-triiodo-l-thyronine (T(3)) conversion with subsequent nuclear binding of T(3) is an important pathway by which circulating T(4) can inhibit thyrotropin release. The present studies were performed to evaluate various physiological and pharmacological influences on these two processes in rat anterior pituitary tissue. Intact pituitary fragments were incubated in buffer-1% bovine serum albumin containing 0.14 ng/ml [(131)I]T(3) and 3.8 ng/ml [(125)I]T(4). Nuclei were isolated after 3 h of incubation and the bound iodothyronines identified by paper chromatography. There was 0.3-1% [(125)I]T(3) contaminating the medium [(125)I]T(4), and this did not change during incubation. Nuclear [(125)I]T(4) was not decreased by 650-fold excesses of medium T(3) or T(4), suggesting that it was nonspecifically bound. The ratio of nuclear to medium [(131)I]- and [(125)I]T(3) were expressed as nuclear counts per minute per milligram wet weight of tissue:counts per minute per microliter medium. Intrapituitary T(4) to T(3) conversion was evidenced by the fact that the nuclear:medium (N:M) ratio for [(131)I]T(3) was 0.45+/-0.21, whereas that for [(125)I]T(3) was 2.23+/-1.28 (mean+/-SD, n = 51). A ratio (R), the N:M [(125)I]T(3) divided by the N:M [(131)I]T(3), was used as an index of intrapituitary T(4) to T(3) conversion. Increasing medium T(3) concentrations up to 50 ng/ml caused a progressive decrease in the N:M ratio for both T(3) isotopes, but no change in the value for R, indicating that both competed for the same limited-capacity nuclear receptors. Increasing concentrations of medium T(4) caused no change in the N:M [(131)I]T(3) but did cause a significant decrease in R in three of four experiments. These results suggest saturation of T(4)-5'-monodeiodination occurred at lower T(4) concentrations than saturation of nuclear T(3) binding sites. In hypothyroid rats, the N:M ratios for both [(131)I]T(3) and [(125)I]T(3) were increased (P &lt; 0.005), but R was three-fold higher than in controls (P &lt; 0.005). Animals given 10 mug T(4)/100 g body wt per d for 5 d had significantly decreased N:M ratios for both [(131)I]T(3) and [(125)I]T(3), as well as a decreased value for R. In fasted rats, neither N:M ratio was depressed, although hepatic T(4) to T(3) conversion in the same animals was 50% of control (P &lt; 0.005). Iopanoic acid (13 muM), but not 6-n-propylthiouracil (29 muM), decreased the N:M [(125)I]T(3) with a significant decrease in the value for R (P &lt; 0.025 or less). Neither sodium iodide (6 muM) nor thyrotropin-releasing hormone (7-700 nM) affected the T(3) N:M ratios. These results indicate that intrapituitary T(4) to T(3) conversion is stimulated in hypothyroidism and depressed in T(4)-treated animals, whereas opposite changes occur in hepatic T(4)-5'-monodeiodination. Unlike liver, anterior pituitary T(4)-5'-monodeiodination is not affected by fasting or incubation with 6-n-propyl-2-thiouracil, but T(4) to T(3) conversion is inhibited in both by iopanoic acid. These results indicate that there are important differences between anterior pituitary and other tissues in the regulation of T(4)-5'-monodeiodination.\n",
      "Metabolism of resorcinylic compounds by bacteria. Purification and properties of orcinol hydroxylase from Pseudomonas putida 01. Orcinol hydroxylase (EC 1.14.13.6), which catalyzes the first reaction of orcinol catabolism in Pseudomonas putida 01, has been purified to homogeneity, and crystallized. Orcinol hydroxylase catalyzes the hydroxylation of orcinol with equimolar consumption of O2 and NADH (or NADPH) to 2, 3, 5-trihydroxytoluene, which is nonenzymically oxidized to a quinone. The visible absorption spectrum of the enzyme shows maxima at 373 and 454 nm and a shoulder at 480 nm. FAD can be dissociated from the protein. Reconstitution of enzymic activity was achieved with FAD, and to a limited extent by FMN. The enzyme has a molecular weight of 63,000 to 68,000 and contains 1 mol of FAD per mol of protein. K-m values for the three substrates orcinol, NADH, and O2 are 0.03, 0.13, and 0.07mM, RESPECTIVELY. The molecular activity of the crystalline enzyme is 1560 min minus 1. In the absence of orcinol, NADH is only slowly oxidized with formation of H2O2. Several analogs of orcinol also serve as substrates for hydroxylation, namely resorcinol, 4-methylresorcinol, and 4-bromoresorcinol. Other analogs, m-cresol, m-ethylphenol, 4-ethylresorcinol, and phloroglucinol, mimic orcinol as effectors, in that they (a) accelerate electron flow from NADH to the flavin and (b) decrease the apparent K-m for NADH but not to the same extent as the substrates that are hydroxylated. The latter compounds are not hydroxylated. Instead H2O2 accumulates as the only product of O2 reduction. The enzyme therefore behaves either as a hydroxylase or an oxidase. The ratio of hydroxylase to oxidase activities of the enzyme is decreased by an increase in the temperature of incubation; at 60 degrees the reaction with orcinol is almost 50% uncoupled from hydroxylation. The apparent K-m values for the effectors are in good agreement with the D-D values obtained for orcinol, resorcinol, and m-cresol. K-D values were obtained by measurement of the effector-induced perturbations of the visible absorption spectrum of the flavoprotein by difference absorption spectroscopy. The circular dichroism spectrum of orcinol hydroxylase is also altered in the presence of orcinol. The participation of the flavin in the over-all reaction is demonstrated by its rapid reduction under anaerobic conditions by NADH in the presence or orcinol, resorcinol, or m-cresol. Subsequent introduction of oxygen restores the oxidized form and yields H2O2 when m-cresol is the effector, but not when orcinol is the effector. Transfer of reducing equivalents from the reduced flavoprotein to free FAD may also occur. Reduction of orcinol hydroxylase by NADH in the absence of an effector is 10-4-fold slower than in the presence of an effector. The minimal structural requirements for effectors appear to be a 1,3-dihydroxy or 1-alkyl-3-hydorxybenzene, but only the former are substrates for hydroxylation.\n",
      "[Production and absorption rate of cerebrospinal fluid in the spinal subarachnoid space of the dog (author's transl)]. Adult mongrel dogs, weighing 10-17 kg. were anesthetized with Nembutal and cervical and lumbosacral laminectomy was performed. The spinal subarachnoid space was blocked by extradural ligation at the level of the C4 to interrupt CSF communication between the cranial and spinal space. Polyethylene catheters were placed in the cervical and lumbosacral subarachnoid space, and artificial Mock CSF buffer, pH 7.35-7.40, containing inulin of 25 mg/dl or 14C-inulin of 1.5-2 muCi/dl as a tracer was perfused in the sacro-cervical direction through the catheter. After a steady state of perfusion was acommplished, the CSF was collected from the outlet catheter. Production and absorption rate of the CSF were calculated after Pappenheimer and Heisey's equation. 1) Effects of CSF pressure on the rate of production (Vf) and absorption (Va) of CSF and on the difference between outflow fluid rate (Vo) and inflow fluid rate (Vi) were studied within the pressure range of -100 to +600 mmH2O. Then, regression lines were calculated by means of the least square method. See Article. Vf was little affected by changes in CSF pressure, while Va increased linearly as CSF pressure elevated. This suggests that the spinal subarachnoid space plays an important role as a site of CSF absorption when the intracranial pressure increases. Vo-Vi, that is difference between absorption and production rate, decreased linearly as the CSF pressure increased. 2) Under a constant CSF pressure of +200 mmH2O, the effects of glucocorticoids (dexamethasone, 0.25 mg/kg and hydrocortisone, 4.15 mg/kg) and a carbonic anhydrase inhibitor (acetazolamide, 10 mg/kg) upon the production and absorption rate of CSF were determined 1/2, 1, 2 and 3 hours after intravenous administration. a) Effect of dexamethasone: The rate of CSF production was reduced to 60.5 +/- 2.4% (p less than 0.001) of the control level. The absorption rate of CSF also decreased to 59.2 +/- 6.09% (p less than 0.001) of the control. b) Effect of hydrocortisone: The production rate of CSF decreased to 67.4 +/- 6.61% (p less than 0.001), and the absorption rate to 76.5 +/- 3.94% (p less than 0.001) of the control level. c) Effect of acetazolamide: The production and absorption rate also decreased to 57.2 +/- 5.61% (p less than 0.001) and to 56.9 +/- 7.02% (p less than 0.001), respectively. 3) Pentration of tritiated dexamethasone and tritiated hydrocortisone from plasma to CSF. The penetration of tritiated dexamethasone and tritiated hydrocortisone from plasma to CSF in the spinal and cranial subarachnoid space was observed after the intravenous administration. The CSF/Plasma ratio of dexamethasone was 30.9% at 15 minutes and gradually increased to 91.5% and 93.5%, respectively, in the cranial and spinal CSF at 3 hours after the injection.\n",
      "The role of sulfhydryl groups on the impaired hepatic 3',3,5-triiodothyronine generation from thyroxine in the hypothyroid, starved, fetal, and neonatal rodent. The role of nonprotein sulfhydryl groups (NPSH) in the decreased in vitro hepatic 3',3,5-triiodothyronine (T(3)) generation from thyroxine (T(4)) in the starved, hypothyroid, fetal and 1- to 4-d-old neonatal rat and dwarf mouse was assessed. NPSH were measured in fresh 25% liver homogenates prepared in 0.1 M PO(4)/10 mM EDTA buffer. As compared with values in adult male rats, NPSH concentration was decreased in the 2-d-starved (1.1+/-0.04 (mean+/-SE) vs. 2.2+/-0.15 mmol/250 g wet liver weight, P &lt; 0.001), fetal (1.0+/-0.04 vs. 3.2+/-0.08, P &lt; 0.001), 1-d-old neonatal (1.1+/-0.03 vs. 2.1+/-0.04, P &lt; 0.001), and hypothyroid (thyroidectomized 60 d) (1.4+/-0.06 vs. 2.2+/-0.15 P &lt; 0.001) rat. NPSH were also decreased in the hypothyroid, hypopituitary dwarf mouse as compared with values in their normal litter mates (1.3+/-0.03 vs. 2.0+/-0.2, P &lt; 0.01). Chronic administration of T(3) (0.5 mug/100 g body wt per d) markedly increased hepatic T(3) generation from T(4) in the thyroidectomized rat and in the dwarf mouse to values similar to those observed in the normal rodent without affecting NPSH concentration. In contrast, T(3) administration to the starved rat did not alter either hepatic T(3) generation from T(4) or NPSH. Reduced glutathione concentration was also markedly decreased in the starved rat (fed; 1.05+/-0.075 mmol/250 g wet tissue vs. starved 0.38+/-0.02, P &lt; 0.001). Dithiothreitol (DTT), a thiol reducing agent, increased hepatic T(3) generation from T(4) in the normal adult male rat by 45+/-5% in six experiments. When compared to DTT-stimulated control homogenates, the addition of DTT completely restored hepatic T(3) generation in starved rats, partially restored T(3) generation in 1- and 4-d-old neonates, but had little or no effect in the fetal and hypothyroid rat and dwarf mouse. Liver homogenates stored for 6 mo at -20 degrees C lost their capacity to generate T(3) from T(4). NPSH concentrations in the frozen homogenates decreased progressively with increasing storage and were absent by 6 mo. 5'-Deiodinase activity correlated with NPSH concentration in the stored homogenates (r = 0.95, P &lt; 0.005). Addition of DTT partially restored hepatic T(3) generation in the frozen homogenate. It is concluded that NPSH are important for the action of the liver 5'-deiodinase. The decreased hepatic T(3) generation in the starved rat is associated with decreased NPSH but not with a decrease in the absolute quantity of 5'-deiodinase because provision of sulfhydryl groups restored hepatic T(3) generation to normal. In contrast, the decreased hepatic T(3) generation in the adult hypothyroid rodent and in the fetal rat is probably due to a decrease in the enzyme concentration per se. In the 1- and 4-d neonatal rat, the decrease in hepatic T(3) generation is secondary to a decrease in NPSH and the deiodinating enzyme.\n",
      "\n",
      "Question: What type of tumors were identified in 20 cases, and how were they characterized in terms of lung scarring and granule properties?\n",
      "\n",
      "Options:\n",
      "A. Lung adenomas, which were found exclusively in healthy lung tissue and lacked any granule properties.\n",
      "B. Bronchial carcinoids, identified in 20 cases, with all tumors occurring in severely scarred lungs and showing no neurosecretory characteristics.\n",
      "C. Pulmonary tumorlets, a type of peripheral carcinoid, were identified in 20 cases, with one-third occurring in severely scarred lungs and the remainder in minimally scarred lungs, displaying characteristics consistent with neurosecretory granules.\n",
      "D. Pulmonary fibromas, characterized by their presence in minimally scarred lungs and exhibiting only fibrous properties without any granules.\n",
      "\n",
      "Answer(pick one between A, B, C and D):\n"
     ]
    },
    {
     "ename": "KeyboardInterrupt",
     "evalue": "",
     "output_type": "error",
     "traceback": [
      "\u001B[0;31m---------------------------------------------------------------------------\u001B[0m",
      "\u001B[0;31mKeyboardInterrupt\u001B[0m                         Traceback (most recent call last)",
      "Cell \u001B[0;32mIn[17], line 1\u001B[0m\n\u001B[0;32m----> 1\u001B[0m accuracy \u001B[38;5;241m=\u001B[39m \u001B[43mevaluate\u001B[49m\u001B[43m(\u001B[49m\n\u001B[1;32m      2\u001B[0m \u001B[43m    \u001B[49m\u001B[43mforward_fn\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mforward_and_get_last_logit\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m      3\u001B[0m \u001B[43m    \u001B[49m\u001B[43mpicker_fn\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mpicker\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m      4\u001B[0m \u001B[43m    \u001B[49m\u001B[43meval_dataset\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mevaluateWithAnswers\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m      5\u001B[0m \u001B[43m)\u001B[49m\n\u001B[1;32m      7\u001B[0m \u001B[38;5;28mprint\u001B[39m(\u001B[38;5;124mf\u001B[39m\u001B[38;5;124m\"\u001B[39m\u001B[38;5;124mAccuracy: \u001B[39m\u001B[38;5;132;01m{\u001B[39;00maccuracy\u001B[38;5;132;01m:\u001B[39;00m\u001B[38;5;124m.2f\u001B[39m\u001B[38;5;132;01m}\u001B[39;00m\u001B[38;5;124m\"\u001B[39m)\n",
      "File \u001B[0;32m~/pytorch_training/10_rag/src/q_and_a/eval.py:35\u001B[0m, in \u001B[0;36mevaluate\u001B[0;34m(forward_fn, picker_fn, eval_dataset, log_each)\u001B[0m\n\u001B[1;32m     32\u001B[0m answer_idx \u001B[38;5;241m=\u001B[39m item[\u001B[38;5;124m\"\u001B[39m\u001B[38;5;124manswer_idx\u001B[39m\u001B[38;5;124m\"\u001B[39m]\n\u001B[1;32m     34\u001B[0m \u001B[38;5;66;03m# Get the model's response\u001B[39;00m\n\u001B[0;32m---> 35\u001B[0m response \u001B[38;5;241m=\u001B[39m \u001B[43mforward_fn\u001B[49m\u001B[43m(\u001B[49m\u001B[43mquestion\u001B[49m\u001B[43m,\u001B[49m\u001B[43m \u001B[49m\u001B[43moptions\u001B[49m\u001B[43m)\u001B[49m\n\u001B[1;32m     37\u001B[0m \u001B[38;5;66;03m# Pick the best option\u001B[39;00m\n\u001B[1;32m     38\u001B[0m picked_idx \u001B[38;5;241m=\u001B[39m picker_fn(response)\n",
      "Cell \u001B[0;32mIn[12], line 10\u001B[0m, in \u001B[0;36m<lambda>\u001B[0;34m(question, options)\u001B[0m\n\u001B[1;32m      1\u001B[0m forward \u001B[38;5;241m=\u001B[39m build_forwarder(\n\u001B[1;32m      2\u001B[0m     model,\n\u001B[1;32m      3\u001B[0m     tokenizer,\n\u001B[0;32m   (...)\u001B[0m\n\u001B[1;32m      7\u001B[0m     device\u001B[38;5;241m=\u001B[39mdevice,\n\u001B[1;32m      8\u001B[0m )\n\u001B[0;32m---> 10\u001B[0m forward_and_get_last_logit \u001B[38;5;241m=\u001B[39m \u001B[38;5;28;01mlambda\u001B[39;00m question, options: \u001B[43mforward\u001B[49m\u001B[43m(\u001B[49m\n\u001B[1;32m     11\u001B[0m \u001B[43m    \u001B[49m\u001B[43mquestion\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m     12\u001B[0m \u001B[43m    \u001B[49m\u001B[43moptions\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43moptions\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m     13\u001B[0m \u001B[43m)\u001B[49m\u001B[38;5;241m.\u001B[39mlogits[\u001B[38;5;241m0\u001B[39m][\u001B[38;5;241m-\u001B[39m\u001B[38;5;241m1\u001B[39m]\n\u001B[1;32m     15\u001B[0m result \u001B[38;5;241m=\u001B[39m forward_and_get_last_logit(\n\u001B[1;32m     16\u001B[0m     question,\n\u001B[1;32m     17\u001B[0m     options\u001B[38;5;241m=\u001B[39moptions,\n\u001B[1;32m     18\u001B[0m )\n",
      "File \u001B[0;32m~/pytorch_training/10_rag/src/q_and_a/forward.py:63\u001B[0m, in \u001B[0;36mbuild_forwarder.<locals>.forward_fn\u001B[0;34m(question, options)\u001B[0m\n\u001B[1;32m     62\u001B[0m \u001B[38;5;28;01mdef\u001B[39;00m\u001B[38;5;250m \u001B[39m\u001B[38;5;21mforward_fn\u001B[39m(question: \u001B[38;5;28mstr\u001B[39m, options: List[\u001B[38;5;28mstr\u001B[39m]) \u001B[38;5;241m-\u001B[39m\u001B[38;5;241m>\u001B[39m Any:\n\u001B[0;32m---> 63\u001B[0m     \u001B[38;5;28;01mreturn\u001B[39;00m \u001B[43mforward\u001B[49m\u001B[43m(\u001B[49m\n\u001B[1;32m     64\u001B[0m \u001B[43m        \u001B[49m\u001B[43mllm\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mllm\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m     65\u001B[0m \u001B[43m        \u001B[49m\u001B[43mtokenizer\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mtokenizer\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m     66\u001B[0m \u001B[43m        \u001B[49m\u001B[43maugmenter\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43maugmenter\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m     67\u001B[0m \u001B[43m        \u001B[49m\u001B[43mk_augmentations\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mk_augmentations\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m     68\u001B[0m \u001B[43m        \u001B[49m\u001B[43mprompt_builder\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mprompt_builder\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m     69\u001B[0m \u001B[43m        \u001B[49m\u001B[43mquestion\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mquestion\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m     70\u001B[0m \u001B[43m        \u001B[49m\u001B[43moptions\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43moptions\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m     71\u001B[0m \u001B[43m        \u001B[49m\u001B[43mdevice\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mdevice\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m     72\u001B[0m \u001B[43m    \u001B[49m\u001B[43m)\u001B[49m\n",
      "File \u001B[0;32m~/pytorch_training/10_rag/src/q_and_a/forward.py:41\u001B[0m, in \u001B[0;36mforward\u001B[0;34m(llm, tokenizer, augmenter, k_augmentations, prompt_builder, question, options, device)\u001B[0m\n\u001B[1;32m     38\u001B[0m prompt \u001B[38;5;241m=\u001B[39m prompt_builder(question, options, items)\n\u001B[1;32m     39\u001B[0m \u001B[38;5;28mprint\u001B[39m(\u001B[38;5;124mf\u001B[39m\u001B[38;5;124m\"\u001B[39m\u001B[38;5;124mPrompt: \u001B[39m\u001B[38;5;132;01m{\u001B[39;00mprompt\u001B[38;5;132;01m}\u001B[39;00m\u001B[38;5;124m\"\u001B[39m)\n\u001B[0;32m---> 41\u001B[0m result \u001B[38;5;241m=\u001B[39m \u001B[43mtokenizer\u001B[49m\u001B[43m(\u001B[49m\u001B[43mprompt\u001B[49m\u001B[43m,\u001B[49m\u001B[43m \u001B[49m\u001B[43mreturn_tensors\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[38;5;124;43m\"\u001B[39;49m\u001B[38;5;124;43mpt\u001B[39;49m\u001B[38;5;124;43m\"\u001B[39;49m\u001B[43m)\u001B[49m\u001B[38;5;241m.\u001B[39mto(device)\n\u001B[1;32m     43\u001B[0m \u001B[38;5;66;03m# Use the language model to generate a response\u001B[39;00m\n\u001B[1;32m     44\u001B[0m \u001B[38;5;28;01mwith\u001B[39;00m torch\u001B[38;5;241m.\u001B[39mno_grad():\n",
      "File \u001B[0;32m~/miniconda3/envs/faiss39/lib/python3.9/site-packages/transformers/tokenization_utils_base.py:2887\u001B[0m, in \u001B[0;36mPreTrainedTokenizerBase.__call__\u001B[0;34m(self, text, text_pair, text_target, text_pair_target, add_special_tokens, padding, truncation, max_length, stride, is_split_into_words, pad_to_multiple_of, padding_side, return_tensors, return_token_type_ids, return_attention_mask, return_overflowing_tokens, return_special_tokens_mask, return_offsets_mapping, return_length, verbose, **kwargs)\u001B[0m\n\u001B[1;32m   2885\u001B[0m     \u001B[38;5;28;01mif\u001B[39;00m \u001B[38;5;129;01mnot\u001B[39;00m \u001B[38;5;28mself\u001B[39m\u001B[38;5;241m.\u001B[39m_in_target_context_manager:\n\u001B[1;32m   2886\u001B[0m         \u001B[38;5;28mself\u001B[39m\u001B[38;5;241m.\u001B[39m_switch_to_input_mode()\n\u001B[0;32m-> 2887\u001B[0m     encodings \u001B[38;5;241m=\u001B[39m \u001B[38;5;28;43mself\u001B[39;49m\u001B[38;5;241;43m.\u001B[39;49m\u001B[43m_call_one\u001B[49m\u001B[43m(\u001B[49m\u001B[43mtext\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mtext\u001B[49m\u001B[43m,\u001B[49m\u001B[43m \u001B[49m\u001B[43mtext_pair\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mtext_pair\u001B[49m\u001B[43m,\u001B[49m\u001B[43m \u001B[49m\u001B[38;5;241;43m*\u001B[39;49m\u001B[38;5;241;43m*\u001B[39;49m\u001B[43mall_kwargs\u001B[49m\u001B[43m)\u001B[49m\n\u001B[1;32m   2888\u001B[0m \u001B[38;5;28;01mif\u001B[39;00m text_target \u001B[38;5;129;01mis\u001B[39;00m \u001B[38;5;129;01mnot\u001B[39;00m \u001B[38;5;28;01mNone\u001B[39;00m:\n\u001B[1;32m   2889\u001B[0m     \u001B[38;5;28mself\u001B[39m\u001B[38;5;241m.\u001B[39m_switch_to_target_mode()\n",
      "File \u001B[0;32m~/miniconda3/envs/faiss39/lib/python3.9/site-packages/transformers/tokenization_utils_base.py:2997\u001B[0m, in \u001B[0;36mPreTrainedTokenizerBase._call_one\u001B[0;34m(self, text, text_pair, add_special_tokens, padding, truncation, max_length, stride, is_split_into_words, pad_to_multiple_of, padding_side, return_tensors, return_token_type_ids, return_attention_mask, return_overflowing_tokens, return_special_tokens_mask, return_offsets_mapping, return_length, verbose, split_special_tokens, **kwargs)\u001B[0m\n\u001B[1;32m   2975\u001B[0m     \u001B[38;5;28;01mreturn\u001B[39;00m \u001B[38;5;28mself\u001B[39m\u001B[38;5;241m.\u001B[39mbatch_encode_plus(\n\u001B[1;32m   2976\u001B[0m         batch_text_or_text_pairs\u001B[38;5;241m=\u001B[39mbatch_text_or_text_pairs,\n\u001B[1;32m   2977\u001B[0m         add_special_tokens\u001B[38;5;241m=\u001B[39madd_special_tokens,\n\u001B[0;32m   (...)\u001B[0m\n\u001B[1;32m   2994\u001B[0m         \u001B[38;5;241m*\u001B[39m\u001B[38;5;241m*\u001B[39mkwargs,\n\u001B[1;32m   2995\u001B[0m     )\n\u001B[1;32m   2996\u001B[0m \u001B[38;5;28;01melse\u001B[39;00m:\n\u001B[0;32m-> 2997\u001B[0m     \u001B[38;5;28;01mreturn\u001B[39;00m \u001B[38;5;28;43mself\u001B[39;49m\u001B[38;5;241;43m.\u001B[39;49m\u001B[43mencode_plus\u001B[49m\u001B[43m(\u001B[49m\n\u001B[1;32m   2998\u001B[0m \u001B[43m        \u001B[49m\u001B[43mtext\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mtext\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m   2999\u001B[0m \u001B[43m        \u001B[49m\u001B[43mtext_pair\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mtext_pair\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m   3000\u001B[0m \u001B[43m        \u001B[49m\u001B[43madd_special_tokens\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43madd_special_tokens\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m   3001\u001B[0m \u001B[43m        \u001B[49m\u001B[43mpadding\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mpadding\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m   3002\u001B[0m \u001B[43m        \u001B[49m\u001B[43mtruncation\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mtruncation\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m   3003\u001B[0m \u001B[43m        \u001B[49m\u001B[43mmax_length\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mmax_length\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m   3004\u001B[0m \u001B[43m        \u001B[49m\u001B[43mstride\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mstride\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m   3005\u001B[0m \u001B[43m        \u001B[49m\u001B[43mis_split_into_words\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mis_split_into_words\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m   3006\u001B[0m \u001B[43m        \u001B[49m\u001B[43mpad_to_multiple_of\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mpad_to_multiple_of\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m   3007\u001B[0m \u001B[43m        \u001B[49m\u001B[43mpadding_side\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mpadding_side\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m   3008\u001B[0m \u001B[43m        \u001B[49m\u001B[43mreturn_tensors\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mreturn_tensors\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m   3009\u001B[0m \u001B[43m        \u001B[49m\u001B[43mreturn_token_type_ids\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mreturn_token_type_ids\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m   3010\u001B[0m \u001B[43m        \u001B[49m\u001B[43mreturn_attention_mask\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mreturn_attention_mask\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m   3011\u001B[0m \u001B[43m        \u001B[49m\u001B[43mreturn_overflowing_tokens\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mreturn_overflowing_tokens\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m   3012\u001B[0m \u001B[43m        \u001B[49m\u001B[43mreturn_special_tokens_mask\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mreturn_special_tokens_mask\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m   3013\u001B[0m \u001B[43m        \u001B[49m\u001B[43mreturn_offsets_mapping\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mreturn_offsets_mapping\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m   3014\u001B[0m \u001B[43m        \u001B[49m\u001B[43mreturn_length\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mreturn_length\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m   3015\u001B[0m \u001B[43m        \u001B[49m\u001B[43mverbose\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mverbose\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m   3016\u001B[0m \u001B[43m        \u001B[49m\u001B[43msplit_special_tokens\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43msplit_special_tokens\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m   3017\u001B[0m \u001B[43m        \u001B[49m\u001B[38;5;241;43m*\u001B[39;49m\u001B[38;5;241;43m*\u001B[39;49m\u001B[43mkwargs\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m   3018\u001B[0m \u001B[43m    \u001B[49m\u001B[43m)\u001B[49m\n",
      "File \u001B[0;32m~/miniconda3/envs/faiss39/lib/python3.9/site-packages/transformers/tokenization_utils_base.py:3073\u001B[0m, in \u001B[0;36mPreTrainedTokenizerBase.encode_plus\u001B[0;34m(self, text, text_pair, add_special_tokens, padding, truncation, max_length, stride, is_split_into_words, pad_to_multiple_of, padding_side, return_tensors, return_token_type_ids, return_attention_mask, return_overflowing_tokens, return_special_tokens_mask, return_offsets_mapping, return_length, verbose, **kwargs)\u001B[0m\n\u001B[1;32m   3063\u001B[0m \u001B[38;5;66;03m# Backward compatibility for 'truncation_strategy', 'pad_to_max_length'\u001B[39;00m\n\u001B[1;32m   3064\u001B[0m padding_strategy, truncation_strategy, max_length, kwargs \u001B[38;5;241m=\u001B[39m \u001B[38;5;28mself\u001B[39m\u001B[38;5;241m.\u001B[39m_get_padding_truncation_strategies(\n\u001B[1;32m   3065\u001B[0m     padding\u001B[38;5;241m=\u001B[39mpadding,\n\u001B[1;32m   3066\u001B[0m     truncation\u001B[38;5;241m=\u001B[39mtruncation,\n\u001B[0;32m   (...)\u001B[0m\n\u001B[1;32m   3070\u001B[0m     \u001B[38;5;241m*\u001B[39m\u001B[38;5;241m*\u001B[39mkwargs,\n\u001B[1;32m   3071\u001B[0m )\n\u001B[0;32m-> 3073\u001B[0m \u001B[38;5;28;01mreturn\u001B[39;00m \u001B[38;5;28;43mself\u001B[39;49m\u001B[38;5;241;43m.\u001B[39;49m\u001B[43m_encode_plus\u001B[49m\u001B[43m(\u001B[49m\n\u001B[1;32m   3074\u001B[0m \u001B[43m    \u001B[49m\u001B[43mtext\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mtext\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m   3075\u001B[0m \u001B[43m    \u001B[49m\u001B[43mtext_pair\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mtext_pair\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m   3076\u001B[0m \u001B[43m    \u001B[49m\u001B[43madd_special_tokens\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43madd_special_tokens\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m   3077\u001B[0m \u001B[43m    \u001B[49m\u001B[43mpadding_strategy\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mpadding_strategy\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m   3078\u001B[0m \u001B[43m    \u001B[49m\u001B[43mtruncation_strategy\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mtruncation_strategy\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m   3079\u001B[0m \u001B[43m    \u001B[49m\u001B[43mmax_length\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mmax_length\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m   3080\u001B[0m \u001B[43m    \u001B[49m\u001B[43mstride\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mstride\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m   3081\u001B[0m \u001B[43m    \u001B[49m\u001B[43mis_split_into_words\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mis_split_into_words\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m   3082\u001B[0m \u001B[43m    \u001B[49m\u001B[43mpad_to_multiple_of\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mpad_to_multiple_of\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m   3083\u001B[0m \u001B[43m    \u001B[49m\u001B[43mpadding_side\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mpadding_side\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m   3084\u001B[0m \u001B[43m    \u001B[49m\u001B[43mreturn_tensors\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mreturn_tensors\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m   3085\u001B[0m \u001B[43m    \u001B[49m\u001B[43mreturn_token_type_ids\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mreturn_token_type_ids\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m   3086\u001B[0m \u001B[43m    \u001B[49m\u001B[43mreturn_attention_mask\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mreturn_attention_mask\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m   3087\u001B[0m \u001B[43m    \u001B[49m\u001B[43mreturn_overflowing_tokens\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mreturn_overflowing_tokens\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m   3088\u001B[0m \u001B[43m    \u001B[49m\u001B[43mreturn_special_tokens_mask\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mreturn_special_tokens_mask\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m   3089\u001B[0m \u001B[43m    \u001B[49m\u001B[43mreturn_offsets_mapping\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mreturn_offsets_mapping\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m   3090\u001B[0m \u001B[43m    \u001B[49m\u001B[43mreturn_length\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mreturn_length\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m   3091\u001B[0m \u001B[43m    \u001B[49m\u001B[43mverbose\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mverbose\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m   3092\u001B[0m \u001B[43m    \u001B[49m\u001B[43msplit_special_tokens\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mkwargs\u001B[49m\u001B[38;5;241;43m.\u001B[39;49m\u001B[43mpop\u001B[49m\u001B[43m(\u001B[49m\u001B[38;5;124;43m\"\u001B[39;49m\u001B[38;5;124;43msplit_special_tokens\u001B[39;49m\u001B[38;5;124;43m\"\u001B[39;49m\u001B[43m,\u001B[49m\u001B[43m \u001B[49m\u001B[38;5;28;43mself\u001B[39;49m\u001B[38;5;241;43m.\u001B[39;49m\u001B[43msplit_special_tokens\u001B[49m\u001B[43m)\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m   3093\u001B[0m \u001B[43m    \u001B[49m\u001B[38;5;241;43m*\u001B[39;49m\u001B[38;5;241;43m*\u001B[39;49m\u001B[43mkwargs\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m   3094\u001B[0m \u001B[43m\u001B[49m\u001B[43m)\u001B[49m\n",
      "File \u001B[0;32m~/miniconda3/envs/faiss39/lib/python3.9/site-packages/transformers/tokenization_utils_fast.py:613\u001B[0m, in \u001B[0;36mPreTrainedTokenizerFast._encode_plus\u001B[0;34m(self, text, text_pair, add_special_tokens, padding_strategy, truncation_strategy, max_length, stride, is_split_into_words, pad_to_multiple_of, padding_side, return_tensors, return_token_type_ids, return_attention_mask, return_overflowing_tokens, return_special_tokens_mask, return_offsets_mapping, return_length, verbose, split_special_tokens, **kwargs)\u001B[0m\n\u001B[1;32m    589\u001B[0m \u001B[38;5;28;01mdef\u001B[39;00m\u001B[38;5;250m \u001B[39m\u001B[38;5;21m_encode_plus\u001B[39m(\n\u001B[1;32m    590\u001B[0m     \u001B[38;5;28mself\u001B[39m,\n\u001B[1;32m    591\u001B[0m     text: Union[TextInput, PreTokenizedInput],\n\u001B[0;32m   (...)\u001B[0m\n\u001B[1;32m    610\u001B[0m     \u001B[38;5;241m*\u001B[39m\u001B[38;5;241m*\u001B[39mkwargs,\n\u001B[1;32m    611\u001B[0m ) \u001B[38;5;241m-\u001B[39m\u001B[38;5;241m>\u001B[39m BatchEncoding:\n\u001B[1;32m    612\u001B[0m     batched_input \u001B[38;5;241m=\u001B[39m [(text, text_pair)] \u001B[38;5;28;01mif\u001B[39;00m text_pair \u001B[38;5;28;01melse\u001B[39;00m [text]\n\u001B[0;32m--> 613\u001B[0m     batched_output \u001B[38;5;241m=\u001B[39m \u001B[38;5;28;43mself\u001B[39;49m\u001B[38;5;241;43m.\u001B[39;49m\u001B[43m_batch_encode_plus\u001B[49m\u001B[43m(\u001B[49m\n\u001B[1;32m    614\u001B[0m \u001B[43m        \u001B[49m\u001B[43mbatched_input\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m    615\u001B[0m \u001B[43m        \u001B[49m\u001B[43mis_split_into_words\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mis_split_into_words\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m    616\u001B[0m \u001B[43m        \u001B[49m\u001B[43madd_special_tokens\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43madd_special_tokens\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m    617\u001B[0m \u001B[43m        \u001B[49m\u001B[43mpadding_strategy\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mpadding_strategy\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m    618\u001B[0m \u001B[43m        \u001B[49m\u001B[43mtruncation_strategy\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mtruncation_strategy\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m    619\u001B[0m \u001B[43m        \u001B[49m\u001B[43mmax_length\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mmax_length\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m    620\u001B[0m \u001B[43m        \u001B[49m\u001B[43mstride\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mstride\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m    621\u001B[0m \u001B[43m        \u001B[49m\u001B[43mpad_to_multiple_of\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mpad_to_multiple_of\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m    622\u001B[0m \u001B[43m        \u001B[49m\u001B[43mpadding_side\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mpadding_side\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m    623\u001B[0m \u001B[43m        \u001B[49m\u001B[43mreturn_tensors\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mreturn_tensors\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m    624\u001B[0m \u001B[43m        \u001B[49m\u001B[43mreturn_token_type_ids\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mreturn_token_type_ids\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m    625\u001B[0m \u001B[43m        \u001B[49m\u001B[43mreturn_attention_mask\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mreturn_attention_mask\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m    626\u001B[0m \u001B[43m        \u001B[49m\u001B[43mreturn_overflowing_tokens\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mreturn_overflowing_tokens\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m    627\u001B[0m \u001B[43m        \u001B[49m\u001B[43mreturn_special_tokens_mask\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mreturn_special_tokens_mask\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m    628\u001B[0m \u001B[43m        \u001B[49m\u001B[43mreturn_offsets_mapping\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mreturn_offsets_mapping\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m    629\u001B[0m \u001B[43m        \u001B[49m\u001B[43mreturn_length\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mreturn_length\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m    630\u001B[0m \u001B[43m        \u001B[49m\u001B[43mverbose\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mverbose\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m    631\u001B[0m \u001B[43m        \u001B[49m\u001B[43msplit_special_tokens\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43msplit_special_tokens\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m    632\u001B[0m \u001B[43m        \u001B[49m\u001B[38;5;241;43m*\u001B[39;49m\u001B[38;5;241;43m*\u001B[39;49m\u001B[43mkwargs\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m    633\u001B[0m \u001B[43m    \u001B[49m\u001B[43m)\u001B[49m\n\u001B[1;32m    635\u001B[0m     \u001B[38;5;66;03m# Return tensor is None, then we can remove the leading batch axis\u001B[39;00m\n\u001B[1;32m    636\u001B[0m     \u001B[38;5;66;03m# Overflowing tokens are returned as a batch of output so we keep them in this case\u001B[39;00m\n\u001B[1;32m    637\u001B[0m     \u001B[38;5;28;01mif\u001B[39;00m return_tensors \u001B[38;5;129;01mis\u001B[39;00m \u001B[38;5;28;01mNone\u001B[39;00m \u001B[38;5;129;01mand\u001B[39;00m \u001B[38;5;129;01mnot\u001B[39;00m return_overflowing_tokens:\n",
      "File \u001B[0;32m~/miniconda3/envs/faiss39/lib/python3.9/site-packages/transformers/tokenization_utils_fast.py:539\u001B[0m, in \u001B[0;36mPreTrainedTokenizerFast._batch_encode_plus\u001B[0;34m(self, batch_text_or_text_pairs, add_special_tokens, padding_strategy, truncation_strategy, max_length, stride, is_split_into_words, pad_to_multiple_of, padding_side, return_tensors, return_token_type_ids, return_attention_mask, return_overflowing_tokens, return_special_tokens_mask, return_offsets_mapping, return_length, verbose, split_special_tokens)\u001B[0m\n\u001B[1;32m    536\u001B[0m \u001B[38;5;28;01mif\u001B[39;00m \u001B[38;5;28mself\u001B[39m\u001B[38;5;241m.\u001B[39m_tokenizer\u001B[38;5;241m.\u001B[39mencode_special_tokens \u001B[38;5;241m!=\u001B[39m split_special_tokens:\n\u001B[1;32m    537\u001B[0m     \u001B[38;5;28mself\u001B[39m\u001B[38;5;241m.\u001B[39m_tokenizer\u001B[38;5;241m.\u001B[39mencode_special_tokens \u001B[38;5;241m=\u001B[39m split_special_tokens\n\u001B[0;32m--> 539\u001B[0m encodings \u001B[38;5;241m=\u001B[39m \u001B[38;5;28;43mself\u001B[39;49m\u001B[38;5;241;43m.\u001B[39;49m\u001B[43m_tokenizer\u001B[49m\u001B[38;5;241;43m.\u001B[39;49m\u001B[43mencode_batch\u001B[49m\u001B[43m(\u001B[49m\n\u001B[1;32m    540\u001B[0m \u001B[43m    \u001B[49m\u001B[43mbatch_text_or_text_pairs\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m    541\u001B[0m \u001B[43m    \u001B[49m\u001B[43madd_special_tokens\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43madd_special_tokens\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m    542\u001B[0m \u001B[43m    \u001B[49m\u001B[43mis_pretokenized\u001B[49m\u001B[38;5;241;43m=\u001B[39;49m\u001B[43mis_split_into_words\u001B[49m\u001B[43m,\u001B[49m\n\u001B[1;32m    543\u001B[0m \u001B[43m\u001B[49m\u001B[43m)\u001B[49m\n\u001B[1;32m    545\u001B[0m \u001B[38;5;66;03m# Convert encoding to dict\u001B[39;00m\n\u001B[1;32m    546\u001B[0m \u001B[38;5;66;03m# `Tokens` has type: Tuple[\u001B[39;00m\n\u001B[1;32m    547\u001B[0m \u001B[38;5;66;03m#                       List[Dict[str, List[List[int]]]] or List[Dict[str, 2D-Tensor]],\u001B[39;00m\n\u001B[1;32m    548\u001B[0m \u001B[38;5;66;03m#                       List[EncodingFast]\u001B[39;00m\n\u001B[1;32m    549\u001B[0m \u001B[38;5;66;03m#                    ]\u001B[39;00m\n\u001B[1;32m    550\u001B[0m \u001B[38;5;66;03m# with nested dimensions corresponding to batch, overflows, sequence length\u001B[39;00m\n\u001B[1;32m    551\u001B[0m tokens_and_encodings \u001B[38;5;241m=\u001B[39m [\n\u001B[1;32m    552\u001B[0m     \u001B[38;5;28mself\u001B[39m\u001B[38;5;241m.\u001B[39m_convert_encoding(\n\u001B[1;32m    553\u001B[0m         encoding\u001B[38;5;241m=\u001B[39mencoding,\n\u001B[0;32m   (...)\u001B[0m\n\u001B[1;32m    562\u001B[0m     \u001B[38;5;28;01mfor\u001B[39;00m encoding \u001B[38;5;129;01min\u001B[39;00m encodings\n\u001B[1;32m    563\u001B[0m ]\n",
      "\u001B[0;31mKeyboardInterrupt\u001B[0m: "
     ]
    }
   ],
   "execution_count": 17
  },
  {
   "metadata": {},
   "cell_type": "code",
   "outputs": [],
   "execution_count": null,
   "source": "",
   "id": "60a14377e38e0845"
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 2
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython2",
   "version": "2.7.6"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
